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Abstract 
PAUL L. WALSH: Advancing Electroanalytical Methods for Monitoring Chemical Messenger 
Release  
(Under the direction of Dr. R. Mark Wightman) 
 
 Chemical communication between cells within the body has been long recognized as an 
integral part of understanding how the human body functions, especially within the central and 
peripheral nervous system.  Electrochemistry at microelectrodes in tissue slices extracted from 
the body has become a method of choice for probing the release, reuptake, and overall function 
of chemical messengers.  Here, fast-scan cyclic voltammetry (FSCV) and constant potential 
amperometry at carbon-fiber microelectrodes is used in various different types of tissues such 
as the adrenal gland and the spinal cord in order to detect and quantify the release of various 
chemical messengers including epinephrine, norepinephrine, and adenosine.  Pharmacological 
manipulation of these signals allows for further analysis of the origins of these signals as well as 
their overall function in integral bodily functions.  Work performed on the adrenal gland gave 
new insight into the exocytotic release characteristics of the hormones epinephrine and 
norepinephrine which had never been carried out in intact tissue.  Also, extensive studies on the 
methods used to probe the release of these hormones were performed, and allowed for the 
distinction of electrical stimulation of two different cell types, both the neurons which innervate 
the tissue, and the chromaffin cells which release the neuromodulators detected with this 
technology.  Moving the detection of adenosine by FSCV into lamina II of the spinal cord 
allowed for determination of enzymatic activity of ectonucleotidases.  Furthermore, it provided 
new proof of adenosine as an antinociceptive neurotransmitter, and gave evidence for an 
adenosinergic tone in these circuits with the first ever detection of adenosine transients 
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anywhere in the nervous system.  Also, total tissue analysis of various brain regions by high 
performance liquid chromatography (HPLC) is used to determine fundamental difference or 
similarities in different strains of animals, animals which have been genetically altered, or 
animals which have been treated with drugs.  Finally, the coating of Ag/AgCl reference 
electrodes with Nafion for chronic implantation is discussed.  These studies use fundamental 
analytical tools to advance our understanding of the nervous system, and shows new methods 
of answering long standing biological questions. 
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Chapter I 
Probing Synaptic Mechanisms in Tissue Slices with Electrochemistry 
Introduction 
 Electrochemistry at carbon-fiber microelectrodes has been recognized as a useful 
tool for studying electroactive neurotransmitters in living tissue since it was first 
demonstrated by Ralph Adams in the 1970s (Gonon et al., 1978).  Carbon-fiber 
microelectrodes are widely used for these kinds of studies due to their large potential 
window, their favorable surface properties for analyzing biogenic amines, excellent 
sensitivity, and low noise.  Furthermore, the small size of carbon-fiber microelectrodes 
provides excellent spatial resolution when implanted into tissue, as well as small, stable 
background currents when using fast scan rates during voltammetric studies.  Additionally, 
the small size of the carbon-fiber results in little to no tissue damage compared to other 
methods for measuring neurotransmitters like microdialysis (Jaquins-Gerstl and Michael, 
2009).  While electrochemistry gives a wealth of information when it is used in whole animal 
studies, the use of electrochemistry at the single cell level as well as in tissue slices has 
profound implications for looking at the mechanisms involved in the release and uptake of 
neurotransmitters at the synaptic level. 
 Previous reviews have covered the use of electrochemical methods, especially fast-
scan cyclic voltammetry for the detection of electroactive neurotransmitters in whole animal 
studies including freely moving animals, and individual cells for the study of vesicular events 
(Travis and Wightman, 1998, Robinson et al., 2008, Kim et al., 2011).  In this chapter, the 
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various methods for neurotransmitter release and production will be discussed, as well as 
the various electrochemical methods used at microelectrodes to detect and quantify these 
chemical messengers.  The focus will include the use of these electrochemical methods in 
tissue slices from various parts of the central and peripheral nervous system including the 
brain, spinal cord, and adrenal gland.  There are many advantages to using tissue slice 
preparations including the ability to visualize the tissue underneath a microscope ensuring 
accurate and precise placement of the sensor, and localized and acute stimulation of the 
tissue being studied which allows for synapses close to the electrode to be studied.  Also, 
when making tissue slices all inputs and outputs are severed, allowing for pharmacological 
manipulation of the specific region being studied without interference from afferent brain 
regions.  Finally, applications of these methods for the study of synaptic mechanisms and 
transgenic disease state animal models for the quantification of neurotransmitter release will 
be covered. 
Chemical Messenger Release and Production in Tissue Slices 
Exocytosis 
 Katz first discovered the quantization of neurotransmitters at the neuromuscular 
junction in the 1950s (del Castillo and Katz, 1954).  Exocytosis is the process by which 
individual vesicles, packets of chemical messengers, are released by a cell into the 
extracellular space.  Figure 1.1 is a diagram which shows the various major steps of the 
exocytotic process.  Catecholaminergic vesicles are packaged with neurotransmitters via 
active transport through the vesicular transporter coupled to a proton pump which allows the 
neurotransmitter to be loaded into the vesicle against its electrochemical gradient (Chaudhry 
et al., 2008).  The vesicle is then segregated into different pools near the cell membrane 
including the readily (or immediately) releasable pool, the slowly releasable pool, both of  
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Figure 1.1.  The synaptic vesicle cycle.  Red arrows indicate steps in exocytosis while 
yellow arrows are steps in endocytosis.  Synaptic vesicles are loaded with neurotransmitter 
via active transport (1).  Vesicles are then mobilized into different pools (2), and eventually 
docked at the plasma membrane (3).  Following the priming step in the active zone (4), the 
fusion pore is formed and the contents released into the extracellular space upon activation 
by intacellular Ca2+ (5).  Vesicles can be recycled in a number of ways including local reuse 
(6), fast recycling without an endosomal intermediate (7), and clathrin mediated endocytosis 
with or without an endosomal intermediate (8-9) (Sudhof, 2004). 
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which are docked near the cell membrane, or, the unprimed pool which is near the cell 
membrane but has yet to be docked, and the depot (or reserve) pool which is not near the 
cell membrane and where the vesicles are loaded with neurotransmitter (Becherer and 
Rettig, 2006).  Through a series of ATP-dependent active processes involving many 
different proteins located on both the vesicle’s membrane as well as the cell membrane, the 
vesicle is recruited, tethered, and docked in the active zone near the presynaptic membrane 
(Sudhof, 2004).  After a final priming step, the vesicle is then ready for a calcium dependent 
fusion with the cell membrane.  As the cell membrane depolarizes, voltage gated calcium 
channels (VGCCs) open allowing calcium to rush into the cell along its electrochemical 
gradient.  There are many different kinds of VGCCs, and the type and distribution of VGCCs 
a cell contains varies from cell type to cell type.  The P/Q type calcium channels, however, 
have been shown to be functionally coupled to exocytosis (Alvarez et al., 2008).  The 
calcium entering the cell can bind proteins including synaptotagmin, the main calcium 
sensor on the vesicular membrane (Xu et al., 2007).  The coupling of the vesicle to the cell 
membrane causes a fusion pore to be formed, and the contents of the vesicle are secreted 
into the extracellular space.  After fusion, the vesicle can then be recycled if the vesicle was 
not fully incorporated with the cell membrane.  Otherwise, a new vesicle must be formed 
from the cell membrane via a process known as endocytosis.   
Non-Classical Transmission 
 While neurotransmitters, whether packaged into vesicles or not, are often produced 
via an enzymatic process, some chemical messengers are made intracellularly or 
extracellularly and diffuse to their point of action.  One prominent example of this is the 
neuromodulator nitric oxide.  Nitric oxide is a reactive free radical which because of its small 
size is able to diffuse across cell membranes and is implicated in various functions in the 
brain including recovery from ischemia, vasodilation, and synaptic plasticity during the 
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formation of memory (Garthwaite and Boulton, 1995, Beckman et al., 1996).  Nitric oxide is 
produced from arginine in the presence of various nitric oxide synthases (NOS), including 
endothelial nitric oxide synthase (eNOS), neuronal nitric oxide synthase (nNOS), and 
inducted nitric oxide synthase (iNOS).  The production of nitric oxide takes place inside post-
synaptic cells during activation of NOS by calcium calmodulin after influx of calcium through 
VGCCs (Ledo et al., 2004).  Typically, depolarization of the cell is achieved when glutamate 
binds to NMDA or AMPA receptors, or acetylcholine binds to nicotinic acetylcholine 
receptors (Garthwaite and Boulton, 1995, Smith et al., 1998). 
Another example of a chemical messenger which is produced via an enzymatic 
process is the nucleoside adenosine.  Ectonucleotidases are enzymes which hydrolyze the 
nucleotides adenosine triphosphase (ATP), adenosine diphosphate (ADP), and adenosine 
monophosphate (AMP), and are found throughout the nervous system (Langer et al., 2008, 
Zimmermann, 2008).  There are numerous different isoforms of ectonucleotidases which are 
present both extracellularly and intracellularly which hydrolyze the nucleotides.  The 
enzymes prostatic acid phosphatase (PAP) and ecto-5’-nucleotidase (CD73, NT5E) are 
membrane-bound enzymes which hydrolyze AMP to adenosine in the extracellular space 
(Zylka et al., 2008, Sowa et al., 2010, Zylka, 2011).  This is of special importance in lamina II 
of the spinal cord, where inputs from dorsal root ganglia (DRG) neurons transmit nociceptive 
information through purinergic signaling.  It has been shown that the hydrolysis of AMP into 
adenosine by PAP and NT5E has strong antinociceptive effects by binding to the adenosine 
A1 receptor, a Gi coupled receptor, counteracting the signaling produced by ATP (Zylka et 
al., 2008, Sowa et al., 2010).  ATP can be released vesicularly (Pankratov et al., 2006, 
Sawada et al., 2008), from voltage-activated anion channels (Fields and Ni, 2010), or from 
hemichannels (Kang et al., 2008).  It remains to be seen whether adenosine can be 
packaged into vesicles or released from other membrane bound transporters (Latini and 
Pedata, 2001), and this gives an example of where neuromodulators are produced in the  
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Figure 1.2.  Ectonucleotidase function in spinal nociceptive circuits.  ATP can be released 
from neurons or glia via exocytosis, through volume activated anion channels (VAACs), or 
through hemichannels.  ATP is then hydrolyzed by various ectonucleotidases to AMP which 
can be further hydrolyzed to AMP by prostatic acid phosphatase (PAP) and ecto-5’-
ectonucleotidase (CD73, NT5E).  Adenosine then binds downstream to A1 receptors and 
propagates the antinociceptive signal (Zylka, 2011). 
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extracellular space and subsequently bind to their post-synaptic receptors.  Figure 1.2 
shows the production of adenosine from ectonucleotidases in spinal nociceptive circuits.     
Tissue Slices for Studying Chemical Messengers 
 There are a number of different tissues which can be isolated from the rest of the 
body and sliced into thin sections for experiments involving the electrochemical study of the 
release of neurotransmitters.  The first and most obvious example is the brain.  Brain slices 
are a robust and simple preparation for studying various compartments of the brain with 
either electrochemistry or electrophysiology (Kelly and Wightman, 1987, Stefani et al., 
1995).  Using a reference atlas such as the Allen Brain Atlas, the sensor can be placed into 
a specific region of interest in a slice taken sagittally (from the side), coronally (from rostral 
to caudal), or horizontally (from dorsal to ventral) (Science, 2009).  The type of slice taken 
can be dictated by the desired experiment.  If an intact pathway is needed, then a horizontal 
or sagittal slice can be taken (in some cases), while coronal slices are ideal for studying the 
terminal region of a pathway in regions such as the striatum.  Upon removal from the rest of 
the brain, the slice can be maintained under physiological conditions by perfusing the slice 
with a buffer containing all the extracellular ions and glucose necessary for normal cellular 
function.  Figure 1.3A shows a coronal brain slice of the striatum where electrochemical 
recording of dopaminergic terminals can be performed in the dorsolateral striatum and 
nucleus accumbens.  In order to achieve neurotransmitter release as measured by 
electrochemistry, electrical stimulation between the two prongs of a bipolar stimulating 
electrode is performed.  Different properties of the stimulation can be fine-tuned for the 
region of interest including the intensity of the stimulation, the duration of the stimulation, the 
number of pulses applied, and the frequency of the stimulation. 
 More recently, a preparation for the slicing of murine (mouse and rat) adrenal glands 
has been developed for the study of the chromaffin cells located in the adrenal medulla  
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Figure 1.3.  Tissue slices for the measurement of chemical messengers with 
electrochemistry.  (A) A coronal brain slice showing the striatum containing dopaminergic 
terminals (CP, caudate putamen, or dorsolateral striatum; ACB, nucleus accumbens) 
(Science, 2009).  (B) A mouse adrenal gland is shown in the left panel (arrow) with a nickel 
for scale.  The slicing of the adrenal gland shown in the right panel reveals the outer cortex 
and the inner medulla, where the chromaffin cells which release epinephrine and 
norepinephrine are contained (Barbara et al., 1998).  (C) A coronal slice of the spinal cord 
with a map shown in the left panel and a spinal slice in the right panel.  The dorsal horn 
contains lamina, labeled 1Sp through 4Sp.  The dorsal root (dr) innervates the dorsal horn 
with signals from afferent neurons (Science, 2009). 
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(Barbara et al., 1998).  Electrophysiological recordings from the chromaffin cells which 
release the hormones epinephrine and norepinephrine have been conducted in these slice 
preparations for the study of exocytosis of these chemical messengers (Moser and Neher, 
1997, Voets et al., 1999).  While brain slice preparations allow for the simplification of 
experiments by severing the inputs and outputs of the region of interest, adrenal slice 
preparations create a more physiologically relevant measurement of the physiology of the 
chromaffin cells to be performed compared to isolated chromaffin cells (Neher and Marty, 
1982).  Slices maintain the splanchnic nerves which innervate the gland and form synapses 
onto the chromaffin cells as well as the vasculature to which the released hormones 
epinephrine and norepinephrine can migrate (Kikuta and Murakami, 1984, Kobayashi and 
Coupland, 1993).  Figure 1.3B shows a picture of a mouse adrenal gland as well as a 
cartoon showing the methods by which the adrenal gland is sliced, and a diagram outlining 
the inner medulla containing the chromaffin cells and the outer cortex.  Due to the small size 
of the adrenal gland, slicing is aided by placing the gland inside agarose to hold it in place 
before orienting it beneath the slicing blade (Barbara et al., 1998). 
 The spinal cord is also an integral part of the central nervous system which sends 
signals between the brain and the peripheral nervous system through the dorsal root ganglia 
which input into the dorsal horn of the spinal cord.  Both serotonin and adenosine are known 
electroactive neurotransmitters released and produced in the spinal cord (Rivot et al., 1995, 
Zylka, 2011).  Just like the brain, the spinal cord can be slices in various orientations.  The 
most common orientation is a coronal slice.  Figure 1.3C shows a map of a coronal cross 
section of the spinal cord as well as a picture of a coronal slice of the spinal cord including 
the dorsal root. 
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Figure 1.4.  SEM images of carbon-fiber microelectrodes.  A) Cylindrical T-650 carbon-fiber 
microelectrode ~25 µm long.  B) Disk T-650 carbon-fiber microelectrode beveled at 30°.  
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Electrochemical Methods for Measuring Chemical Messengers 
 The carbon-fiber microelectrode is widely accepted as the sensor with the best 
spatial resolution for probing small brain regions in which neurotransmitters detected 
electrochemically are released.  Fabrication of these electrodes has been previously 
described (Cahill et al., 1996).  Carbon-fiber electrodes can be used in two basic 
geometries. Cylindrical electrodes typically have higher sensitivity to detected 
neurotransmitters because of their larger surface area as the carbon-fiber protrudes from 
the glass seal 25-150 µm depending on the application.  For slices, lengths of 25-50 µm are 
typically used.  Polished disk electrodes which have a flat carbon surface exposed at the tip 
of the glass seal are typically used in single cell experiments, or in slices where the 
electrode can sit flush on top of cell which release chemical messengers, such as the 
adrenal gland (Arroyo et al., 2006).  Figure 1.4 shows SEM images of the two kinds of 
carbon-fiber microelectrodes.  There are numerous chemical and physical modifications 
which can be used to increase the sensitivity or selectivity of the electrode.  One of the most 
common modifications performed on carbon- fiber microelectrodes is the coating of Nafion, 
a cation exchange polymer, onto the surface.  Nafion allows for the preconcentration of 
cationic analytes such as dopamine, norepinephrine and serotonin, while excluding 
negatively charged interfering species such as ascorbic acid, uric acid, and the dopamine 
metabolite 3,4-dihydroxyphenylacetic acid (DOPAC) (Brazell et al., 1987).  One 
disadvantage of chemical and physical manipulations of carbon-fiber microelectrodes such 
as coating the electrode with Nafion is the increase in the time response of the electrode 
from the partition of species into the film and the diffusion of the species through the film to 
the electrode. 
 12 
Constant Potential Amperometry 
 One of the instrumentally simple electrochemical methods for detecting released 
neurotransmitters in tissue slices is constant potential amperometry.  During recordings, the 
electrode is held at a constant potential sufficient to completely oxidize the neurotransmitter 
when it comes into contact with the electrode, typically 650-750 mV for biogenic amines.  
The main disadvantage of using this method is the lack of chemical resolution.  Any species 
which can be oxidized at the applied potential will cause the flow of current.  Therefore, 
there is no way to tell exactly which neurotransmitter is causing the observed signal.  While 
exogenous neurotransmitter can be injected into tissue to circumvent this issue (Gerhardt et 
al., 1999), less information can be obtained from these measurements because the 
concentration of neurotransmitter achieved during ejection are non-physiological, and the 
data is difficult to interpret due to the long time course of the measurements made.  
 Increasing chemical resolution during amperometric detection is obtainable through 
the chemical modifications discussed above.  As an example, nitric oxide is a highly reactive 
gaseous free radical neuromodulator which plays a key role in many brain functions 
including recovery during brain ischemia as well as learning and memory in the 
hippocampus (Gally et al., 1990, Garthwaite and Boulton, 1995, Bishop and Anderson, 
2005).  Carbon-fiber microelectrodes have been modified using a Nafion coating to prevent 
interference from species like ascorbic acid, and an electropolymerized layer of o-
phenylenediamine, making them less sensitive to catecholamines while still allowing the 
smaller gaseous species to diffuse to the electrode (Friedemann et al., 1996).  These 
electrodes have limits of detection in the nanomolar range for nitric oxide, and have been 
used to detect nitric oxide production in hippocampal brain slices upon stimulation with 
exogenous stimulants including N-methyl-D-aspartic acid (NMDA) receptor agonist such as 
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glutamate and NMDA, or cholinergic receptor agonists such as nicotine (Smith et al., 1998, 
Ferreira et al., 2005).   
Although amperometric detection is not always ideal because specific chemical 
identification is not possible in tissue slices, there are times when amperometry can be used 
to study release events that occur on very fast time scales.  Exocytotic release occurs on the 
order of millisecond time scales, and constant potential amperometry at carbon-fiber 
microelectrodes has been shown to be an excellent way of studying the temporal dynamics 
of the various stages of exocytosis at single cells by directly oxidizing the contents of 
vesicles as they are released from the cell through the fusion pore (Wightman et al., 1991, 
Jankowski et al., 1992, Travis and Wightman, 1998, Wightman and Haynes, 2004).  When 
making these measurements, there are a number of different properties of the amperometric 
spikes which can be analyzed and give information about the neurotransmitter being 
released.  These properties include the total number of spikes observed upon stimulation, 
the interspike interval, the width at half height of the spike, and the total charge underneath 
the spike which is related to the number of moles released by Faraday’s Law (Bard and 
Faulkner, 2001):  
Q=nFm 
where Q is the total charge (in coulombs), n is the number of electrons transferred during 
the oxidation, F is Faraday’s constant (96,500 coulombs/mole), and m is the number of 
moles.  Additionally, pre-spike features of the exocytotic event can be observed including 
the presence of a pre-spike foot.  Pre-spike feet are present on a fraction of the events 
observed and are attributed to the leak of transmitter through the fusion pore intermediate 
before full fusion (Chow et al., 1992). 
More recently, constant potential amperometry has been used to study exocytosis 
from chromaffin cells in intact adrenal slice preparations.  Figure 1.5 shows an example of 
amperometric spikes detected in an adrenal slice upon electrical stimulation as well as an  
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Figure 1.5.  Amperometric detection of exocytosis from an adrenal slice.  A) Representative 
amperometric spikes after an electrical pulse (the artifact from the pulse denoted by #).  B) A 
single amperometric spike from (A) (denoted by the asterisk) showing the spike 
characteristics of width at half height (horizontal bar, t1/2) and the charge underneath the 
spike (shaded gray, Q).  Figure modified from Arroyo et al (Arroyo et al., 2006). 
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individual spike showing the characteristics described above.  Remarkably, using this 
technique, the spike features for the exocytosis of epinephrine and norepinephrine including 
quantal size (charge) and number of spikes upon exposure to a high K+ solution, were 
statistically similar between the intact slice preparation and cultured chromaffin cells while 
others parameters such as the spike half width were statistically different (Arroyo et al., 
2006).  These differences could be due to the location of the electrode and whether or not it 
is able to sit flush with the cell surface in the slice preparation.  Even small distances can 
greatly affect this measured value (Wightman et al., 1995).  Moving this detection scheme 
into slices allowed for the detection of quantal release from chromaffin cells by not only 
application of secretagogues such as a high potassium solution or acetylcholine, but also 
the use of electrical stimulation to excite the cholinergic splanchnic nerves which innervate 
the adrenal gland (Douglas and Rubin, 1961b).   
Fast-Scan Cyclic Voltammetry 
Fast-scan cyclic voltammetry (FSCV) at carbon-fiber microelectrodes has become an 
excellent alternative to constant potential methods due to its higher chemical resolution 
when compared to constant potential methods.  Although traditionally some temporal 
resolution is lost (see Chapter 2), the utilization of faster scan rates still allows for sub-
second measurements of neurotransmitter concentration to be made within tissue.  In 
FSCV, the potential is scanned at high rates allowing for the oxidation and/or reduction of 
the species present at the electrode surface.  This high scan rate causes a large 
background current from the charging of the double-layer.  The background current is 
stable, however, allowing for it to be digitally subtracted from a signal when the electrode is 
in the presence of an analyte.  This background subtraction leads to the characteristic cyclic 
voltammogram (CV) for the analyte of interest.  The peak current for the oxidation of the 
analyte is proportional to the concentration of the analyte according to the equation for  
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Figure 1.6.  Fast-scan cyclic voltammetry data from a brain slice. (A) Brightfield image of a 
coronal brain slice in the dorsolateral striatum with the bipolar tungsten stimulating electrode 
on top of the slice above and the carbon fiber microelectrode inserted into the slice below.  
(B) Color plot of stimulated dopamine release (350 µA, biphasic, 1 pulse), showing time on 
the abscissa, potential on the ordinate, and current shown in false color with green being 
oxidative currents, and blue and black being reductive currents.  (C) A concentration versus 
time plot extracted from the horizontal white line in (B).  (D) The cyclic voltammogram 
extracted from the vertical line shown in (B) showing the characteristic shape for dopamine. 
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adsorbed species and the current change over time can be converted to the change in 
concentration of the neurotransmitter with time from a post-calibration of the electrode.  In 
order to visualize all three of the variables which take place during FSCV measurements 
(potential, time and current), experiments use color plots which show time on the abscissa, 
potential on the ordinate unfolded so for a traditional triangle waveform, the switching 
potential is in the middle, and current shown in false color, where traditionally oxidation 
currents are shown in green and reduction currents are shown in blue and black (Michael et 
al., 1998).  Figure 1.6 shows an example of FSCV data collected in the dorsal striatum of a 
brain slice showing all of the various ways that FSCV data can be displayed with a color 
plot, concentration versus time with the aide of calibration of the electrode in vitro, and the 
cyclic voltammogram for dopamine. 
 The main benefit of FSCV is the chemical resolution that it provides compared to 
amperometry (Robinson et al., 2008).  This allows for the specific identification of the 
neurotransmitter being studied based upon its cyclic voltammogram given the potential limits 
of the waveform being used.  In many cases, the initial potential or the upper limit of the 
waveform is varied to either promote the adsorption of positively charged biogenic amines to  
the surface of the electrode in order to increase the sensitivity of the electrode to the analyte 
(Heien et al., 2003).  While some very similar biogenic amines such as dopamine and 
norepinephrine (which differ solely due to the addition of a hydroxide group on the beta 
carbon) cannot be differentiated using voltammetry, there are a number of neurotransmitters 
that can be distinguished.  Figure 1.7 shows examples of different waveforms which can be 
used to detect various neurotransmitters in tissue samples including dopamine or 
norepinephrine in the striatum or bed nucleus of the stria terminalis (BNST) (Kennedy et al., 
1992a, Miles et al., 2002), norepinephrine and epinephrine in adrenal tissue slices (Petrovic 
et al., 2010), 5-hydroxytryptamine (5-HT, serotonin) in the dorsal raphe nucleus (DRN), the 
substantia nigra reticulata (SNr) (Bunin and Wightman, 1998) or the dorsal horn of the spinal  
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Figure 1.7.  Voltammetric waveforms used to detect different neurotransmitters.  Top panel: 
chemical structures of neurotransmitters, middle panel: voltammetric waveforms with 
starting potential, high potential, low potential, and scan rate labeled, bottom panel: 
representative cyclic voltammograms.  (A) dopamine waveform,  (B) serotonin waveform, 
(C) adrenergic waveform for norepinephreine (left, top), epinephrine (right, bottom), (D) 
adenosine waveform. 
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cord (Rivot et al., 1995), and adenosine in the striatum (Pajski and Venton, 2010).  Even in 
areas of the brain where FSCV cannot distinguish two similar catecholamines (dopamine 
and norepinephrine) that are released such as the bed nucleus of the stria terminalis 
(BNST) (Miles et al., 2002), coupling FSCV with precise anatomical targeting and 
pharmacological methods can be used in order to determine which of the two 
catecholamines is being detected during the experiment (Park et al., 2009).  
FSCV has even been used to detect gaseous species such as oxygen.  In order to 
accomplish this, the electrode is scanned to very negative potentials, allowing for oxygen to 
be reduced to hydrogen peroxide (Zimmerman and Wightman, 1991).  This was 
accomplished in tissue slices in order to study the use of oxygen by tissue (Kennedy et al., 
1992b).  As the electrode was placed into the tissue, upon electrical stimulation and release 
of dopamine, more oxygen was used.  This response was found to be both calcium and 
action potential dependent, as removal of extracellular Ca2+ from the buffer or addition of 
tetrodotoxin (TTX) to the perfusion buffer significantly decreased the observed oxygen 
signal (Kennedy et al., 1992b).  This provides yet another example of how FSCV can be 
utilized to detect a myriad of different analytes and probe the numerous events which must 
occur in order for synaptic transmission. 
Examining Synaptic Mechanisms with Electrochemistry 
Pharmacology 
 Using electrochemistry in brain slices is an excellent method for studying the 
pharmacological manipulation of receptors, transporters and channels because of the high 
spatial resolution and the isolation of the tissue from peripheral inputs.  Since FSCV 
measures the release which occurs from the presynaptic terminals, pharmacological 
manipulations of the region of interest focus on the presynaptic receptors, transporters and 
channels.  Dopaminergic terminals have been thoroughly studied through pharmacology of 
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both the dopamine transporter using DAT blockers such as cocaine and nomifensine as well 
as the dopamine D2 autoreceptor using antagonists such as sulpiride and agonists such as 
quinpirole (Kennedy et al., 1992a, Jones et al., 1995b).  Slices are an excellent tool for the 
study of the pharmacology of these targets because the concentration and timing of the 
application of drugs can be controlled by perfusion of the drug in the physiological buffer or 
localized pressure ejection from a micropipette. 
 One example of the use of pharmacology in brain slices of the striatum is measuring 
the uptake of dopamine in both the dorsal striatum as well as the nucleus accumbens 
(Jones et al., 1995b).  In these studies, multiple concentrations of cocaine and nomifensine 
can be applied to the same slice taking measurements of dopamine release and uptake as 
each concentration is applied to the slice.  Using modeling of the profile for the release and 
uptake, using a Michaelis-Menten model, the amount of transporter near the electrode can 
be determined (Vmax), and as the cocaine is applied, the apparent Km can be determined and 
when plotted against the concentration of the inhibitor applied, the inhibition constant, Ki can 
be calculated.  It was shown in this study that the Ki for cocaine was not significantly 
different between the two brain regions, but interestingly the Ki for nomifensine was higher in 
the dorsal striatum than it was in the nucleus accumbens. 
 In adrenal slices, the pharmacology of both the splanchnic nerve as well as the 
chromaffin cells themselves can be exploited, both by local application of secretagogues, as 
well as the bath application of drugs which block the receptors located on the chromaffin 
cells which bind to the acetylcholine released by the splanchnic nerve (Douglas and Rubin, 
1961a, Arroyo et al., 2006).  In these experiments, upon electrical stimulation, which was 
believed to excite the splanchnic nerve, hexamethonium, a nicotinic acetylcholine receptor 
blocker (Wakade and Wakade, 1983) was bath applied for a brief time and showed a 
dramatic decrease in the number of spikes observed while hexamethonium was present.  
These studies showed that the electrical stimulation applied during these measurements 
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was indeed stimulating the splanchnic nerve and not the chromaffin cells and the role that 
the acetylcholine released by the splanchnic nerve plays in the vesicular secretion of 
epinephrine and norepinephrine by chromaffin cells in the adrenal medulla. 
Transgenic Mouse Models 
 Over the last two decades, transgenic manipulations in mice have become an 
unprecedented advancement in the field of genetics (Deursen and Hofker, 2003).  
Specifically, the removal of individual genes, making genetic knockout animals, has allowed 
for the understanding of the roles that single genes can play in cellular functions.  Knockout 
animals have found a place in research as disease-state models showing that the removal 
or mutation of a gene can lead to a disease (Kola and Tymms, 2001).  While it is not the 
purpose of this review to discuss the methods used in making these transgenic mouse 
models, the subsequent analysis of the presynaptic function and neurotransmitter release in 
tissue slices of these animals is paramount in understanding the depth and breadth that 
using electrochemistry allows for determining the function of various genes studied and how 
electrochemical methods can be used to study innumerable synaptic mechanisms. 
 One of the first studies using electrochemistry to determine the effect of the deletion 
of a gene on the electrochemical signal observed in brain slices was that of the dopamine 
transporter (DAT) knockout animal.  DAT functions to re-uptake the excess dopamine 
released into the synapse.  Earlier, it had been shown how FSCV can be used in brain 
slices in order to model the uptake of dopamine by DAT using Michaelis-Menten kinetics 
allowing for the determination of the amount of DAT near the electrode (Vmax) as well as the 
affinity of dopamine for DAT (Km), and how that affinity changes as drugs which block DAT 
such as cocaine are applied (Km,app) (Jones et al., 1995a).  FSCV was used to monitor the 
release and uptake of dopamine in slices from animals with all copies of the DAT gene 
(DAT+/+), heterozygous animals (DAT+/-), and homologous knockouts of the DAT gene (DAT-
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/-) (Giros et al., 1996).  Differences in uptake were observed between all three genotypes 
with the slices from the DAT-/- animals having the slowest uptake rate.  Furthermore, bath 
application of the drug of abuse amphetamine showed that in animals lacking DAT, tonic 
extracellular concentrations of dopamine did not increase.  These observations coupled with 
behavioral observations indicated the critical role DAT plays in the molecular function of 
amphetamine on synapses in the mesolimbic and nigrostriatal pathways.  Without the 
temporal and spatial resolution that FSCV allows, the function of DAT on the synapse and 
how it relates to the functions of drugs of abuse could not be elucidated. 
 Another early example of the use of electrochemistry in tissue slices from a disease 
state animal model is the measurement of dopamine in the dorsal striatum of the R6/2 
transgenic mouse model of Huntington’s disease (Johnson et al., 2006).  Huntington’s 
disease is a neurodegenerative, fatal, genetic disorder in which there is an expansive CAG 
repeat in the gene which encodes for the gene huntingtin causing an abnormally long 
polyglutamine segment near the N-terminus (Johnson et al., 2007).  The R6/2 transgenic 
mouse model is one of the models which has been used extensively in the research of this 
disease (Levine et al., 2004).  The release of dopamine in the dorsal striatum is an obvious 
candidate for being affected due to the symptoms of the disease which include motor and 
cognitive defects, as well as degeneration of medium spiny neurons in the striatum (Bates et 
al., 2002).  In these studies, it was observed that there is a decrease in the amount of 
dopamine release in the R6/2 animals at various ages (6-14 weeks old) compared to wild-
type (WT) animals.  Furthermore, decreases observed in cocaine-induced locomotion were 
due to this decrease in dopamine release, because the calculated inhibition constants for 
both cocaine and methamphetamine in these slices at various ages were not significantly 
different between WT and R6/2 animals.   
In subsequent studies, it was determine that this is not limited to dopamine release in 
the striatum as individual chromaffin cells from these mice showed a decrease in the total 
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quantal content released by individual vesicular events measured with constant potential 
amperometry (Johnson et al., 2007).  More recently, experiments involving the use of 
methamphetamine to release intracellular dopamine to be measured by FSCV in the 
striatum of slices showed that there is a significant decrease in the total amount of 
dopamine stored vesicularly in R6/2 Huntington’s mice (Ortiz et al., 2011a).  These 
experiments show a fundamental difference in the catecholamine release characteristics of 
animals with a transgenic model of Huntington’s disease.  Again, the temporal and spatial 
resolution of FSCV and constant potential amperometry at carbon-fiber microelectrodes 
allowed for these otherwise unknown characteristics of the disease to be discovered. 
 One final example of the use of a knockout mouse in order to study the mechanisms 
by which a specific gene affects synaptic transmission of an electroactive neurotransmitter is 
the knockout of the synapsin genes.  There are three mammalian synapsin genes (synapsin 
I, II, and III) which are phosphoproteins located on the surface of synaptic vesicles.  They 
are thought to play a role in keeping vesicles in the reserve pool and away from the active 
zone of the nerve ending where exocytosis occurs (Greengard et al., 1993).  In this study, 
Kile et al used mice lacking all three synapsin genes, or a triple knockout animal (TKO), to 
study the release of two neurotransmitters which are electrochemically active, dopamine 
and serotonin (5-HT) (Kile et al., 2010).  It was found that mice lacking the synapsin genes 
showed significantly more release of dopamine while 5-HT release was no different between 
the two genotypes.  Total content of both dopamine and 5-HT were the same between the 
genotypes, pointing to the role that the Synapsin proteins play in exocytotic release of 
dopamine.  Further study of the synapsin III knockout animal showed similar results to the 
TKO indicating that in the dopamine terminals in the dorsal striatum, the synapsin III gene 
plays the largest role.  This was not unexpected since the synapsin genes are differentially 
expressed throughout the brain while synapsin III is restricted  to regions such as the 
dentate gyrus of the hippocampus and the caudate putamen (Pieribone et al., 2002).  The 
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differential release was also found to be highly dependent on the concentration of the 
extracellular calcium indicating the role the protein plays in the exocytotic mechanism.  This 
example once again shows the versatility of FSCV, allowing for differences in the release of 
two different neurotransmitters, dopamine and 5-HT, in mice lacking proteins which play an 
important role in vesicular trafficking to be elucidated.  This could not be accomplished with 
another electrochemical technique which does not have the chemical resolution that FSCV 
has. 
 The above examples of the use of transgenic mice for the study of synaptic 
mechanisms with electrochemistry in disease-state animals are just a few selected studies 
from a myriad of ongoing research in a number of different areas.  Some other examples 
include R6/1 Huntington’s disease state mice (Ortiz et al., 2011a), Fragile X retardation 
syndrome (Annangudi et al., 2010, Fulks et al., 2010), transgenic mice with extra copies of 
the dopamine transporter gene (Salahpour et al., 2008), Parkinson’s disease (Zhang et al., 
2011, Littrell et al., 2012), mice lacking MsrA (Oien et al., 2008), mice lacking sulfoxide 
reductase A (Ortiz et al., 2011b). 
Summary 
 The work reviewed herein shows the ability of electrochemical methods used in 
tissue slices in order to study the mechanism of neurotransmitter release and uptake at the 
synaptic level.  Using a slice preparation has many advantages over using whole animal 
experiments including knowing the exact location of where the sensor is placed as well as 
the ability for local stimulation and the probing of the biological processes in play at the 
synapse without interference from other systems in the brain.  Electrochemistry at carbon 
fiber microelectrodes has the spatial and temporal resolution other methods do not possess.  
With the use of FSCV, chemical resolution can also be obtained and allow for the 
measurement of many different electroactive neurotransmitters.  Pharmacological and 
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transgenic methods have allowed researchers to probe mechanisms at the synaptic level for 
many different proteins implicated in important diseases including Huntington’s and 
Parkinson’s disease.  One can imagine that there are a number of different proteins which 
play key roles in synaptic transmission which have yet to be studied using these methods.  
With the advancements which have been made in the production of transgenic and genetic 
knockout animals, the limit of the use of electrochemistry to study synaptic transmission in 
animals lacking or having excess various genes is only limited by the genome itself and the 
viability of the animals produced.   
Dissertation Overview 
 In the work presented herein, electrochemistry at carbon-fiber microelectrodes is 
used in both adrenal as well as spinal cord tissue slices for the evaluation of chemical 
messenger release.  Specifically, CPA and FSCV were used in mouse adrenal slices for the 
evaluation of biogenic amine release from chromaffin cells.  Pharmacological methods were 
used to study both electrically stimulated as well as spontaneous exocytotic release.  A 
modified waveform was also used to determine the chemical messenger being released 
from individual chromaffin cell clusters.  These techniques were then used to characterize 
the stimulation methods for eliciting catecholamine release from adrenal slices and the 
implications of the use of high intensity electrical stimulations in tissue slices.  Furthermore, 
in collaboration with Mark Zylka in the Department of Cell and Molecular Physiology, FSCV 
was utilized to address the function of ectonucleotidases for the production of adenosine in 
spinal nociceptive circuits.  Furthermore, a possible source of adenosine tone in the spinal 
cord was discovered.  Finally, with the use of high-performance liquid chromatography with 
electrochemical detection (HPLC-ECD), total tissue and metabolite content was determined 
in various brain regions of biogenic amines in animal models of disease-states to determine 
differences.  As a whole, these studies help to contribute to solving long-standing 
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methodological and physiological questions in the fields of analytical chemistry and 
neuroscience. 
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Chapter II 
Real-Time Chemical Transmission in Mouse Adrenal Slices 
Introduction 
Electrophysiological and electrochemical measurements at chromaffin cells, 
homologues of sympathetic ganglion cells, have revealed fundamental mechanisms 
underlying exocytosis, the secretory process that initiates intercellular signaling (Travis and 
Wightman, 1998, von Gersdorff and Matthews, 1999, Bader et al., 2002, Borges et al., 2008, 
Suudhof, 2008).  The majority of these studies have been conducted in primary cultures of 
chromaffin cells where exocytosis was evoked by pressure ejection of secretagogues such 
as K+ and Ba2+ (Fox, 1996, Montero et al., 2000, Amatore et al., 2005, Amatore et al., 2006, 
Haynes et al., 2007, Montesinos et al., 2008).  In vivo, splanchnic innervations consisting of 
preganglionic cholinergic neurons play a central role in the initiation of catecholamine 
secretion (Douglas and Rubin, 1961b).  They synapse onto chromaffin cells and release 
acetylcholine that binds to postsynaptic cholinergic nicotinic and muscarinic receptors 
located on chromaffin cells.  Binding of acetylcholine at cholinergic receptors leads to cell 
depolarization (Wakade and Wakade, 1982, Borges, 1997, Kajiwara et al., 1997, Aunis and 
Langley, 1999, de Diego et al., 2008).  This change in membrane potential triggers the entry 
of extracellular Ca2+ (Brandt et al., 1976, Kidokoro and Ritchie, 1980).  A rise in cytosolic 
Ca2+ concentration initiates a series of events culminating in exocytosis of catecholamines.   
To evaluate processes that occur after exocytosis, more intact preparations are 
required.  One approach is to perfuse the blood vessels of the intact adrenal gland.  
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Catecholamines released into the perfusion fluid can then be analyzed by traditional 
methods (Wakade and Wakade, 1982).  While this approach allows triggers of secretion to 
be identified, it does not have sufficient time resolution to determine fast events.  An 
alternate approach is to use microelectrodes in adrenal slices, thin pieces of tissue that 
retain many of the features of the intact gland.  Using patch-clamp techniques, the 
capacitance of cells within slices have been investigated (Moser and Neher, 1997, Barbara 
et al., 1998).  However, these electrophysiological signals can be difficult to interpret since 
they represent a temporal mosaic of both exocytotic and endocytotic events.  Recently, 
Arroyo et al. reported on the kinetics of exocytosis in murine adrenal slices employing 
constant potential amperometry at carbon-fiber microelectrodes (Arroyo et al., 2006).  They 
showed that catecholamine exocytosis from individual chromaffin cells located on a slice’s 
surface could be measured when evoked by electrical field stimulation of the splanchnic 
nerve innervations.   
In this work we describe a real-time study of factors that control the secretion of 
catecholamines in an in situ murine adrenal slice preparation.  The spatial and temporal 
resolution of carbon-fiber microelectrode sensor was exploited to probe the heterogeneity of 
the preparation.  Cyclic voltammetry was used to identify the released substances as 
catecholamines.  Optical imaging techniques, in particular standard light microscopy and 
confocal laser scanning microscopy, were utilized for identification and visualization of 
adrenomedullary compartments.  Both spontaneous and electrically stimulated release of 
catecholamines were measured inside clusters of chromaffin cells.  Spontaneous events 
originated from single vesicles whereas electrical stimulation evoked release comprised of 
multiple vesicles. 
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Experimental 
Animals 
 Wild-type C57BL/6J female mice 4-8 weeks of age were used in the experiments 
described herein (stock no. 000664, Jackson Laboratories, Bar Harbor, ME, USA).  Mice 
were housed at the University of North Carolina Husbandry Facility (Kerr Hall – UNC School 
of Pharmacy) with ab libitum access to food and water and under closely controlled 
environmental conditions (temperature, humidity, and 12-hr light/dark cycles).  Live animal 
handling procedures and experimental protocols have been approved by the University of 
North Carolina’s Institutional Animal Care and Use Committee.   
Adrenal Slice Methods 
Adrenal gland slicing procedures were as described previously with slight 
modifications (Moser and Neher, 1997, Barbara et al., 1998).  Mice were anesthetized using 
ethyl ether (Fisher Scientific), decapitated, and subjected to a midline abdominal incision 
which allowed for access to the adrenal glands.  Glands were placed into ice-cold and 95 % 
O2 – 5 % CO2 saturated bicarbonate-buffered saline containing (in mM):  0.1 CaCl2, 125 
NaCl, 26 NaHCO3, 2.5 KCl, 1.25 NaH2PO4, 3 MgCl2, 10 glucose and 10 HEPES or Tris at 
pH=7.4.  Fat tissue was removed under a dissecting microscope (Leica Wild M3Z) and each 
gland was placed into 3 % agarose (w / v), (Promega, gelling point of 24-28 °C).  Agarose 
blocks containing a gland were placed on ice in order to complete gel formation (< 3 min), 
secured onto the Teflon specimen holder, and mounted into a vibroslicer (Campden 
Instruments, World Precision Instruments, Leics, U.K.) filled with ice-cold buffer.  The 
agarose block was oriented so that the largest base of the gland was parallel to the 
specimen holder (Barbara et al., 1998).  Adrenal glands were cut into slices of ~ 200 µm in 
thickness.   
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Slices were immediately placed into a perfusion chamber (open diamond bath 
heated chamber, RC-22, Warner Instruments, Hamden, CT) and secured with a Lycra® 
thread anchor (1.5 mm-2.0 mm thread spacing, Warner Instruments, Hamden, CT).  The 
chamber was continually perfused with 95 % O2 – 5 % CO2 saturated bicarbonate-buffered 
saline at a rate of 1-2 mL/min and containing (in mM):  2 CaCl2, 125 NaCl, 26 NaHCO3, 2.5 
KCl, 1.25 NaH2PO4, 1 MgCl2, 10 glucose and 10 HEPES or Tris at pH=7.4.  Osmolarities of 
all buffers were maintained at ~ 310 mOsM/L by adjusting the concentrations of MgCl2 and 
CaCl2 accordingly.  The temperature of the perfusion chamber was kept at 37 °C using a 
dual automatic temperature controller (Warner Instruments, LLC).  Slices were electrically 
stimulated via two tungsten microelectrodes glued together and separated by a distance of 
approximately 150 µm (FHC, Bowdoin, ME).  To evoke catecholamine release, trains of 
biphasic pulses (150 µA, 2 ms each phase, 10 pulse, 10 Hz) were applied to the stimulating 
electrodes.  These stimulation parameters are similar to those used in brain slices (Miles et 
al., 2002).  All of the experiments were completed within a 10-hr post mortem period. To 
avoid recordings from a damaged tissue layer, microelectrodes were lowered to a distance 
of approximately 30 µm below the slice surface (Kennedy et al., 1992).  Slices were 
equilibrated for ~ 2 hrs prior to data collection.  During the equilibration period slices were 
electrically stimulated every 3-5 min.  These data were used to establish a baseline level of 
catecholamine release. 
Immunohistochemistry and Confocal Microscopy 
Free-floating 200 µm thick adrenal tissue slices were fixed in 2 % para-formaldehyde 
solution, made from a 37 % formaldehyde solution in H2O (Sigma-Aldrich), which was 
diluted in Sorensen’s phosphate buffer (0.15 M K2HPO4/NaH2PO4, pH=7.4).  After a 4 hr 
fixation period, slices were rinsed with phosphate buffered saline (PBS) at room temperature 
(6 x 10 min, pH=7.4).  Slices were then transferred to blocking solution containing 25 mL of 
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PBS (pH=7.4), 1 % bovine serum albumin (Sigma-Aldrich), 10 % normal goat serum 
(Invitrogen) and 0.3 % Triton-X 100 (The Chemistry Store, Pompano Beach, FL) for 2 hrs at 
room temperature.  The blocking solution was then removed and slices were incubated with 
the primary antibody to tyrosine hydroxylase (1/100, Chemicon-Millipore AB152) at 4 °C for 
72 hrs.  Slices were rinsed with PBS (6 x 10 min) at room temperature and incubated with 
the secondary antibody for 48 hours at 4 °C (1/4000, Molecular Probes, A21245).  Hoechst 
33342 nuclear stain (Invitrogen) was added after 6 x 10 min PBS rinses following secondary 
antibody incubation for 10 min and was followed by rinsing with PBS (6 x 10 min).  The 
slices were then affixed to microscope slides with ProLong Gold mounting media 
(Invitrogen).  Slides were then coverslipped and the mounting media was allowed to dry for 
24 hrs.  Adrenal tissue slices were examined with a Leica SP2 laser scanning confocal 
fluorescence microscope (Michael J. Hooker Microscopy Facility, UNC-CH).  A 
photomultiplier tube was used as a detector.  Confocal images were processed in Leica 
Confocal Software (Leica Microsystems, Germany) and Adobe Photoshop (version 7.0). 
Preparation of Isolated Chromaffin Cells 
Murine chromaffin cells were prepared as previously described (Kolski-Andreaco et 
al., 2007) with some modifications.  Mice were deeply anesthetized with ether, decapitated, 
and the adrenal glands rapidly removed into ice-cold, oxygenated Ca2+ and Mg2+-free 
Locke's buffer containing (in mM): 154 NaCl, 3.6 KCl, 5.6 NaHCO3, 5.6 glucose, and 10 
HEPES, pH = 7.2.  The medullae were isolated via gentle removal of cortical tissue and 
digested for 20 min at 37 oC in Dulbecco's Modified Eagle's Medium/Nutrient Mixture F-12 
Ham (DMEM/F12) with 25 U/mL papain.  The digestion media was replaced with a fresh 
aliquot, followed by a second 20 min digestion period.  Digested tissue was washed and 
triturated with pipette tips of decreasing bore size in 500 µL DMEM/F12 with 10 % fetal 
bovine serum and 2 % horse serum.  The resulting cell suspension was distributed evenly to 
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3 poly-L-lysine-coated (0.1 mg/mL) 25 mm round glass coverslips.  After 15 min attachment, 
plates were fed with 2 mL DMEM/F12 containing 100 U/mL penicillin, 0.1 mg/mL 
streptomycin, 50 U/mL nystatin, and 40 µg/mL gentamicin.  Plates were maintained in a 
humidified, 5 % CO2 atmosphere at 37 
oC for at least 24 hrs prior to experimentation. 
Fabrication of the Microelectrode 
Carbon-fiber elliptical microelectrodes were fabricated as previously described 
(Kawagoe et al., 1993, Cahill et al., 1996).  A single T-650 or P-55 carbon fiber (Thornel, 
Amoco Corp., Greenville, SC) was aspirated into a glass capillary (1.2 mm x 0.68 mm x 4,” 
A-M Systems, Sequim, WA) and gravity pulled with a vertical pipette puller (model PE-21, 
Narishige Group, Japan).  The glass seal was cut with a surgical blade, sealed with epoxy 
as previously described (Kawagoe et al., 1993), and polished at 45o on a fine diamond 
abrasive plate mounted onto a microelectrode beveler (BV-10, Sutter Instruments).  Prior to 
use, carbon-fiber microelectrodes were soaked in activated carbon / 2-propanol mixture for 
a minimum of 30 min.  Microelectrodes were backfilled with 4 M CH3COOK/0.15 M NaCl and 
mounted onto a potentiostat headstage using stainless steel wire to make an electrical 
contact.   
Fast-Scan Cyclic Voltammetry   
In FSCV studies, a triangular waveform was applied to the carbon-fiber 
microelectrode with an Axopatch 200B patch-clamp amplifier in voltage clamp mode and 
β=0.1 configuration (Axon Instruments, Molecular Devices, Union City, CA).  The potential 
was swept at 600 V/s from - 400 mV to + 1000 mV and back to - 400 mV at a frequency of 
10 Hz.  Under these conditions the catecholamines are oxidized at + 600 mV and reduced at 
- 200 mV versus Ag/AgCl reference electrode.  In between scans, the electrode potential 
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was held at - 400 mV allowing for catecholamine adsorption onto the carbon fiber surface.  
The signal was filtered with a built-in analog low-pass Bessel filter (80 dB/decade) at 5 kHz. 
To distinguish between epinephrine and norepinephrine an extended waveform was 
used as previously described (Pihel et al., 1994).  Briefly, the working electrode was held at 
+ 100 mV and scanned from + 100 mV to + 1425 mV at 800 V/s at a frequency of 10 Hz.  
Due to the Axopatch 200B being unable to perform potential scans beyond 1000 mV, a 
custom made Universal Electrochemistry Instrument (UEI, UNC Electronics Design Facility) 
was used.  This instrument is a two-electrode system optimized for FSCV.  While this 
waveform eliminates catecholamine reduction, it forces epinephrine to undergo a secondary 
amine oxidation reaction resulting in a second oxidation peak at near + 1400 mV.  
Norepinephrine does not undergo this second oxidation since it is a primary amine.   
  Both potentiostats as well as the stimulation parameters were controlled via locally 
written LABVIEW software, TarHeel CV (ESA, Chelmsford, MA).  Stimulations were applied 
in between each voltammetric scan while the working electrode was held at - 400 mV so 
electrochemical recordings were not stopped during the electrical stimulation. Measured 
currents were digitized using a National Instruments PCI-MIO-16XE-10 card and monitored 
as a function of the applied potential.  
Voltammetric Data Analysis 
Voltammetric data analysis was performed with the locally written LABVIEW software 
TarHeel CV data analysis (ESA, Chelmsford, MA).  The voltammograms were background 
subtracted using files obtained before stimulation.  Sets of background-subtracted cyclic 
voltammograms were displayed as color plots (Michael et al., 1998) in which the cyclic 
voltammograms are sequentially stacked together in time (abscissa) and plotted against the 
applied potential (ordinate).  The measured currents are shown in false color.  The current 
that flows at + 600 mV is due to catecholamine oxidation, and it was calibrated in 
 42 
concentration units by measurement of authentic standards in a flow injection analysis 
system.  Since the electrochemical signals recorded in the adrenal medulla consist of both 
epinephrine and norepinephrine, calibration factors in this work were derived using solutions 
of 1-10 µM epinephrine, norepinephrine, or mixtures.  Data obtained during administration of 
pharmacological agents are reported as current values normalized to currents recorded 
under control (pre-drug) conditions.   
Constant-Potential Amperometry 
The potential applied to the carbon-fiber microelectrode was + 700 mV to assure 
complete electrolysis of released catecholamines.  Amperometric data was obtained at a 
collection frequency of 20-50 kHz, and  recorded amperometric traces were analog filtered 
at 5 kHz with an internal low-pass Bessel filter (Digidata 1320A controlled by P-Clamp 
software, Molecular Devices).  The data were then digitally filtered at 300 Hz with a 
Butterworth filter in locally written LABVIEW program (Tar Heel Amperometry) (Haynes et 
al., 2007).  Exocytosis was monitored either in the absence or presence of electrical or 
chemical stimulation.  Acetylcholine (1 mM) was pressure ejected at 2-5 psi for 50-100 ms 
using a Picospritzer (Parker Instruments, Pine Brook, NJ) from capillaries with a 0.68 mm 
inner diameter (AM Systems, Sequim, WA) that were pulled on a Sachs-Flaming 
Micropipette Puller Model PC-84 (Sutter Instruments, Novato, CA) and adjusted to a final 
inner diameter of 10-15 µm at the tip.  
Amperometric Data Analysis 
Amperometric traces were analyzed with MiniAnalysis software (version 6.0.3, 
Synaptosoft, Inc., Decatur, GA).  Events were classified as an exocytotic event if they were 
five times greater than the root mean square of noise.  Amperometric spike parameters 
quantified were the area under the spike (Q) and the spike’s width at half height (t1/2).  
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Examination of t1/2 allowed for kinetics and underlying physiological mechanisms of 
catecholamine release to be studied.          
Pharmacology 
Pharmacological agents employed in studies include tetrodotoxin (TTX), 
hexamethonium (HEX), atropine (ATR), 4-Diphenylacetoxy-N-(2-chloroethyl)piperidine 
hydrochloride (4-DAMP), and carbenoxolone (COX).  Drugs were dissolved in recording 
buffer and superfused through the slice chamber at a rate of ~ 2 mL/min.  All of the drugs 
were obtained from Sigma-Aldrich (St. Louis, MO, USA) and used as received. 
Statistical Analysis 
Statistical analysis was performed in GraphPad Prism (GraphPad Software, Inc., 
San Diego, CA, USA).  Data are reported as means ± SEM.  Student’s t-test (paired) was 
used to test for significant differences between data sets.  Data were considered significant 
at the 95 % confidence level and are reported as the mean ± SEM.  The number of slices is 
indicated by n, unless noted otherwise.    
Results 
Brightfield and Immunofluorescent Assessment of Murine Adrenal Slices 
Rat chromaffin cells within the adrenal medulla are organized into clusters containing 
~ 20 cells with each cell receiving one to four synaptic boutons (splanchnic nerve 
innervations) (Kajiwara et al., 1997).  Brightfield imaging of murine tissue slices revealed 
similar clusters.  In addition to chromaffin cell clusters, the pericellular space (space 
between two neighboring clusters), and the vasculature (in particular the central vein) were  
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Figure 2.1.  Adrenomedullary microenvironments.  (A) Representative brightfield image of 
adrenomedullary microenvironments:  AM – adrenal medulla, CV – central vein, CX – 
adrenal cortex.  Asterisks mark four chromaffin cell clusters.  Brightfield images (B) and (F) 
show two adrenomedullary microenvironments identified as chromaffin cell clusters.  
Fluorescent images (C – E) show a negative control experiment where the primary antibody 
to TH was omitted from the immunohistochemical protocol.  Images (G – I) show the 
localization of the TH immunofluorescence to cytoplasm of chromaffin cells contained within 
a cluster.  In both experiments, the nuclei were stained with Hoechst 33342 (C) and (G).  In 
H, TH antibody conjugated to Alexa Fluor® 647 labels chromaffin cells contained within a 
cluster.  (E) and (I) show C / D and G / H overlays respectively.  Scale bar:  25 µm. 
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also apparent (Figure 2.1A).  The murine chromaffin cell clusters were on average 60-80 µm 
in diameter and contained ~ 15 chromaffin cells. 
Brightfield images of clusters are shown in Figure 2.1, B and F.  These slices were 
labeled to allow confocal microscopy of nuclei and tyrosine hydroxylase (TH).  To visualize 
cell nuclei, tissue slices were incubated with Hoechst 33342, and, as expected, labeling was 
found in all cells (Figure 2.1, C and G). To visualize TH containing cells, an indirect 
immunofluorescence method was employed.  A secondary antibody conjugated to Alexa 
Fluor® 647 fluorochrome was used to react with the primary antibody to TH (Pickel et al., 
1975) (Figure 2.1H).  In a negative control experiment the primary antibody to TH was 
omitted from the immunohistochemical protocol and no labeling was present (Figure 2.1D). 
The overlay reveals tight packaging of chromaffin cells within a cluster (Figure 2.1, E and I) 
that is apparent even with brightfield illumination.  These experiments make clear that 
chromaffin cells exist in clustered arrangements in murine adrenal glands, and the clusters 
can be visualized by brightfield microscopy. 
Cyclic Voltammetric Recording of Electrically Evoked Release 
Clusters were chosen for the measurement of electrically evoked catecholamine 
release.  A carbon-fiber microelectrode was positioned within a cluster, approximately 30 µm 
below the slice surface, with the stimulating electrodes on either side of the working 
electrode (Figure 2.2).  The color plot (lower part of Figure 2.3) reveals the cyclic 
voltammetric changes in electrochemically active species that occur over a 55 s interval.  At 
t = 0 in Figure 2.3, an electrical stimulation (1-s train of biphasic pulses, 10 Hz) was initiated.  
Catecholamines are oxidized at + 600 mV under these voltammetric conditions, and the 
current at this potential is plotted above the color plot in Figure 2.3.  Fluctuations in 
catecholamine concentrations are apparent before and after the stimulation, and this was 
the case in 90 % of adrenal tissue preparations (14 out of 16 slices).  Typically, the rapid  
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Figure 2.2.  Brightfield micrograph of an electrochemical recording setup.  Carbon-fiber 
microelectrode (arrow points to the microelectrode tip) is positioned within a chromaffin cell 
cluster; the stimulating electrode consisting of two tungsten electrodes (tip of each is marked 
with an asterisk) is placed on top a slice straddling the electrochemical sensor.  Scale bar:  
100 µm.  
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spontaneous events occurred near the natural basal firing frequency of chromaffin cells, 0.5 
Hz (Chan and Smith, 2003).  The electrical stimulation evokes a large, immediate increase 
in catecholamine concentration, and the increase continues for ~ 2 s after the end of the 
stimulation.  The concentration then returns to baseline within 10-15 s where the 
spontaneous release events are apparent.  The cyclic voltammograms for both the 
electrically evoked release and the spontaneous events (Figure 2.3, inset) were identical to 
those of norepinephrine and epinephrine.   
Modulation of Electrically Evoked Release by Ions 
Exocytotic release of catecholamines is Ca2+ dependent at isolated bovine 
chromaffin cells (von Ruden and Neher, 1993).  To verify that this is the case in chromaffin 
cells of murine adrenal slices, tissue was superfused with low Ca2+ buffer (0.1 mM).  
Electrically evoked release was completely eliminated (Figure 2.4A, upper panel) at a 
location where spontaneous events were not evident.  Cumulative results are summarized in 
Figure 2.4A, lower panel (n = 3 slices).  Reintroduction of 2.0 mM Ca2+ restored the 
electrically stimulated release (97 ± 4 % of control, p > 0.05).   
To confirm that release in murine adrenal slices requires electrical excitability, slices 
were superfused with physiological buffer containing 1 µM tetrodotoxin, TTX, a Na+ channel 
blocker (Fuhrman, 1986).  With a superfusion rate of 2 mL/min, it took 5 minutes for TTX to 
abolish catecholamine release (Figure 2.4A, lower panel, n = 4 slices).  Evoked release 
returned to pre-drug levels 20 min after its washout (95 ± 2 % of control, p > 0.05). 
Role of Cholinergic Neurotransmission and Gap Junctions During Electrically Evoked 
Catecholamine Release   
Chromaffin cells have nicotinic and muscarinic receptors that are activated by acetylcholine 
release from the splanchnic nerve (Douglas and Rubin, 1961a, Douglas and Poisner, 1965).  
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Figure 2.3.  Representative electrically evoked catecholamine release event in a chromaffin 
cell cluster.  The color plot shows current changes observed prior to (-5 s to 0 s), during (0 s 
to 1 s), and following (1 s to 50 s) the delivery of an electrical stimulus.  Catecholamines are 
oxidized at + 600 mV vs. Ag/AgCl (green) and the resultant o-quinone is reduced at – 200 
mV (dark blue).  The trace above the color plot shows the changes in catecholamine 
concentrations that occur as a result of the electrical stimulation (extracted at + 600 mV, 
solid horizontal line).  The delivery of electrical stimulation at time 0 s is indicated by a red 
bar; the second red bar at time 1 s marks the end of stimulation.  Cyclic voltammograms 
(inset) that confirms signal’s catecholaminergic chemical identity were extracted from the 
color plot at the time of the maximum concentration change (striped vertical lines).  The 
black arrow points to the maximum concentration change for electrically stimulated release 
and it corresponds to the cyclic voltammogram plotted in black; the gray arrow points to the 
maximum concentration change for spontaneous catecholamine release event and it 
corresponds to the gray cyclic voltammogram. 
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To establish whether elements of the splanchnic nerve are depolarized by the stimulation, 
two pharmacological agents were used.  The cholinergic nicotinic receptor (nAChR) 
antagonist, hexamethonium (HEX, 100 µM) was perfused through the slice.  Following 20 
min of superfusion with HEX, electrically evoked catecholamine release was inhibited 
(representative example in Figure 2.4B, upper panel, cumulative results in Figure 2.4B, 
lower panel, n = 5 slices, p < 0.001).  Release returned to its original levels 20 min after 
removal of HEX.  In contrast, 25 min exposure of slices to the muscarinic receptor (mAChR) 
antagonists, atropine (ATR, 0.5 µM), competitive and nonselective antagonist at mAChR’s 
(Zwart and Vijverberg, 1997) or 4-DAMP (1 µM), an irreversible antagonist at M1, M3, M4 and 
M5 mAChR subtypes (Moriya et al., 1999), did not significantly affect the released 
catecholamine concentrations (Figure 2.4B, lower panel, n = 3 and p > 0.05 for both drugs). 
We also examined whether gap junctions (electrical synapses) were involved in the 
electrically evoked release in slices (Moser, 1998, Martin et al., 2001).  Superfusion of 
murine adrenal slices with the uncoupling agent and gap junction blocker carbenoxolone 
(COX, 100 µM) did not alter electrically evoked catecholamine release (Figure 2.4B, lower 
panel, n = 3, p > 0.05).  Thus, chromaffin cell junctional coupling does not contribute to 
catecholamine secretion evoked by electrical stimulation.   
Spontaneous Catecholamine Secretion  
Spontaneous events closely resemble the exocytotic release events recorded at 
individual cultured chromaffin cells (Troyer and Wightman, 2002).  The spiking activity was 
confined to cell clusters and it was entirely absent in the pericellular microdomain and 
vascular recordings (data not shown).  We used FSCV to find sites that exhibited 
spontaneous catecholamine release, and the recording mode was then switched to 
amperometry to determine coulometrically the amount released (representative example in 
Figure 2.5A). When the electrode potential was held at 0.0 V instead of + 700 mV,  
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Figure 2.4.  Modulation of electrically stimulated catecholamine release.  (A) Transmural 
electrical stimulation of tissue slices during perfusion of low Ca2+ buffer (0.1 mM) results in 
the absence of catecholamine release.  Top panel shows representative catecholamine 
concentration vs. time traces and their corresponding color plots before (left), during 
(middle), and after (right) low Ca2+ buffer perfusion.  The inset cyclic voltammograms confirm 
catecholaminergic nature of the detected signal.  Lower panel shows a summary of the 
modulation of catecholamine release by low Ca2+ buffer and tetrodotoxin.  (B) Slice 
perfusion with HEX abolishes electrically stimulated release.  Similar to (A), top panel of (B) 
shows representative catecholamine concentration vs. time traces and their corresponding 
color plots before (left), during (middle), and after (right) 100 µM HEX perfusion.  Lower 
panel summarizes the modulation of release by the nicotinic (HEX) and muscarinic (ATR 
and 4-DAMP) AChR antagonists as well as the gap junction blocker COX.  *** p < 0.001 
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spontaneous activity was not observed (data not shown).  Amperometric spikes were 
recorded at 7 spontaneously active sites, and the area under each spike (Q, fC) and the 
width at half height (t1/2, ms), were quantified.  These were compared to the same values 
measured during exocytosis at 21 isolated murine chromaffin cells stimulated with a high 
extracellular K+ solution.  In slices the average Q value was 418 ± 37 fC whereas in cells it 
was 377 ± 43 fC.  In slices the average t1/2 value was 12.5 ± 1.7 ms whereas it was 8.9 ± 1.5 
ms at single cells.  The values of Q and t1/2 are not statistically different in the two 
preparations (p > 0.05). 
To test whether these spontaneous events were triggered by endogenous 
acetylcholine, 100 µM HEX was perfused through the slice.  Twenty minutes after HEX 
perfusion, the number of spontaneous events was dramatically reduced (Figure 2.5B).  
While Q and t1/2 remained unchanged between the pre-drug recordings and those obtained 
in the presence of HEX (data not shown), the spiking frequency was found to decrease to 
30% of the pre-drug levels (Table 2.1, p > 0.05).  Therefore, spontaneous catecholaminergic 
release events are triggered by acetylcholine originating either from leakage or spontaneous 
activity at the splanchnic nerve terminals.  To confirm both the exocytotic origin of the 
events, low Ca2+ (0.1 mM) buffer was perfused through the slice.  Twenty minutes after 
perfusion with low Ca2+, the number of spontaneous events was 10% of pre-drug levels 
(Table 2.1, Figure 2.5, C and D). After the reintroduction of 2 mM Ca2+, spontaneous 
exocytotic event frequency remained low (Figure 2.5E, 0.03 ± 0.01 Hz).  However, 
catecholamine secretion events were evoked by pressure ejection of 1 mM acetylcholine 
(ACh) and returned to a modest frequency of 0.24 ± 0.09 Hz for t > 1 min (Figure 2.5F).  In 
this experiment, the concentration of ACh that reaches the secreting cell is not known—it is 
certainly lower than the applied concentration because the 60 µm distance between the 
pressure ejection pipette and the secretion site within the slice is much larger than the 
radius of the ejected droplet (~20 µm).   
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Figure 2.5.  Biological origin of spontaneous catecholamine secretion.  The representative 
amperometric recording of spontaneous catecholamine release in (A) was obtained by 
holding the microelectrode at a DC potential of + 700 mV; in (B), the number of spontaneous 
release events was reduced by ~ 70 % following a 20 min perfusion of the slice preparation 
with HEX, a nAChR blocker.  A 20 min perfusion with a low Ca2+ (0.1 mM) buffer reduced 
the number of spontaneous events by ~ 90% (C and D) and was recoverable by pressure 
ejection of 1 mM ACh (E and F). 
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Table 2.1.  Summary of exocytotic spikes measured by amperometry in adrenal slices.  
Amperometric spike parameter analysis prior to and following inclubation in hexamethonium 
or low extracellular Ca2+ treatment.  For hexamethonium, n = 9 slices and for low Ca2+, n = 5 
slices. 
 
 
Trace f (Hz) ttotal (sec) nspikes 
HEX Control 0.27 ± 0.03 540 146 
HEX 0.08 ± 0.01 540 44 
Ca2+ Control 0.33 ± 0.10 300 100 
Low Ca2+ 0.04 ± 0.01 300 11 
Post Low Ca2+ 0.03 ± 0.01 300 8 
1 mM ACh 
Pressure Ejection 
0.24 ± 0.09 300 73 
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Chemical Analysis of Spontaneous and Electrically Stimulated Release 
Murine adrenal glands contain approximately twice as much epinephrine as 
norepinephrine and negligible amounts of dopamine (Ally et al., 1986).  To reveal the 
contributions of individual catecholamines to both spontaneous and electrically stimulated 
release, cyclic voltammetric measurements were made using a waveform that allows the 
two catecholamines to be distinguished (Pihel et al., 1994).  Epinephrine yields a second 
oxidation wave at + 1300 mV on the reverse scan.  Thus, the cyclic voltammogram is due to 
epinephrine if there is a peak at + 600 mV and + 1300 mV, and it is norepinephrine if it only 
has a peak at + 600 mV.  With the microelectrode in a chromaffin cell cluster, the 
voltammograms revealed that spontaneous release events were either adrenergic or 
noradrenergic but not both (representative example in Figure 2.6).  Note that the 
norepinephrine example shown has no peaks at + 1300 mV and the current trace from that 
potential exhibits no fluctuations.  A total of 13 cells were investigated; 8 were adrenergic 
and 5 were noradrenergic. 
Upon electrical stimulation, sites that spontaneously released exclusively 
epinephrine remained adrenergic (representative example in Figure 2.7, left panel).  Post-
calibration of the electrode in norepinephrine and epinephrine solutions confirmed that the 
signal was 95.5 ± 1.3 % epinephrine (n = 8).  However, electrically stimulated release in 
sites where spontaneous release was due to norepinephrine showed a different response.  
Release at these sites clearly contained an epinephrine component (Figure 2.7, right panel).  
In this case post-calibration showed that the electrically stimulated release was 43.5 ± 8.1 % 
epinephrine (n = 5).   
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Figure 2.6.  Electrochemical analysis of spontaneous catecholamine release.  
Catecholamine concentration vs. time traces and their corresponding color plots show 
spontaneous adrenergic (left panel) and noradrenergic (right panel) secretory activity 
observed within two separate cell clusters.  Top (green, extracted at + 1300 mV) and bottom 
(blue, extracted at + 600 mV) concentration traces reveal chemical identity of the 
catecholamine released:  spontaneous secretion of epinephrine is established by the 
presence of voltammetric spikes at both + 1300 mV (striped white line in color plot) and + 
600 mV (solid white line in color plot) while spontaneous norepinephrine secretion is 
confirmed by the presence of spikes at + 600 mV but not at + 1300 mV.  Catecholamine 
concentration vs. time traces for + 600 mV and + 1300 mV are offset for clarity. 
 
 56 
 
 
 
Figure 2.7.  Electrochemical analysis of electrically evoked catecholamine release.  
Catecholamine concentration vs. time traces and their corresponding color plots reveal the 
chemical identity of electrically evoked release in locations that have been identified based 
on spontaneous secretory activity as either adrenergic (left) or noradrenergic (right).  The 
site that was previously found to spontaneously release only norepinephrine displays the 
presence of a second oxidation event as evident from the color plot on the right as well as 
the concentration vs. time trace at + 1300 mV.   
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Discussion 
This work extends that of Arroyo et al. who examined catecholamine release by 
amperometry at the surface of murine adrenal slices (Arroyo et al., 2006).  Here, we have 
used cyclic voltammetry to identify the released substances as catecholamines.  In addition, 
we measured release from chromaffin cells located deep within tissue slices where they are 
surrounded by their normal physiological conditions.  Consistent with the work of Arroyo et 
al., we found two patterns of release.  Spontaneous release events occurred at a low 
frequency, were composed of either norepinephrine or epinephrine, and had a duration of a 
few milliseconds.  These events appeared to be triggered by endogenous acetylcholine 
since they were significantly less frequent in the presence of the nicotinic receptor 
antagonist, HEX.  The amount released during those events was identical to individual 
exocytotic events at single cultured cells.  Local electrical stimulation evoked a massive 
release that lasted for multiple seconds.  Electrically stimulated release was almost 
completely eliminated by HEX indicating that the secretion was not a direct consequence of 
depolarization of chromaffin cells.  Rather, electrical stimulation appeared to activate the 
splanchnic nerve, releasing acetylcholine that in turn triggered catecholamine secretion. In 
contrast to the spontaneous release events, electrically stimulated release at sites that 
showed noradrenergic release was composed of a mixture of adrenergic and noradrenergic 
electrochemical signals.  This finding supports the concept that electrically evoked release 
consists of multiple catecholamine quanta originating from several chromaffin cells that 
release in synchrony.   
Although chromaffin cells are electrically excitable (Biales et al., 1976, Kidokoro and 
Ritchie, 1980), the electrical stimulation used in this work does not directly affect them.  
Rather, the stimulation appears to be activating the splanchnic nerve, a group of fibers that 
are not distinguishable by brightfield microscopy (Barbara et al., 1998), because it was 
virtually abolished by HEX.  Electrically stimulated release in murine slices was independent 
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of ATR and 4-DAMP, the two pharmacological agents that collectively block all five subtypes 
of muscarinic receptors found in chromaffin cells.  Thus, electrically stimulated release is 
mediated by the evoked release of acetylcholine that activates nicotinic receptors on 
chromaffin cells.  While some literature reports that muscarinic receptor activation can evoke 
catecholamine release (Nassar-Gentina et al., 1988), we did not find that muscarinic 
antagonists affected release even with long incubation times.  We did not investigate other 
agents that have been reported to evoke catecholamine release from adrenal cells such as 
pituitary adenylate cyclase-activating polypeptide (Przywara et al., 1996) or opioids 
(Malhotra and Wakade, 1987).  Electrically evoked catecholamine release in adrenal slices 
was dependent on extracellular [Ca2+] implying that release arises from exocytosis.  Release 
was also blocked by TTX indicating that functional Na+ channels are necessary for release.  
However, due to the involvement of the splanchnic nerve in electrically stimulated release, 
the TTX and low Ca2+ findings may be due to regulation of acetylcholine release, which in 
turn regulates catecholamine release.  Unlike prior work, we did not find evidence for cell 
junctional coupling in the slice (Moriya et al., 1999). 
Spontaneous catecholamine release events were detected via fast scan cyclic 
voltammetry and their vesicular nature was confirmed with amperometry.  By comparison 
with results in cultured cells, it is clear that these events are single exocytotic events 
ongoing within adrenal tissue slices.  This finding was unexpected because in brain slices, 
prepared in an identical fashion, spontaneous release events are not observed with carbon-
fiber microelectrodes in regions that are rich in catecholaminergic terminals (Kelly and 
Wightman, 1987, Jones et al., 1995, Jones et al., 1996, Bunin et al., 1998, Miles et al., 
2002, Johnson et al., 2007).   However, chemical neurotransmission in the brain is a local 
process with transporters regulating the long range spread of chemical messengers.  In 
contrast, the adrenal gland architecture is optimized to allow access of catecholamines to 
the blood stream where they are directed to distant receptors.  Similar to electrically evoked 
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release, the spontaneous events are triggered by endogenous acetylcholine, presumably 
arising from the splanchnic nerve.   
Some spikes may originate from damaged chromaffin cells caused while lowering 
the microelectrode. However, the approximate 3-fold reduction in the frequency of 
spontaneous catecholamine secretory events caused by HEX indicates that a significant 
amount of the release was from intact chromaffin cells.  In a survey of 16 tissue slices that 
exhibited spontaneous release when the electrode was first inserted, only two showed a 
rundown of secretory events after two hours.  Additionally, after perfusion in a low Ca2+ 
buffer, spontaneous release events decreased by 90% and they did not recover when high 
Ca2+ was reintroduced.  However, pressure ejection of 1 mM ACh after reintroduction of 
extracellular Ca2+ caused spontaneous catecholamine release events indicating the 
rundown was in the splanchnic nerve, not in chromaffin cells.  
Electrochemical detection of a single exocytotic event requires that it occurs very 
close (within a few micrometers) to the sensor surface.  The approximately 1 x 106 
molecules (obtained from the Q values and Faraday’s law (Wightman et al., 1991)) in a 
vesicle are rapidly diluted following release.  When this number of molecules is confined to 
the volume of a chromaffin cell vesicle, the concentration is very high, on the order of 0.5 M 
(Wightman et al., 1991).  However, upon release the concentration rapidly dissipates until it 
reaches an immeasurable concentration a few micrometers from the cell surface (Wightman 
et al., 1995, Cragg and Rice, 2004).  Thus, the vesicular release site on the cell surface can 
be viewed as a point source of material that rapidly dilutes into the extracellular space due 
to the steep concentration gradient.  For this reason, the microelectrode has to be directly 
adjacent to a vesicular release site when fast exocytotic events are observed.  This is true 
even with cyclic voltammetry, an experiment in which the catecholamines are oxidized and 
then returned to their original, reduced form. 
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Amperometry can also be used to analyze observed release during electrical 
stimulation.  The average quantal size of spontaneously released catecholamines in slices 
(~ 418 fC) and electrically stimulated catecholamine release at the same location yields ~ 
600,000 fC detected when measured by amperometry.  Thus, the minimum number of 
quantal events that were evoked was 600,000 fC / 418 fC or ~ 1440 exocytotic events (since 
release is evoked over a larger spatial area than sampled by the electrode, this number is a 
significant underestimate).  If each chromaffin cell contains ~ 140 vesicles in its readily 
releasable pool (Voets et al., 1999), the measured charge corresponds to the contribution 
from a minimum of 10 cells.  Thus, electrically stimulated catecholamine release is the 
merger of release from multiple cells. 
Immunohistochemical surveys (Kippenberger et al., 1999), and content data (Ally et 
al., 1986, Ciolkowski et al., 1992) show that the murine adrenal medulla contain fewer 
noradrenergic than adrenergic sites.  Evidence for this has also been shown in levels of the 
two catecholamines in the blood stream of mice (Forman et al., 1988).  Using a voltammetric 
waveform that allows distinction of norepinephrine and epinephrine, we found that exocytotic 
spikes were always of the same catecholamine subtype when sampled at the same location.  
This is because the majority of chromaffin cells contain only one catecholamine, epinephrine 
or norepinephrine (Ciolkowski et al., 1992), and they secrete what they contain (Pihel et al., 
1994).  However, in cultured cells a minority (< 20 %) release both catecholamines 
(Ciolkowski et al., 1992).  We found that sites that exhibited adrenergic spontaneous events 
showed adrenergic release evoked by electrical stimulation.  A very different situation was 
found during electrical stimulation in which sites that were noradrenergic with respect to 
spontaneous release showed a mixture of catecholamines released with electrical 
stimulation.   
We interpret this as a consequence of forcing multiple cells to fire in synchrony.  With 
synchronous firing from multiple sites, the extracellular concentrations merge.  This makes 
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the concentration gradient less steep and decreases the tendency to dilute.  Thus, 
appreciable concentrations accumulate around the sensor and it takes longer for their 
dilution (Garris et al., 1994).  At adrenergic sites, the probability is that it is surrounded by 
other adrenergic secreting cells because epinephrine is the major catecholamine.  Indeed, 
labeling for phenylethanolamine N-methyltransferase (PNMT), the enzyme that methylates 
norepinephrine into epinephrine, provides evidence that clusters are either adrenergic or 
noradrenergic (Kippenberger et al., 1999, Phillips et al., 2001).  In contrast, noradrenergic 
sites are more likely to have adrenergic neighbors.  Thus, consistent with the experimental 
findings, contributions from both catecholamines become evident during electrically 
stimulated release.   
Conclusion 
 Prior to the present work, only individual exocytotic events from cells on the surface 
of adrenal slices had been investigated using constant potential amperometry.  Here, 
carbon-fiber microelectrodes were inserted beneath the surface of mouse adrenal slices in 
order to look at spontaneous exocytotic and electrically evoked release using both constant 
potential amperometry and fast-scan cyclic voltammetry.  Pharmacological manipulation of 
the observed signals showed that both electrically stimulated release as well as 
spontaneous release occurs from acetylcholine released from the splanchnic nerve binding 
to nAChR on the chromaffin cells, and is exocytotic in nature.  An FSCV waveform which 
can distinguish between epinephrine and norepinephrine was utilized for the first time in 
slices and data collected agreed with previous findings which show that individual clusters of 
chromaffin cells release either epinephrine or norepinephrine, but not both.  The work 
presented here is a major step forward in advancing the methodologies used to study the 
adrenal gland as well as the knowledge of the release of the major hormones released into 
the bloodstream by the adrenal gland. 
 62 
 Dr. Jelena Petrovic is gratefully acknowledged for her contributions for the early 
study of electrically stimulated and spontaneous catecholamine release. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 63 
References 
Ally AI, Vieira L, Reuhl KR (1986) Trimethyltin as a selective adrenal chemosympatholytic 
agent in vivo: effect precedes both clinical and histopathological evidence of toxicity. 
Toxicology 40:215-229. 
Amatore C, Arbault S, Bonifas I, Bouret Y, Erard M, Ewing AG, Sombers LA (2005) 
Correlation between vesicle quantal size and fusion pore release in chromaffin cell 
exocytosis. Biophys J 88:4411-4420. 
Amatore C, Arbault S, Bouret Y, Guille M, Lemaitre F, Verchier Y (2006) Regulation of 
exocytosis in chromaffin cells by trans-insertion of lysophosphatidylcholine and 
arachidonic acid into the outer leaflet of the cell membrane. Chembiochem 7:1998-
2003. 
Arroyo G, Fuentealba J, Sevane-Fernandez N, Aldea M, Garcia AG, Albillos A (2006) 
Amperometric study of the kinetics of exocytosis in mouse adrenal slice chromaffin 
cells: physiological and methodological insights. J Neurophysiol 96:1196-1202. 
Aunis D, Langley K (1999) Physiological aspects of exocytosis in chromaffin cells of the 
adrenal medulla. Acta Physiol Scand 167:89-97. 
Bader MF, Holz RW, Kumakura K, Vitale N (2002) Exocytosis: the chromaffin cell as a 
model system. Ann N Y Acad Sci 971:178-183. 
Barbara JG, Poncer JC, McKinney RA, Takeda K (1998) An adrenal slice preparation for the 
study of chromaffin cells and their cholinergic innervation. J Neurosci Methods 
80:181-189. 
Biales B, Dichter M, Tischler A (1976) Electrical excitability of cultured adrenal chromaffin 
cells. J Physiol 262:743-753. 
Borges R (1997) The rat adrenal gland in the study of the control of catecholamine 
secretion. Semin Cell Dev Biol 8:113-120. 
Borges R, Camacho M, Gillis KD (2008) Measuring secretion in chromaffin cells using 
electrophysiological and electrochemical methods. Acta Physiol (Oxf) 192:173-184. 
Brandt BL, Hagiwara S, Kidokoro Y, Miyazaki S (1976) Action potentials in the rat chromaffin 
cell and effects of acetylcholine. J Physiol 263:417-439. 
 64 
Bunin MA, Prioleau C, Mailman RB, Wightman RM (1998) Release and uptake rates of 5-
hydroxytryptamine in the dorsal raphe and substantia nigra reticulata of the rat brain. 
J Neurochem 70:1077-1087. 
Cahill PS, Walker QD, Finnegan JM, Mickelson GE, Travis ER, Wightman RM (1996) 
Microelectrodes for the measurement of catecholamines in biological systems. Anal 
Chem 68:3180-3186. 
Chan SA, Smith C (2003) Low frequency stimulation of mouse adrenal slices reveals a 
clathrin-independent, protein kinase C-mediated endocytic mechanism. J Physiol 
553:707-717. 
Ciolkowski EL, Cooper BR, Jankowski JA, Jorgenson JW, Wightman RM (1992) Direct 
observation of epinephrine and norepinephrine co- secretion from individual adrenal 
medullary chromaffin cells. J Am Chem Soc 114:2815-2821. 
Cragg SJ, Rice ME (2004) DAncing past the DAT at a DA synapse. Trends Neurosci 
27:270-277. 
de Diego AMG, Gandia L, Garcia AG (2008) A physiological view of the central and 
peripheral mechanisms that regulate the release of catecholamines at the adrenal 
medulla. Acta Physiologica 192:287-301. 
Douglas WW, Poisner AM (1965) Preferential release of adrenaline from the adrenal 
medulla by muscarine and pilocarpine. Nature 208:1102-1103. 
Douglas WW, Rubin RP (1961a) Mechanism of nicotinic action at the adrenal medulla: 
calcium as a link in stimulus-secretion coupling. Nature 192:1087-1089. 
Douglas WW, Rubin RP (1961b) The role of calcium in the secretory response of the 
adrenal medulla to acetylcholine. J Physiol 159:40-57. 
Forman DT, Bradford BU, Handler JA, Glassman EB, Thurman RG (1988) Involvement of 
hormones in the swift increase in alcohol metabolism. Ann Clin Lab Sci 18:318-325. 
Fox GQ (1996) A morphometric analysis of exocytosis in KCl-stimulated bovine chromaffin 
cells. Cell Tissue Res 284:303-316. 
Fuhrman FA (1986) Tetrodotoxin, tarichatoxin, and chiriquitoxin: historical perspectives. Ann 
N Y Acad Sci 479:1-14. 
 65 
Garris PA, Ciolkowski EL, Pastore P, Wightman RM (1994) Efflux of dopamine from the 
synaptic cleft in the nucleus accumbens of the rat brain. J Neurosci 14:6084-6093. 
Haynes CL, Siff LN, Wightman RM (2007) Temperature-dependent differences between 
readily releasable and reserve pool vesicles in chromaffin cells. Biochim Biophys 
Acta 1773:728-735. 
Johnson MA, Villanueva M, Haynes CL, Seipel AT, Buhler LA, Wightman RM (2007) 
Catecholamine exocytosis is diminished in R6/2 Huntington's disease model mice. J 
Neurochem 103:2102-2110. 
Jones SR, Garris PA, Wightman RM (1995) Different effects of cocaine and nomifensine on 
dopamine uptake in the caudate-putamen and nucleus accumbens. J Pharmacol Exp 
Ther 274:396-403. 
Jones SR, Lee TH, Wightman RM, Ellinwood EH (1996) Effects of intermittent and 
continuous cocaine administration on dopamine release and uptake regulation in the 
striatum: in vitro voltammetric assessment. Psychopharmacology (Berl) 126:331-338. 
Kajiwara R, Sand O, Kidokoro Y, Barish ME, Iijima T (1997) Functional organization of 
chromaffin cells and cholinergic synaptic transmission in rat adrenal medulla. Jpn J 
Physiol 47:449-464. 
Kawagoe KT, Zimmerman JB, Wightman RM (1993) Principles of voltammetry and 
microelectrode surface states. J Neurosci Methods 48:225-240. 
Kelly RS, Wightman RM (1987) Detection of dopamine overflow and diffusion with 
voltammetry in slices of rat brain. Brain Res 423:79-87. 
Kennedy RT, Jones SR, Wightman RM (1992) Simultaneous measurement of oxygen and 
dopamine: coupling of oxygen consumption and neurotransmission. Neuroscience 
47:603-612. 
Kidokoro Y, Ritchie AK (1980) Chromaffin cell action potentials and their possible role in 
adrenaline secretion from rat adrenal medulla. J Physiol 307:199-216. 
Kippenberger AG, Palmer DJ, Comer AM, Lipski J, Burton LD, Christie DL (1999) 
Localization of the noradrenaline transporter in rat adrenal medulla and PC12 cells: 
evidence for its association with secretory granules in PC12 cells. J Neurochem 
73:1024-1032. 
 66 
Kolski-Andreaco A, Cai H, Currle DS, Chandy KG, Chow RH (2007) Mouse adrenal 
chromaffin cell isolation. J Vis Exp 129. 
Malhotra RK, Wakade AR (1987) Non-cholinergic component of rat splanchnic nerves 
predominates at low neuronal activity and is eliminated by naloxone. J Physiol 
383:639-652. 
Martin AO, Mathieu MN, Chevillard C, Guerineau NC (2001) Gap junctions mediate 
electrical signaling and ensuing cytosolic Ca2+ increases between chromaffin cells in 
adrenal slices: A role in catecholamine release. J Neurosci 21:5397-5405. 
Michael D, Travis ER, Wightman RM (1998) Color images for fast-scan CV measurements 
in biological systems. Anal Chem 70:586A-592A. 
Miles PR, Mundorf ML, Wightman RM (2002) Release and uptake of catecholamines in the 
bed nucleus of the stria terminalis measured in the mouse brain slice. Synapse 
44:188-197. 
Montero M, Alonso MT, Carnicero E, Cuchillo-Ibanez I, Albillos A, Garcia AG, Garcia-
Sancho J, Alvarez J (2000) Chromaffin-cell stimulation triggers fast millimolar 
mitochondrial Ca2+ transients that modulate secretion. Nat Cell Biol 2:57-61. 
Montesinos MS, Machado JD, Camacho M, Diaz J, Morales YG, Alvarez de la Rosa D, 
Carmona E, Castaneyra A, Viveros OH, O'Connor DT, Mahata SK, Borges R (2008) 
The crucial role of chromogranins in storage and exocytosis revealed using 
chromaffin cells from chromogranin A null mouse. J Neurosci 28:3350-3358. 
Moriya H, Takagi Y, Nakanishi T, Hayashi M, Tani T, Hirotsu I (1999) Affinity profiles of 
various muscarinic antagonists for cloned human muscarinic acetylcholine receptor 
(mAChR) subtypes and mAChRs in rat heart and submandibular gland. Life Sci 
64:2351-2358. 
Moser T (1998) Low-conductance intercellular coupling between mouse chromaffin cells in 
situ. J Physiol 506 ( Pt 1):195-205. 
Moser T, Neher E (1997) Rapid exocytosis in single chromaffin cells recorded from mouse 
adrenal slices. J Neurosci 17:2314-2323. 
Nassar-Gentina V, Pollard HB, Rojas E (1988) Electrical activity in chromaffin cells of intact 
mouse adrenal gland. Am J Physiol 254:C675-683. 
 67 
Phillips JK, Dubey R, Sesiashvilvi E, Takeda M, Christie DL, Lipski J (2001) Differential 
expression of the noradrenaline transporter in adrenergic chromaffin cells, ganglion 
cells and nerve fibres of the rat adrenal medulla. J Chem Neuroanat 21:95-104. 
Pickel VM, Joh TH, Field PM, Becker CG, Reis DJ (1975) Cellular localization of tyrosine 
hydroxylase by immunohistochemistry. J Histochem Cytochem 23:1-12. 
Pihel K, Schroeder TJ, Wightman RM (1994) Rapid and Selective Cyclic Voltammetric 
Measurements of Epinephrine and Norepinephrine as a method to Measure 
Secretion from Single Bovine Adrenal Medullary Cells. Anal Chem 66:4532-4537. 
Przywara DA, Guo X, Angelilli ML, Wakade TD, Wakade AR (1996) A non-cholinergic 
transmitter, pituitary adenylate cyclase-activating polypeptide, utilizes a novel 
mechanism to evoke catecholamine secretion in rat adrenal chromaffin cells. J Biol 
Chem 271:10545-10550. 
Suudhof TC (2008) Neurotransmitter release. Handb Exp Pharmacol 1-21. 
Travis ER, Wightman RM (1998) Spatio-temporal resolution of exocytosis from individual 
cells. Annu Rev Biophys Biomol Struct 27:77-103. 
Troyer KP, Wightman RM (2002) Temporal separation of vesicle release from vesicle fusion 
during exocytosis. J Biol Chem 277:29101-29107. 
Voets T, Neher E, Moser T (1999) Mechanisms underlying phasic and sustained secretion in 
chromaffin cells from mouse adrenal slices. Neuron 23:607-615. 
von Gersdorff H, Matthews G (1999) Electrophysiology of synaptic vesicle cycling. Annu Rev 
Physiol 61:725-752. 
von Ruden L, Neher E (1993) A Ca-dependent early step in the release of catecholamines 
from adrenal chromaffin cells. Science 262:1061-1065. 
Wakade AR, Wakade TD (1982) Secretion of catecholamines from adrenal gland by a single 
electrical shock: electronic depolarization of medullary cell membrane. Proc Natl 
Acad Sci U S A 79:3071-3074. 
Wightman RM, Jankowski JA, Kennedy RT, Kawagoe KT, Schroeder TJ, Leszczyszyn DJ, 
Near JA, Diliberto EJ, Jr., Viveros OH (1991) Temporally resolved catecholamine 
spikes correspond to single vesicle release from individual chromaffin cells. Proc Natl 
Acad Sci U S A 88:10754-10758. 
 68 
Wightman RM, Schroeder TJ, Finnegan JM, Ciolkowski EL, Pihel K (1995) Time course of 
release of catecholamines from individual vesicles during exocytosis at adrenal 
medullary cells. Biophys J 68:383-390. 
Zwart R, Vijverberg HP (1997) Potentiation and inhibition of neuronal nicotinic receptors by 
atropine: competitive and noncompetitive effects. Mol Pharmacol 52:886-895. 
 
 
  
Chapter III 
Distinguishing Splanchnic Nerve and Chromaffin Cell Stimulation 
Introduction 
Electrical stimulation is frequently used to excite neuronal tissue and evoke 
exocytosis.  However, selectivity is always a concern because the stimulus can cause 
exocytosis from afferent terminals within the tissue as well as depolarizing cell bodies within 
the tissue (Merrill et al., 2005).  An example that was characterized several years ago is the 
electrical stimulation of the intact adrenal gland.  Wakade and Wakade showed that an 
electrical stimulation could evoke catecholamine release both by directly depolarizing the 
chromaffin cells as well as by depolarizing the splanchnic nerve that causes acetylcholine 
release that in turn triggers catecholamine exocytosis from chromaffin cells (Wakade and 
Wakade, 1982).  These investigators were able to distinguish these two contributions by the 
select use of pharmacological agents and well as by adjusting the stimulation parameters.   
Release of catecholamines from isolated chromaffin cells has been extensively 
investigated in recent years by electrochemical and patch-clamp techniques. 
Electrochemistry with carbon-fiber microelectrodes can resolve each exocytotic event by 
oxidizing the packet of released catecholamines.  Patch clamp probes exocytosis by 
measuring capacitance changes as the area of the cell membrane is increased by 
exocytotic events (Neher and Marty, 1982, Wightman et al., 1991, Travis and Wightman, 
1998, Troyer and Wightman, 2002).  More recently, these techniques have been used in 
slices of the adrenal gland to understand the processes that occur in a more intact 
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preparation (Moser and Neher, 1997, Voets et al., 1999).  Arroyo et al. showed that 
amperometric recordings in adrenal slices can resolve exocytotic events that are identical to 
those measured at the single cell level (Arroyo et al., 2006).  Petrovic et al. used both 
amperometry and cyclic voltammetry to probe the pharmacology of catecholamine release 
within adrenal slices (Petrovic et al., 2010).  Cyclic voltammetry is an electrochemical 
method that allows the identification of the species detected, allowing norepinephrine and 
epinephrine to be distinguished.  Both electrochemical studies in intact slices demonstrated 
that electrically evoked release was caused by activation of the splanchnic nerve because 
hexamethonium, a nicotinic receptor antagonist, blocked the evoked release. 
In this work, we reinvestigate the dual release pathway identified many years ago by 
Wakade and Wakade.  Patch clamp recordings have shown that chromaffin cells become 
permeable to Ca2+ when their membranes are depolarized and that Ca2+ plays an integral 
role in the process of exocytosis (Augustine and Neher, 1992, Neher and Augustine, 1992, 
Neher, 1998, Smith et al., 1998).  In addition, chromaffin cells are capable of firing action 
potentials that can be decreased in frequency by tetrodotoxin (TTX), a Na+ channel blocker, 
and that is dependent on K+ channels for repolarization (Kidokoro and Ritchie, 1980, 
Nassar-Gentina et al., 1988).  Here, we use a method with high special and temporal 
resolution, fast-scan cyclic voltammetry (FSCV), as well as more modern pharmacology 
probing the roles of specific Ca2+ channels to resolve the originally claimed dual mechanism 
of electrically evoked catecholamine release with contribution both from splanchnic nerve 
stimulation and direct chromaffin cell depolarization.  These studies reveal that the 
chromaffin cell is more difficult to depolarize than the splanchnic nerve. 
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Experimental 
Animals 
 Wild-type C57BL/6J female mice, 4-8 weeks old, were used in this work (stock no. 
000664, Jackson Laboratories, Bar Harbor, ME, USA).  Upon receipt, mice were housed at 
the University of North Carolina Husbandry Facility with ab libitum access to food and water 
and under closely controlled environmental conditions (temperature, humidity, and 12-hr 
light/dark cycles).  Live animal handling procedures and experimental protocols were 
approved by the University of North Carolina’s Institutional Animal Care and Use Committee.   
Adrenal Slice Methods 
Adrenal gland slicing procedures were adapted from literature descriptions with slight 
modification (Moser and Neher, 1997, Barbara et al., 1998, Petrovic et al., 2010).  Mice 
were anesthetized under anhydrous ethyl ether (Fisher Scientific) and decapitated.  A 
midline abdominal incision allowed for access to the adrenal glands.  Glands were placed 
into ice-cold and 95 % O2 – 5 % CO2 saturated low Ca
2+ bicarbonate-buffered saline (BBS), 
containing (in mM):  0.1 CaCl2, 125 NaCl, 26 NaHCO3, 2.5 KCl, 1.25 NaH2PO4, 3 MgCl2, 10 
glucose, and 10 HEPES, and its pH was adjusted to 7.4.    Excess fat was removed from the 
glands, and the glands were embedded in a 3% agarose (w/v) in low Ca2+ BBS (Promega). 
Once cooled, agarose blocks containing the glands were secured onto a Teflon specimen 
holder that was used to orient the largest base of the gland parallel to the slicing blade. The 
glands were cut into slices of ~200 µm in thickness using a vibratome slicer filled with low 
Ca2+ BBS (Campden Instruments, World Precision Instruments, Leics, U.K.).    
Slices were immediately placed into a perfusion chamber (open diamond bath 
heated chamber, RC-22, Warner Instruments, Hamden, CT) and secured with a stainless 
steel Lycra® thread anchor (1.5 mm-2.0 mm thread spacing, Warner Instruments, Hamden, 
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CT).  The chamber was continually perfused with 95 % O2 – 5 % CO2 saturated BBS, at a 
rate of 1-2 mL/min with the same composition as the low Ca2+ BBS, except with 2 mM CaCl2 
and 1 mM MgCl2 at pH 7.4.  To ensure physiological conditions and to minimize slice 
perturbations, the temperature of the perfusion chamber was kept at 37 °C using an 
automatic temperature controller (Warner Instruments, LLC).  All of the experiments were 
completed within a 10-hr post mortem period. 
Fast-Scan Cyclic Voltammetry 
Carbon-fiber elliptical microelectrodes were fabricated as previously described 
(Kawagoe et al., 1993, Cahill et al., 1996).  Prior to use, carbon-fiber microelectrodes were 
soaked in an activated carbon / 2-propanol mixture for a minimum of 30 min to remove 
surface debris (Ranganathan et al., 1999).  Microelectrodes were then backfilled with 4 M 
CH3COOK / 0.15 M NaCl and mounted onto a potentiostat headstage.  A stainless-steel 
wire was inserted into the microelectrode to make electrical contact.  Experiments were 
conducted inside a grounded Faraday’s cage.  Catecholamine release was monitored with 
an Axopatch 200B patch-clamp amplifier in voltage clamp mode and β=0.1 configuration 
(Axon Instruments, Molecular Devices, Union City, CA).  The signal was filtered with a built-
in analog low-pass Bessel filter (80 dB/decade) at 5 kHz.  The potentiostat was controlled 
via LABVIEW software, TarHeel CV (ESA, Chelmsford, MA).  Measured currents were 
digitized using a National Instruments PCI-MIO-16XE-10 card and monitored as a function 
of the applied potential.  The waveform for cyclic voltammetry was a potential sweep from -
400 mV to +1000 mV and back to -400 mV at a scan rate of 600 V/s applied at a 10 Hz 
repetition rate.  In between scans, the electrode potential was held at -400 mV allowing for 
catecholamine adsorption onto a carbon fiber surface, a procedure that increases the 
sensitivity to catecholamines (Heien et al., 2003).  
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Electrical stimulation of slices employed two tungsten microelectrodes glued together 
with their tips separated by approximately 250 µm (FHC, Bowdoin, ME).  The stimulating 
electrode was positioned on the slice surface under a 40X water immersion objective Fluor 
WD 2.0 on an upright microscope (Nikon Eclipse E600FN, Lewisville, TX).  Microelectrodes 
were positioned with a multi-manipulator controller (1 µm display resolution, MPC-200-ROE, 
Sutter Instruments).  To avoid recordings from a damaged tissue layer, microelectrodes 
were lowered approximately 30 µm below the slice surface (Kennedy et al., 1992, Petrovic 
et al., 2010).  To evoke catecholamine release, trains of initially positive biphasic pulses (10 
pulse, 10 Hz) were applied to the stimulating electrodes between scans using a National 
Instruments PCI-6711 card, controlled by Tar Heel CV to ensure no overlap between CV 
scans for data collection and stimulation pulses.  Slices were equilibrated for ~ 2 hrs prior to 
data collection.  During the equilibration period slices were electrically stimulated every 3-5 
min.  These data were used to establish a baseline level of catecholamine release.  
Voltammetric data analysis employed the TarHeel CV data analysis package (ESA, 
Chelmsford, MA).  Digital background subtraction was used to remove the background 
current to reveal the cyclic voltammogram of the species detected. Sets of cyclic 
voltammograms were displayed as color plots (Michael et al., 1998).  Each color plot 
displays a set of cyclic voltammograms that were sequentially acquired in time (abscissa) 
while the applied potential is shown as the ordinate.  The currents are shown in color.  To 
follow the time course of concentration changes, the current at +600 mV (the peak current 
for catecholamine oxidation) was extracted from the color plots.  Since the electrochemical 
signals recorded in the adrenal gland are a mixture of epinephrine, and norepinephrine 
(Petrovic et al., 2010), electrodes were post calibrated in a flow injection system with 5 µM 
epinephrine, norepinephrine, and a 50:50 mixture of 2.5 µM of each catecholamine. 
Concentrations measured during application of pharmacological agents are reported as 
values normalized to currents recorded before drug application.   
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Pharmacology 
Pharmacological agents employed herein include thapsigargin (THG), tetrodotoxin 
(TTX), hexamethonium (HEX), 4-DAMP, ethylene glycol tetraacetic acid (EGTA), and 
nifedipine, were all from Sigma-Aldrich (St. Louis, MO, USA) and used as received.  Drugs 
were dissolved in low Ca2+ or recording BBS and superfused through a slice chamber at a 
rate of ~ 2 mL/min. 
Statistical Analysis 
Statistical analysis was done in GraphPad Prism (GraphPad Software, Inc., San 
Diego, CA, USA).  Student’s t-test (unpaired) was used to test for significant differences 
between data sets.  Data were considered significantly different at the 95 % confidence 
level.   n = number of slices, unless noted otherwise.    
Results 
Characteristics of Evoked Catecholamine Release 
In prior work we showed that local electrical stimulation of adrenal medullary slices 
with stimulus trains consisting of 10 biphasic pulses, 1 ms/phase, 150 µA at 10 Hz results in 
catecholamine release that increases during the stimulation and then decreases 1-2 s after 
the stimulation is terminated (Petrovic et al., 2010).  Furthermore, we showed that the 
pharmacological manipulation during such stimulations were consistent with activation of the 
splanchnic nerve causing release of acetylcholine.  We refer to this as the fast phase of 
catecholamine release.  However, quite different results were obtained with an identical 
stimulation except with a greater amplitude (n = 3, Figure 3.1A).  With stimulus amplitude of 
450 µA, catecholamine release is still evoked, but it lasts over a longer time frame.  A 
maximum corresponding to the fast phase is observed shortly (1-2 s) after the stimulation is 
terminated and it is followed by a broad, larger increase that maximizes ~ 8 -10 s after the 
 75 
 
 
 
 
Figure 3.1.  Effect of stimulation intensity on biphasic release.  (A) Representative 
electrically stimulated catecholamine release with decreasing intensity (350 – 150 µA) with 
2.0 ms/phase pulse width.  (B) Color plot of catecholamine release from a 450 µA 
stimulation.  Cyclic voltammograms at 2 (black, fast phase) and 9 (red, slow phase) seconds 
are shown on the right as indicated by the dashed lines.  (C) Color plot of catecholamine 
release from a 150 µA stimulation.  Cyclic voltammograms at 2 (black, fast phase) and 9 
(red, slow phase) seconds are shown on the right as indicated by the dashed lines.  (D) 
Stimulation intensity data were summarized for the fast and slow phase as the amount of 
release relative to that collected with a 350 µA stimulation (n = 3). 
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stimulation.  We refer to this second feature as the slow phase of release.  As the stimulus 
amplitude was diminished, the slow phase diminished more rapidly than the fast phase.  
Similar behavior was seen within chromaffin-cell clusters throughout the adrenal medulla.  In 
some instances, the slow phase was larger in amplitude than the fast phase and 
overwhelmed it. The cyclic voltammograms (Figure 3.1B and C, encoded as color plots) 
show that catecholamine release is the primary contributor to both phases.  The maximum 
amplitude of each phase as a function of stimulus intensity is shown in Figure 3.1D. 
To probe further the effects of electrical stimulation parameters on catecholamine 
release, various stimulation pulse widths were applied to the slice using a 350 µA 
stimulation amplitude.  Stimulating pulse widths (per phase) of 2.0 ms, 1.5 ms, 1.0 ms, and 
0.5 ms were employed (pulse widths were delivered in random order).  The slow phase was 
not present with stimulation widths of ≤ 1 ms per phase (n = 5, Figure 3.2).  The remaining 
experiments described here were designed to probe the origin of the slow release phase 
and used relatively large stimulations (350 µA and 2.0 ms/phase width).   
Modulation of Catecholamine Release by Ions 
We investigated the role of cholinergic receptors on the slow phase of catecholamine 
release.  As previously shown, the fast phase was diminished in the presence of 100 µM 
HEX, a nicotinic acetylcholine receptor blocker.  In contrast, the slow phase was only 
marginally affected by HEX (representative traces in Figure 3.3A, average maximal 
amplitudes in Figure 3.3B, n = 5).  Previous work has shown that splanchnic nerve 
dependent catecholamine release measured by FSCV is independent of muscarinic 
receptors (Petrovic et al., 2010).   Perfusion with 1.0 µM 4-DAMP (n = 3, data not shown), a 
selective muscarinic receptor antagonist also did not affect the slow phase of electrically 
stimulated release.  Further, perfusion with 0.5 µM atropine (n = 3, data not shown), a high 
affinity muscarinic receptor antagonist had no effect on the biphasic release.  The inability of  
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Figure 3.2.  Effect of stimulation width on biphasic release. Representative electrically 
stimulated catecholamine release at an intensity of 350 µA with decreasing pulse width (2.0 
– 0.5 ms/phase). 
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Figure 3.3.  Modulation of catecholamine release by ions.  (A) Representative trace for the 
perfusion of 100 µM HEX before and after the application of drug.  (B) Summary of effects of 
HEX on fast and slow catecholamine release (n = 5).  (C) Representative trace for the 
perfusion of 1 µM TTX before and after the application of drug.  (D) Summary of effects of 
TTX on fast and slow catecholamine release (n = 5).  *, p<0.05, ***, p<0.001. 
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cholinergic antagonists to affect the slow phase of catecholamine release indicates that 
acetylcholine released from the splanchnic nerve is unnecessary for this type of release. 
To evaluate the involvement of Na+-dependent action potentials in slow phase 
catecholamine release, 1 µM TTX, an inhibitor of voltage-gated Na+ channels (Catterall, 
1980), was perfused through the slice.  The slow phase of the electrically stimulated release 
was found to be much less sensitive to TTX than the fast phase, which was abolished 
almost immediately upon perfusion as previously reported (representative example m Figure 
3.3C).  A summary of the effects of TTX on the maximum amplitude of the two phases is 
shown in Figure 3.3D (n = 5).   
Biphasic Signal Dependence on Intra- and Extracellular [Ca2+]  
 To explore the [Ca2+] dependence of the slow phase of electrically stimulated 
release, the slices were perfused with BBS containing 0.1 mM Ca2+.  In this media, the fast 
phase release component was eliminated while the slow phase remained intact 
(representative example shown in Figure 3.4A).  Data from multiple trials are summarized in 
Figure 3.4B (n = 3).  When the slice was perfused with BBS containing 0 mM Ca2+ and 1 
mM EGTA, both the fast and slow release was abolished within 15 minutes (representative 
example in Figure 3.4C).  Both phases partially recovered when extracellular Ca2+ levels 
were returned to their normal level (2 mM). These data are summarized in Figure 3.4D (n = 
5).  Thus, while the slow phase does not require concentrations of physiological levels of 
extracellular Ca2+, it does require some Ca2+ for release to occur.   
 To test the possibility that the slow phase requires release of cytoplasmic Ca2+ levels 
from intracellular stores such as endoplasmic reticulum, the slices were perfused with 
thapsigargin (THG).  THG is  a pharmacological agent that increases cytosolic Ca2+ levels 
by binding to SERCA enzymes and preventing Ca2+ from being pumped into the 
sarcoplasmic and endoplasmic reticula (Miranda-Ferreira et al., 2009).  Perfusion of 1 µM  
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Figure 3.4.  Biphasic signal dependence on extracellular Ca2+.  (A) Representative 
experiment for perfusion with a low extracellular calcium (0.1 mM) buffer before and after 
application of low Ca2+ buffer.  (B) Summary of effects of perfusion of low calcium buffer on 
fast and slow catecholamine release (n = 3).  (C) Representative experiment where 
extracellular calcium was completely removed from the perfusion buffer using 1 mM EGTA 
before and after application of drug.  (D) Summary of effects of EGTA on fast and slow 
catecholamine release (n = 5).  **, p<0.01, ***, p<0.001. 
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THG dissolved in low [Ca2+] BBS buffer for 1 hour did not have an effect on either the fast or 
the slow components of electrically stimulated release (n = 4, data not shown).   
Effect of L-type Ca2+ Channel Blocker on Slow Release 
 It has been shown that L-type voltage gated Ca2+ channels (VGCCs) are located on 
chromaffin cells but not on the splanchnic nerve and that they play a key role in the 
homeostatic mechanism of catecholamine release (Shukla and Wakade, 1991, Akiyama et 
al., 2004, Marcantoni et al., 2008).  To evaluate the role of these channels in the different 
phases of release, we perfused 10 µM nifedipine, an L-type Ca2+ channel blocker, through 
the slice. The maximal amplitude of the slow phase was decreased to 29% of its original 
value by this perfusion while 74% of the fast phase remained.  Figure 3.5A shows biphasic 
release before nifedipine is put onboard, while 5B is the observed release 10 minutes after 
nifedipine application, and finally Figure 3.5C shows that the slow phase was completely 
abolished by nifedipine 20 minutes after nifedipine had been put on board.  A summary of 
the effects of nifedipine on the biphasic response is shown in Figure 3.5D (n = 5). 
Biphasic Signal Dependence on the Distance between Working and Stimulating Electrodes 
To probe the effect of the location of the stimulating electrode relative to the carbon 
fiber microelectrode, the stimulating electrode was moved away from the working electrode 
in 50 µm increments and release was evoked (Figure 3.6).  At increasing distances, both the 
fast and slow phases decrease in intensity.  The slow phase is diminished to a greater 
degree, however, allowing the fast phase to predominate at greater separations of the 
stimulating electrode and the carbon-fiber microelectrode.  At the greatest distances 
between the electrodes, where only the fast phase was present (200 µm), perfusion with 
100 µM HEX (Figure 3.7A), or 1 µM TTX (Figure 3.7B) reversibly eliminated the stimulated 
release.  These data are summarized in Figure 3.7C (n = 3, p<0.001 for each drug).  
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Figure 3.5.  Role of L-type Ca2+ channels on biphasic release.  (A) Biphasic release before 
the application of drug.  (B) Release 10 min into perfusion with 10 µM nifedipine.  (C) 
Release 20 min into perfusion with 10 µM nifedipine.  (D)  Summary of effects of nifedipine 
on fast and slow catecholamine release after at least 15 minutes of incubation (n = 5).  
***,p<0.001. 
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Figure 3.6.  Biphasic signal dependence on the distance between the working and 
stimulating electrodes. Using a 350 µA, 1 ms/phase stimulation (10 Hz, 10 pulses), the 
stimulating electrode was placed (A) 0 µm, (B) 50 µm, (C) 100 µm, (D) 200 µm away from 
the working electrode.  
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Figure 3.7.  Modulation of remotely stimulated release by ions.  (A) Representative 
experiment showing the effect of 100 µM HEX with 200 µm between the stimulating and 
working electrode.  (B) Representative experiment showing the effect of 1 µM TTX with 200 
µm between the stimulating and working electrode.  (C) Summary of effects of perfusion of 
HEX (n = 3) and TTX (n = 3) as well as the recovery of fast release when the stimulating 
electrode is 200 µm from the working electrode.  ***, p<0.001. 
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Discussion 
Prior work in the perfused adrenal gland demonstrated that electrical stimulation 
could evoke catecholamine release by two mechanisms:  indirectly by depolarization of the 
splanchnic nerve or directly by depolarization of the chromaffin cells themselves (Wakade, 
1981, Wakade and Wakade, 1982).  Catecholamine release arising from splanchnic nerve 
stimulation occurs because released acetylcholine from the splanchnic nerve activates 
nicotinic receptors on chromaffin cells.  The prior work demonstrated that direct 
depolarization of chromaffin cells required higher stimulation intensity than were required to 
activate the splanchnic nerve.  The present work in which release is detected with a 
microsensor inserted directly into slices containing the adrenal medulla supports the prior 
findings, and provides additional information concerning the temporal and spatial 
dependence of the two mechanisms that cause catecholamine release.  The fast phase of 
release clearly originates from splanchnic nerve stimulation because it is blocked by a 
nicotinic antagonist. The slow phase of release is unaffected by nicotinic antagonists, but it 
is inhibited by an L-type calcium channel antagonist.  This demonstrates that the slow phase 
of release originates from direct depolarization of chromaffin cells because acetylcholine 
release from the splanchnic nerve is known to be unaffected by L-type calcium channel 
antagonists whereas their presence inhibits catecholamine release from electrically excited 
adrenal glands (Akiyama et al., 2004).   
Evidence that the splanchnic nerve is not involved in the slow phase of 
catecholamine release also comes from the experiments with TTX incubation.  Consistent 
with our prior work, TTX blocked the splanchnic-nerve dependent component of release of 
catecholamines, demonstrating the need for action potential propagation supported by 
voltage-dependent Na+ channels (Kao and Fuhrman, 1963, Watanabe et al., 1967).   
Chromaffin cells are drastically different, however, because they do not require the opening 
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of Na+ for catecholamine release.  Rather, direct depolarization of the chromaffin cell can 
cause release due to opening of VGCCs (Sontag et al., 1990, Gerber et al., 1995).  This is 
an important distinction as it illustrates the different mechanisms in play during high intensity 
electrical stimulation and the resulting biphasic release.   
The splanchnic nerve consists of fine fibers closely associated with Schwann cells 
that innervate the chromaffin cells (Tomlinson and Coupland, 1990, de Diego, 2010).  As 
such, they would be expected to be depolarized by milder electrical stimulations than the 
chromaffin cells themselves.  The splanchnic nerve can be depolarized over large distances 
(over 200 µm) due to the morphology of its innervation throughout the gland (Tomlinson and 
Coupland, 1990, Kajiwara et al., 1997, de Diego, 2010).  This propagation of the stimulation 
through the splanchnic nerve network allows release to be evoked from chromaffin cells 
throughout the tissue including those directly adjacent to the microelectrode.   Release 
adjacent to the microelectrode would appear rapidly leading to the fast appearance of 
released catecholamines.  While chromaffin cells themselves are electrically excitable 
(Kidokoro and Ritchie, 1980), their lack of myelination and their larger size  requires that 
they receive a greater stimulus intensity to cause exocytosis (Millar et al., 1985).  Thus, the 
chromaffin cells most likely to be directly depolarized by the stimulation are those that are 
closest to the stimulating electrode.  For detection, the released catecholamines from direct 
chromaffin cell stimulation must diffuse to the detecting microelectrode, a time-dependent 
process.  Consistent with this interpretation, the amplitude of the slow phase diminished 
more rapidly than the fast phase when the stimulating electrode was moved further away 
from the carbon-fiber microelectrode.   
We also considered other mechanisms that could be the origin of the slow phase of 
release.  One is the interplay of intracellular [Ca2+] and muscarinic cholinergic receptors.  At 
isolated chromaffin cells muscarinic receptor activation has been shown to cause release of 
Ca2+ from intracellular stores (Role and Perlman, 1983, Wakade and Wakade, 1983, Cheek 
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et al., 1989).  Exocytosis, when evoked by mobilization of intracellular Ca2+ stores, is 
temporally delayed in comparison to endogenous acetylcholine induced response 
(Misbahuddin et al., 1985).  However, the slow phase did not display any dependence on 
THG, a pharmacological agent that causes release of Ca2+ from intracellular stores.  
Furthermore, the slow phase was insensitive to both ATR and 4-DAMP, a group of highly 
selective muscarinic receptor blockers.  Taken together, the negative findings indicate that 
the slow phase of catecholamine release does not originate from mobilization of intracellular 
Ca2+ via activation of muscarinic receptors.  Electroporation was also considered as a 
mechanism contributing to the slow phase of release.  High electric fields are known to 
cause transient pores in cell membranes (Ryttsen et al., 2000, Gehl, 2003, Olofsson et al., 
2003).  Electroporation was achieved at single cells stimulated with microelectrodes as 
evidenced by entry of fluorescent dye (Figure 3.8A-D) (Ryttsen et al., 2000).  However, no 
evidence for electroporation was detected within slices using the tungsten stimulating 
electrodes with the stimulation parameters used to observe the slow (or fast) phases of 
catecholamine release (Figure 3.8E-F).  It requires very large electric fields to cause 
electroporation of cells (at least 1 kV/cm).  Given the intensity of the stimulation (2.45 V to 
achieve 350 µA) as well as the distance between the stimulating electrodes (100 µm), 
electric fields no larger than 250 V/cm were exposed to chromaffin cells within a slice.  
Furthermore, when electric fields close to 1 kV/cm were applied to the tungsten stimulating 
electrodes, bubbles were observed at the electrode surface indicating that electroporation 
using electrodes with a tungsten surface is not feasible because the electric fields required 
to cause electroporation also cause the breakdown of water at the electrode. 
Due to the crucial contribution of Ca2+ signaling in the secretion of catecholamines 
(Burgoyne, 1991, Burgoyne et al., 1993, Garcia et al., 2006), it is important to pay close 
attention to the types of VGCCs that are present on the cell being studied, as well as the 
different roles each plays in the multi-step process of release. It has been shown that while  
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Figure 3.8.  Analysis of electroporation at single cells and in slices.  (A) and (C) Brightfield 
images of single chromaffin cells.  (B) Fluorescence of the same cell as in (A) after 
incubation with 10 µM fluorescein but not exposed to an electric field.  (D) Fluorescence of 
the same cell as in (C) after incubation with 10 µM fluorescein and electroporated with a 1.5 
kV/cm electric field between two plastic insulated carbon-fiber microelectrodes.  (E) 
Brightfield image of an adrenal slice with the tungsten stimulating electrodes placed on the 
surface.  (F) Fluorescence image of the slice shown in (E) after incubation with 10 µM 
fluorescein and applied stimulation between the bipolar tungsten electrode (350 µA, 
biphasic, 10 Hz, 10 pulses). Scale bar A-D, 5 µm.  Scale bar E-F, 50 µm. 
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N and P/Q VGCCs are functionally coupled with exocytosis on chromaffin cells and are 
believed to be spatially related to one another (Alvarez et al., 2008, Fox et al., 2008), while 
L-type VGCCs, which take a longer time than P/Q and N VGCCs to inactivate, are known to 
regulate the autorhythmicity of chromaffin cell action potentials and could play a key role in 
the homeostatic mechanism of catecholamine release (Marcantoni et al., 2008).  However, 
L-type VGCCs are not present on splanchnic nerves (Akiyama et al., 2004).  These 
properties of L-type VGCCs support the data observed here where the slow phase, not 
observed in stimulations exciting only the splanchnic nerve, is slower in onset and due to 
chromaffin cell excitation near the stimulating electrodes.  Similar to results previously 
observed, the nicotinic acetylcholine receptor mediated release decreased approximately 
25% in the presence of nifedipine, while the slow phase was no longer distinguishable, 
leaving only the signal due to the decay of the fast phase (Akiyama et al., 2004).  Similar to 
earlier work, the fast phase was highly dependent on extracellular calcium, further 
corroborating the splanchnic origin of this signal.  As shown by Wakade and Wakade, 
completely depleting the extracellular buffer of calcium using EGTA abolishes 
catecholamine release elicited by direct depolarization of the chromaffin cells (Wakade and 
Wakade, 1982). 
In this study, the high temporal and spatial resolution of FSCV at carbon fiber 
microelectrodes allowed us to distinguish between direct depolarization of chromaffin cells in 
murine adrenal slices and depolarization of splanchnic nerves that innervate them.  While 
whole gland stimulations (Wakade, 1981, Wakade and Wakade, 1982, Malhotra and 
Wakade, 1987) established this difference, in this work we were able to temporally and 
spatially resolve the two components.  It is well known in the literature that care must be 
taken to select appropriate parameters for electrical stimulation of living tissue to study 
mechanisms of release (Merrill et al., 2005).  The present work shows that lower currents 
and smaller stimulation pulse widths are the proper choice when studying secretion from 
 90 
murine adrenal slices since they trigger the physiological mechanisms which lead to 
catecholamine release. 
Conclusions 
 The present work uses an electrochemical technique in order to monitor the direct 
release of the hormones epinephrine and norepinephrine directly in mouse adrenal slices to 
determine the effects of varying the stimulating current used to elicit the exocytotic events.  
Prior to these studies being performed, the only direct chemical analysis of the 
catecholamines released was performed by analyzing the perfusate of whole glands by 
HPLC upon stimulation, and subsequent application of pharmacological agents, 
experiments which are inherently lacking in temporal resolution.  By employing FSCV, a 
technique with a sub-second temporal resolution, the stimulation of the splanchnic nerve 
and chromaffin cells were distinguished and examined pharmacologically.  Given the results 
of these experiments, prior experimentation on adrenal glands, or adrenal slices where large 
stimulation intensities and durations must be taken with a grain of salt given that both the 
splanchnic nerve and the chromaffin cells could have been depolarized by these 
stimulations.  Furthermore, future studies should use smaller intensity electrical stimulations 
since they elicit release from the physiologically relevant mechanism. 
 Dr. Jelena Petrovic is gratefully acknowledged for her contributions to the early 
pharmacological studies on biphasic release. 
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Chapter IV 
Quantifying Adenosine Production from Ectonucleotidases in Spinal Nociceptive Circuits 
Introduction 
Neurons and glia throughout the nervous system release adenosine 5’-triphosphate 
(ATP) spontaneously and in response to diverse pathological insults, including tissue 
damage, inflammation, hypoxia and nerve injury (Nakamura and Strittmatter, 1996, Arcuino 
et al., 2002, Matsuka et al., 2008, Gourine et al., 2010).  In the somatosensory system, ATP 
excites and sensitizes nociceptive DRG neurons and can activate spinal microglia (Dussor 
et al., 2009).  The excitatory effects of extracellular ATP can be terminated by a cascade of 
ectonucleotidases that hydrolyze ATP to adenosine (Dunwiddie et al., 1997, Zimmermann, 
2008), although the speed at which these ectonucleotidases work in any region of the 
nervous system is unknown.  Adenosine can signal through the adenosine A1 receptor (A1R) 
to inhibit neurotransmission and nociception (Sawynok and Liu, 2003, Zylka, 2011).   
Recently, two ectonucleotidases in nociceptive neurons that hydrolyze extracellular 
AMP to adenosine were identified.  These enzymes include the trans-membrane isoform of 
prostatic acid phosphatase (PAP, also known as ACPP) and ecto-5’-nucleotidase (NT5E). 
PAP and NT5E are extensively co-localized in nociceptive DRG neurons and on axon 
terminals located in lamina II of the dorsal spinal cord (Zylka et al., 2008, Sowa et al., 
2010b).  PAP deficient (Pap-/-) and NT5E deficient (Nt5e-/-) mice have similar behavioral 
phenotypes, including enhanced nociceptive sensitization following nerve injury and 
following peripheral inflammation.  Mice lacking A1R likewise show enhanced sensitization in 
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models of chronic pain (Wu et al., 2005).  Humans with null mutations in Nt5e develop very 
painful arterial calcifications (St Hilaire et al., 2011), suggesting loss of an adenosine 
generating ectonucleotidase exacerbates an already painful condition in humans (Zylka and 
Sowa, 2011).  While these and other data suggest adenosine tonically inhibits nociceptive 
circuits (Keil and DeLander, 1996, Tian et al., 2010), the time frame over which adenosine is 
produced and the molecular source of adenosine (from ectonucleotidases and/or directly 
released from cells) are unknown (Wall and Dale, 2008). 
Several studies suggest ectonucleotidases inhibit nociception by generating 
adenosine from endogenously released nucleotides.  Notably, pharmacological inhibitors of 
ectonucleotidases reduce adenosine production from adenosine 5’-monophosphate (AMP) 
in dorsal spinal cord and reduce adenosine release in dorsal spinal cord synaptosomes 
(Sweeney et al., 1989, Patterson et al., 2001).  Moreover, AMP hydrolysis in spinal lamina II 
was reduced, but not eliminated, in Pap-/- and Nt5e-/- single knockout mice (Zylka et al., 
2008, Sowa et al., 2010b).  Lastly, intrathecal injection of soluble (non-membrane bound) 
PAP or NT5E protein had long-lasting (2-3 days) antinociceptive effects that were entirely 
dependent on A1R activation (Zylka et al., 2008, Sowa et al., 2009, Sowa et al., 2010a, 
Sowa et al., 2010c). 
Here, we generated mice lacking PAP and NT5E to investigate the combined 
importance of these enzymes in nociceptive mechanisms.  Then, we used FSCV to measure 
adenosine levels at sub-second resolution in the spinal microdomain (lamina II) where these 
enzymes are located (Swamy and Venton, 2007, Cechova and Venton, 2008).  As 
previously outlined,, certain criteria are necessary to confirm an electrochemical signal 
(Marsden et al., 1988, Phillips and Wightman, 2003).  Pharmacological verification was 
obtained by using dipyridamole, an adenosine transporter blocker.  Our data indicate PAP 
and NT5E rapidly hydrolyze nucleotides to adenosine and generate inhibitory adenosine 
transients in spinal nociceptive circuits.  Furthermore, any residual AMP hydrolysis is 
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performed by alkaline phosphatase, a group of ectonucleotidases found ubiquitously 
throughout the body.  Finally, adenosine transients were observed for the first time 
anywhere in the central nervous system.  The implications of this signal to adenosinergic 
tone and antinociception are discussed. 
Experimental 
Animals 
All procedures and behavioral experiments involving vertebrate animals were 
approved by the Institutional Animal Care and Use Committee at the University of North 
Carolina at Chapel Hill. Wild-type (WT) C57BL/6 mice were purchased from Jackson 
Laboratories or bred in house from C57BL/6J stock.  Pap-/- (Vihko et al., abstract from 
Proceedings of the AACR, 2005, 96th Annual Meeting, Anaheim, CA) (Zylka et al., 2008), 
Nt5e-/- (Thompson et al., 2004) mice were backcrossed to C57BL/6J mice for > 10 
generations.  dKO mice were generated by breeding backcrossed Nt5e-/- and Pap-/- mice. 
Slice Preparation 
Transverse (800-900 µm, used in field recordings) and sagittal (400 µm, used in 
FSCV experiments) spinal cord slices were prepared as previously described from 1-2 
month old mice (Wang and Zylka, 2009).  Briefly, mice were anesthetized with urethane (1.5 
g/kg, i.p.) and the lumbar spinal cord was quickly dissected and sliced on a Vibratome 
3000EP at 4°C.  The dissection buffer contained the following (in mM): 87 NaCl, 2.5 KCl, 
1.25 NaH2PO4, 25 NaHCO3, 75 sucrose, 10 glucose, 1.5 ascorbic acid, 0.5 CaCl2, 7 MgCl2.  
The slices were then incubated at 37°C for 45 minutes and then at room temperature in 
regular artificial cerebrospinal fluid (aCSF) that contained (in mM): 125 NaCl, 2.5 KCl, 1.25 
NaH2PO4, 26 NaHCO3, 25 glucose, 2.5 CaCl2, 1.5 MgCl2.  For cyclic voltammetry 
experiments, the slices were incubated for one hour or less before the experiments were 
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carried out.  All solutions were bubbled with 95% O2/5% CO2 for the duration of the 
dissection and incubation steps. 
Fast-Scan Cyclic Voltammetry of Adenosine 
Disk-shaped carbon-fiber microelectrodes were fabricated as previously described 
(Cahill et al., 1996).  Briefly, a single 6 µm diameter T-650 carbon fiber (Thornell, Amoco 
Corp. Greenville, SC) was aspirated into a glass capillary (1.2 mm x 0.68 mm, AM Systems, 
Carlsborg, WA) which was then sealed on a vertical pipette puller (model PE-21, Narishige 
Group, Japan).  Electrodes were then cut with a surgical blade, sealed with epoxy, and 
polished at 30º on a K. T. Brown micro-pipette beveller (model BV-10, Sutter Instruments, 
Novato, CA).  Before use, electrodes were soaked in a mixture of isopropanol and activated 
carbon for at least 20 minutes (Bath et al., 2000).  To detect adenosine, the electrode’s 
potential was held at -0.4 V between each scan, and was ramped from -0.4 V to 1.5 V at a 
scan rate of 400 V/s every 100 ms.  The peak at 1.0 V was used to quantify the peak 
concentrations of adenosine because it is unique to adenosine and not observed with ATP, 
ADP or AMP (Swamy and Venton, 2007).  A Ag/AgCl reference electrode was used for all 
experiments.  FSCV data was collected using a custom LABVIEW program, Tar Heel CV.  
Two computer interface boards (National Instruments PCI 6052 and PCI 6711, Austin, TX) 
were used to apply the triangular waveform, digitize the resulting current, and to control 
pressure ejection synchronization with the waveform application through a homemade 
breakout box.  A Chem-Clamp Voltammeter (Dagan Corporation, Minneapolis, MN) was 
used to control the electrode potential and measure the resulting current, which was filtered 
with a built-in analog low pass Bessel filter at 10 kHz.  To make electrical contact with the 
head stage, a stainless steel wire was inserted into the back of the microelectrode which 
was backfilled with an electrolyte mixture of 4 M potassium acetate and 0.15 M potassium 
chloride. 
 100 
FSCV data were viewed in the form of color plots with sequentially stacked cyclic 
voltammograms shown over time (abscissa), plotted against the electrode potential 
displayed on the ordinate where the switching potential (1.5 V) is in the middle.  The current 
is displayed in false color, with oxidative currents being shown in green and reductive 
currents being shown in blue and black.  From these plots, the current at a specific potential 
can be plotted against time to examine how the adenosine concentration changes.  These 
current traces are converted to concentration from calibrations performed in a flow injection 
apparatus which allows for a bolus of adenosine ranging in concentration from 1-10 µM or 
10 µM AMP to be introduced to the electrode surface. 
To detect the production of adenosine by PAP and NT5E, 100 µM AMP was 
pressure ejected five times at 5 minute intervals using a Picospritzer® III (Parker 
Instrumentation, Pinebrook, NJ) for 1 s at 20 psi from a micropipette inserted into sagittal 
slices, approximately 100 µm from the carbon fiber microelectrode.  To minimize tissue 
damage, electrodes were inserted at 30° from the slice surface with the disk facing down, 
approximately 50 µm below the surface of the slice. AMP solutions were freshly prepared for 
each experiment to overcome the possible confound of degradation into adenosine.  
Furthermore, the absence of adenosine in the pressure ejection pipette was confirmed 
before and after each experiment by ejections onto the electrode above the slice (confirmed 
by the absence of current at 1.0 V).  For experiments carried out at pH 5.6, five consecutive 
ejections at 5 minute intervals were performed 10 minutes after application of pH 5.6 buffer.  
The buffer used for experiments at pH 5.6 contained in mM: 10 Tris Maleate, 140 NaCl, 4 
KCl, 2 MgCl2, 2 CaCl2, 5 Glucose, and pH adjusted to 5.6 with NaOH.  When detecting 
spontaneous adenosine transients, the carbon fiber was inserted into the slice without any 
stimuli applied to the slice.  For adenosine assignment, each event had a distinguishable 
cyclic voltammogram with a current peak at 1.0 V that was more than 5 times the standard 
deviation of the baseline noise. 
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Pharmacology 
 Dipyridamole and MLS-0038949 were used as received.  Stock solutions were 
prepared in DMSO.  The stock solution was then diluted into the recording buffer and 
perfused across the slice at a flow rate of ~2 mL/min. 
Statistical Analysis 
Statistical analysis was performed in GraphPad Prism (GraphPad Software, Inc., 
San Diego, CA, USA).  Student’s t-test (paired), or one-way ANOVA were used to test for 
significant differences between data sets.  Data were considered significant at the 95 % 
confidence level and are reported as the mean ± SEM.  The number of slices is indicated by 
n, unless noted otherwise.    
Results 
Determination of Adenosine Production from PAP and NT5E in Lamina II with Fast-Scan 
Cyclic Voltammetry 
 Before beginning experiments with animals that lack PAP, NT5E, or both 
ecotnucleotdases, developing a method for measuring the production of adenosine from 
AMP was necessary.  The voltammetry of adenosine has already been well described 
elsewhere (Swamy and Venton, 2007).  This method allows for detection of just adenosine 
without interference from metabolites like inosine.  Furthermore, the adenosine cyclic 
voltammogram has peaks at both 1.0 and 1.5 V while the precursors for adenosine such as 
AMP and ATP only show a peak at 1.5 V.   
While typical methods of stimulation such as applying a current from a bipolar 
stimulation electrode proved unsuccessful, injecting the substrate of these enzymes and 
measuring the production of adenosine with a carbon-fiber microelectrode gave reproducible 
results in WT animals.  Pressure ejection from pulled capillaries allowed for a localized  
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Figure 4.1.  Method for monitoring adenosine production from ectonucleotidases.  (A) 
Cartoon showing placement of pulled capillary and carbon-fiber microelectrode in lamina II 
of the spinal cord.  (B)  Representative color plot (below) and concentration versus time 
trace (above) from the pressure ejection of 100 µM AMP for 1 s at time t=0 s.  The color plot 
shows the horizontal line for where the concentration versus time plot was extracted from, 
and the vertical line shows where the cyclic voltammogram in the inset was taken from.  The 
cyclic voltammogram obtained from this experiment matches that obtained in vitro. 
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delivery of 100 µM AMP ~100 µm from the carbon-fiber multiple times (up to 20 ejections).  
Figure 4.1 shows a representative example of how this experiment is carried out.  A cartoon 
of a spinal cord slice showing the placement of the pulled capillary and the carbon-fiber 
microelectrode into lamina II of the spinal cord is shown in Figure 4.1A.  Below in Figure 
4.1B, a representative color plot from the pressure ejection of AMP at time t = 0 s for 1 s at 
20 psi is seen, and the concentration versus time plot is seen above it, showing a rapid 
production of adenosine which peaks about 4 s after the ejection and then shows the 
diffusion of adenosine away from the electrode.  As shown by the horizontal dotted line in 
the color plot, the peak at 1.0 V was used to quantify the amount of adenosine being 
produced, because it is distinct to adenosine and cannot be attributed to the AMP being 
applied to the slice.  Lastly, the cyclic voltammogram from the vertical dotted line in the color 
plot is seen as the inset next to the concentration versus time plot.  The cyclic 
voltammogram from the pressure ejection has the distinct shape of adenosine previously 
described, and is also comparable to that seen in vitro.  Furthermore, pressure ejection of 
AMP directly onto the electrode in buffer solution, or in agarose, produced no peak at 1.0 V 
(data not shown). 
Once the method for determination of adenosine production in the spinal cord was 
complete, experiments were performed in order to determine the contributions of PAP and 
NT5E to the hydrolysis of AMP in lamina II of the spinal cord.  In WT slices, adenosine levels 
peaked within ~4 s at a concentration of 4.34 ± 0.57 M at pH 7.4 (Figure 4.2A, E, F).  
Adenosine production and peak levels (4.13 ± 0.55 M) were not impaired in Pap-/- slices at 
pH 7.4 (Figure 4.2B, E, F).  However, adenosine production and peak levels were 
significantly impaired in Pap-/- slices at pH 5.6 compared to WT slices (0.72 ± 0.05 M 
verses 1.66 ± 0.06 M, respectively, Figure 4.2G, H).  In addition, adenosine production and 
peak levels were significantly impaired in Nt5e-/- and dKO slices at neutral and acidic pH  
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Figure 4.2.  Adenosine production is impaired in spinal nociceptive circuits of Pap-/-, Nt5e-/- 
and dKO mice.  (A-D) Color plots for the 1 s pressure ejection of 100 µM AMP into lamina II 
of (A) WT, (B) Pap-/-, (C) Nt5e-/-, and (D) dKO slices at pH 7.4.  (E) Current extracted at 1.0 
V from the dashed horizontal lines in A-D), converted to concentration of adenosine and 
plotted versus time.  (F) Peak adenosine production following pressure ejection of AMP into 
lamina II at pH 7.4 (n = 5 for each genotype).  (G) Current extracted at 1.0 V from 
representative experiments performed at pH 5.6.  (H) Peak adenosine production following 
pressure ejection of AMP into lamina II at pH 5.6 (n = 5 for each genotype).  (F, H) One way 
ANOVAs with Bonferroni’s post-hoc tests were used to compare each genotype to WT and 
to compare between genotypes.  *p < 0.05, **p < 0.005.  Data presented as means ± SEM. 
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(Figure 4.2C-H).  Notably, peak adenosine levels at pH 7.4 were significantly lower in dKO 
slices than in Nt5e-/- slices (1.34 ± 0.11 M verses 2.30 ± 0.36 M, respectively), unmasking 
a contribution of PAP to adenosine production at neutral pH, (Figure 4.2F).  Lastly, at pH 
5.6, almost no adenosine was produced after pressure ejecting AMP into lamina II of dKO 
slices (Figure 4.2G, H).  Taken together, these direct measures with gene knockout mice 
indicate PAP and NT5E rapidly generate adenosine at neutral and acidic pH and together 
are the main adenosine-generating ectonucleotidases in spinal nociceptive circuits. 
Remarkably, some adenosine was still produced in dKO spinal slices at pH 7.4 
(Figure 4.2F), suggesting there is at least one more adenosine-generating enzyme.  The 
presence of this third enzyme could not have been anticipated without first studying 
Pap/Nt5e dKO mice. AMP hydrolysis and adenosine production were largely eliminated in 
lamina II at pH 5.6 in dKO mice, making it unlikely this enzyme is another acid phosphatase.  
However, this enzyme could have a neutral to alkaline pH optimum given that adenosine is 
produced at pH 7.4 (albeit at levels that are only ~30% of WT levels; Figure 4.2F).  Alkaline 
phosphatases are present in the spinal cord, have such a pH optimum and can hydrolyze 
ATP, ADP and AMP extracellularly (MacGregor et al., 1995, Zimmermann, 2008).   
Determination of Adenosine Production from Alkaline Phosphatases in Lamina II with Fast-
Scan Cyclic Voltammetry 
To determine whether alkaline phosphatases (of which there are four functional 
genes in the mouse) or other ectonucleotidases contribute to residual adenosine production 
in spinal nociceptive circuits, an alkaline phosphatase inhibitor MLS-0038969 was perfused 
onto WT and dKO slices using the above experimental parameters (Sergienko et al., 2009).  
Figure 4.3 shows representative examples of these experiments.  In WT slices, the peak 
adenosine concentration was determined to be 6.13 ± 0.64 µM without the alkaline 
phosphatase inhibitor (Figure 4.3A), and 5.34 ± 0.98 µM with the inhibitor being bath applied  
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Figure 4.3.  Alkaline phosphatase contributes to adenosine production when PAP and 
NT5E are not present.  (A-D) Color plots for the 1 s ejection of 100 µM AMP at 20 psi at time 
t=0 s into lamina II of (A) WT, (B) DKO, (C) WT with 00038949 on board, and (D) dKO with 
00038949 on board.  (E) Concentration versus time plots for the data extracted at 1.0 V from 
the horizontal lines in A-D.  The inset shows the cyclic voltammogram taken from the vertical 
line in A.  (F) Peak adenosine concentration for all experiments upon pressure ejection of 
AMP into lamina II with and without alkaline phosphatase inhibitor present (n = 5 for each 
genotype).  Paired student’s t-tests were used to compare genotypes before and after drug 
application.  **p<0.005.  Data presented as mean ± SEM. 
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(Figure4.3C), values which are not statistically different (Figure 4.3F, p>0.05, n = 5, paired 
student’s t-test).  In dKO slices, however, the peak adenosine concentration from the 
application of AMP was determined to be 1.97 ± 0.35 µM before application of drug (Figure 
4.3B), while it was 0.59 ± 0.26 µM (Figure 4.3D), a significant decrease of about 70% in the 
amount of adenosine being produced down to almost none (Figure 4.3F, p<0.005, n = 5, 
paired student’s t-test).  These data show that while the ectonucleotidases PAP and NT5E 
produce the majority of adenosine from AMP in spinal nociceptive circuits, alkaline 
phosphatase does provide a significant role in AMP hydrolysis when these more active 
enzymes are absent. 
Pharmacological Verification of Adenosine Signal 
 In order to have further verification that the signal observed upon the application of 
AMP into lamina II of the spinal cord is indeed adenosine, a highly selective adenosine 
transporter blocker, dipyridamole (DIP), was used to observe its effect on the signal (Thorn 
and Jarvis, 1996).  AMP was pressure ejected into lamina II of the spinal cord, as described 
above.  After a stable signal was obtained, 25 µM DIP was bath applied to the slice, and 
adenosine production was monitored.  Figure 4.4A shows an example from one of these 
experiments.  After application of DIP, the peak adenosine concentration about 4 s upon 
pressure ejection of AMP is nearly double that of the signal before drug application.  While it 
might be expected that the falling phase of the signal would be affected as when cocaine is 
applied to a slice when cocaine or a dopamine transporter blocker is applied (Jones et al., 
1995), this experiment is different because the adenosine transporter is probably already 
saturated by applying and producing such large amounts of adenosine that the falling phase 
is governed by diffusion.  The peak concentration increases because the adenosine that is 
produced between the pulled capillary and the carbon-fiber is not taken up, and is allowed to 
be detected.  Figure 4.4B shows a summary of the three experiments performed.  The  
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Figure 4.4.  A nucleoside transport inhibitor promotes the buildup of ectonucleotidase-
generated adenosine.  (A) AMP was pressure ejected into lamina II of WT spinal cord slices 
in the absence or presence of DIP.  FSCV was used to measure extracellular adenosine; (B) 
Average responses ± SEM, from n = 3 slices.  DIP significantly increased the concentration 
of extracellular adenosine for 0.7 to 8 s following AMP addition (p < 0.005 by one-way 
ANOVA), and peak adenosine concentration .increased from 5.77 ± 0.46 µM to 10.86 ± 0.40 
µM after application (p<0.005, paired student’s t-test, n = 3) 
 
 
 
 
 
 109 
traces show the concentration of adenosine before and after DIP application ± SEM.  
Control experiments showed peak adenosine concentrations of 5.77 ± 0.46 µM, which 
increased to 10.86 ± 0.40 µM after application, values which are statistically significant from 
each other (P<0.005, paired student’s t-test, n=3).  These data give pharmacological 
verification that the signal observed upon application of AMP to the slice is indeed 
adenosine. 
Adenosine Transients Occur Spontaneously and Are Generated by PAP and NT5E 
While performing FSCV studies, we unexpectedly observed ―adenosine transients,‖ 
spontaneous and transient increases in adenosine concentration, every time a freshly-
polished carbon-fiber microelectrode was placed in lamina II of WT slices (Figure 4.5A).  We 
did not see these transients if microelectrodes were re-used without being re-polished, 
suggesting debris on the tip interferes with detection of these transients.  The peaks at 1.0 V 
and 1.5 V in color plots and cyclic voltammograms (Figure 4.5) confirmed that these 
transients contained adenosine.  Transient release was observed at a low frequency (0.35 ± 
0.04 events/min) in all WT slices (Table 4.1; with 2.5 mM extracellular calcium).  These 
transients were also observed when freshly polished carbon-fiber electrodes were placed 
into slices from Pap-/-, Nt5e-/- and dKO animals (Figure 4.5B-D). 
To ascertain if these events were Ca2+ dependent, we chelated intracellular Ca2+ by 
pre-incubating slices in 10 µM BAPTA-AM for 45 minutes and removed extracellular Ca2+ 
from the bath.  Under these conditions, adenosine transients were observed in four of the 
five slices, at a frequency (0.06 ± 0.03 events/min) that was significantly less than when 
calcium was present in the bath (Table 4.1).  PAP and NT5E do not require divalent cations 
for activity, so this reduction was not likely due to inhibition of PAP or NT5E.  
Next, to determine if PAP and NT5E generate adenosine transients, electrodes were 
placed into Pap-/-, Nt5e-/-, and dKO slices and up to 20 consecutive one-minute intervals  
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Figure 4.5.  Spontaneous adenosine transients detected in lamina II by FSCV.  (A-D) 
Concentration versus time traces (top) and color plots (bottom) in slices containing lamina II 
from (A) WT, (B) Pap-/-, (C) Nt5e-/-, and (D) dKO mice. Scale bars are for the 1.0 V traces.  
The inset in A shows the cyclic voltammogram for the transient denoted with an asterisk. 
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Table 4.1.  Summary of adenosine transient events in spinal cord lamina II.  One-way 
ANOVA (p < 0.05) followed by Newman-Keuls multiple comparison post-hoc test to compare 
all genotypes relative to WT (2.5 mM Ca2+); *p < 0.05, **p < 0.005.  # Transient time was 
measured from the onset of the transient until the signal decayed to baseline. 
 
 
 
Genotype [Ca2+] 
(mM) 
[Ado]peak 
(nM) 
Frequency 
(events/min) 
Transient Time 
(s)# 
WT (n = 19) 2.5 570 ± 50 0.35 ± 0.04 1.5 ± 0.1 
WT (n = 5) 0.0 410 ± 50 0.06 ± 0.03** 1.8 ± 0.3 
Pap-/- (n = 10) 2.5 690 ± 150 0.14 ± 0.04* 1.5 ± 0.1 
Nt5e-/- (n = 10) 2.5 360 ± 20 0.14 ± 0.07* 1.5 ± 0.1 
dKO (n = 16) 2.5 380 ± 40 0.10 ± 0.03** 1.2 ± 0.1 
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were recorded, background subtracted and corrected to account for background drift of the 
electrode over time (Figure 4.6A, experiments with WT slices were interleaved with knockout 
slices).  Unlike WT slices where transients were observed in every (19/19) slice, 
spontaneous events were observed in a subset of slices from Pap-/- (8/10 slices), Nt5e-/- 
(6/10 slices) and dKO (9/16 slices) mice.  Furthermore, in slices from Pap-/-, Nt5e-/- and dKO 
mice where transients were observed, the frequency was significantly lower than in WT 
slices (Figure 4.6B).  This reduction is unlikely to be due to deficits in synaptic transmission 
since evoked field excitatory postsynaptic potential (fEPSP) amplitudes were not 
significantly different between WT and mutant backgrounds (Figure 4.6C).  Collectively, 
these findings (summarized in Table 4.1) indicate PAP and NT5E generate a majority of all 
adenosine transients, presumably through hydrolysis of nucleotides that are released by 
neurons and/or glia.  Moreover, the observation that transient frequency can be reduced in 
single and dKO mice suggests these transients can be dynamically modulated by 
manipulating ectonucleotidase activity. 
Discussion 
Nucleotides cause pain by exciting and sensitizing nociceptive neurons. While the 
duration of nucleotide signaling can be limited by purinergic receptor desensitization and 
nucleotide hydrolysis, surprisingly, it is unknown how rapidly specific ectonucleotidases 
break down nucleotides in any region of the nervous system. The speed at which hydrolysis 
occurs could affect the balance between the excitatory effects of nucleotides and the 
inhibitory effects of adenosine. While it has been previously found that PAP and NT5E were 
co-expressed in nociceptive neurons and could hydrolyze AMP (Zylka et al., 2008, Sowa et 
al., 2010b), it was not shown that either enzyme could generate adenosine directly in 
nociceptive circuits or how fast these enzymes generate adenosine. Moreover, since studies  
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Figure 4.6.  Spontaneous adenosine transients in lamina II are reduced in frequency in  
Pap-/-, Nt5e-/- and dKO mice.  (A) Representative traces from each genotype showing 
adenosine concentration versus time, calculated from FSCV currents measured at 1.5 V.  
Traces were background subtracted every 60 s and baseline corrected to compensate for 
electrode drift over time (which creates a visible 60 s oscillation in the baseline).  Raster 
plots below each trace mark each adenosine transient.  Adenosine transients were 
considered to be events if the peak at 1.0 V was more than five times the standard deviation 
of the noise.  (B) Adenosine transient frequency in WT (0.35 ± 0.04 events/min; n=19 
slices), Pap-/- (0.14 ± 0.04 events/min; n=10 slices), Nt5e-/- (0.14 ± 0.07 events/min; n=10 
slices), and dKO (0.11 ± 0.05 events/min; n=16 slices) mice.  One-way ANOVAs with 
Bonferroni’s post-hoc tests were used to compare each genotype to WT and to compare 
between genotypes.  *P < 0.05, **P < 0.005.  (C) Baseline fEPSP amplitude in WT, Pap-/-, 
Nt5e-/-, and dKO mice (n=5 / genotype).  There were no significant differences between WT 
and mutant mice.  Data presented as means ± SEM. 
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were focused on Pap and Nt5e single knockout mice, it could not be predicted a priori if 
these enzymes had redundant or non-redundant functions.  
To resolve these issues, we generated Pap/Nt5e dKO mice—the first double 
knockout of any pair of ectonucleotidases. Our analysis revealed that PAP and NT5E 
together generate the majority of all adenosine from AMP in nociceptive axon terminals. In 
addition, we were the first to use FSCV to study the speed at which ectonucleotidases 
generate adenosine and the first to use FSCV in the pain field. This technique is particularly 
powerful, because the small probe size allowed us to monitor adenosine production in the 
spinal microdomain where these enzymes are located. To our surprise, we found that PAP 
and NT5E very rapidly generate adenosine from pressure ejected AMP and from 
endogenously released nucleotides.  
Our conclusions are supported by an array of sophisticated in vitro experiments. 
Indeed, we found that dKO animals had pronounced deficits in hydrolyzing AMP to 
adenosine, AMP → adenosine-dependent antinociception, and AMP → adenosine-
dependent synaptic inhibition. While a pH preference for these enzymes was evident in 
former histochemical and FSCV experiments (Sowa et al., 2009, Sowa et al., 2010b), both 
enzymes contribute additively to nucleotide hydrolysis under physiologically relevant in vivo 
conditions. PAP and NT5E are likely to encounter wide extracellular pH fluctuations under 
normal physiological and pathological conditions. For example, excitatory synapses become 
transiently acidified following glutamate release (DeVries, 2001), synaptic vesicle pH can 
reach pH 5.6 (Miesenbock et al., 1998), and pathological conditions lead to prolonged 
acidification and nucleotide release (Birdsong et al., 2010).  
This method is novel and brings new light to the field of adenosine production 
because it is currently unknown how rapidly ectonucleotidases generate adenosine in any 
tissue or cell of the body.  This lack of knowledge reflects technical limitations in existing 
biochemical and biosensor based methods, all of which sample adenosine levels over 
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minutes to hours (Sweeney et al., 1989, Patterson et al., 2001, Swamy and Venton, 2007, 
Cechova and Venton, 2008, Goldman et al., 2010).  And, enzyme histochemistry detects 
inorganic phosphate following AMP hydrolysis, not adenosine.  As such, enzyme 
histochemistry is an indirect way to measure adenosine production.  Since FSCV has a high 
temporal and spatial resolution, it is an excellent way to elucidate the speed at which these 
enzymes produce adenosine.  This marks the first time FSCV was used to monitor 
adenosine generation by ectonucleotidases and the first time FSCV was used in the pain 
field. 
Unexpectedly, our experiments also revealed that at least one more adenosine 
generating ectonucleotidase is present in nociceptive circuits. This finding could not have 
been predicted from studying Pap or Nt5e single knockouts, and suggests nociceptive 
circuits have a highly redundant molecular apparatus for eliminating nucleotides while 
simultaneously generating adenosine.  We hypothesized that the other ectonucleotidase 
was tissue nonspecific alkaline phosphatase (TNALP), an enzyme which can hydrolyze 
AMP to adenosine which is found throughout the body (Narisawa et al., 2007).  Using a 
novel, nonspecific alkaline phosphatase inhibitor, we were able to pharmacologically verify 
that the remaining adenosine generation signal which was observed in dKO mice was due 
to TNALP. 
FSCV allowed us to measure rapid changes in adenosine concentration in a micron-
sized region of spinal cord. The temporal and spatial resolution of this method far surpasses 
all previously used methods for measuring adenosine (including direct approaches like 
enzyme biosensors or microdialysis coupled with HPLC and indirect approaches like 
quantifying signaling downstream of adenosine receptors) (Sweeney et al., 1989, Li and 
Perl, 1994, Patterson et al., 2001, Swamy and Venton, 2007, Cechova and Venton, 2008, 
Goldman et al., 2010). Unexpectedly, we detected spontaneous adenosine transients in 
spinal lamina II, the termination zone for nociceptive afferents. This is the first time 
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adenosine transients were detected in any region of the nervous system. The duration of 
these events was remarkably short (lasting 1.5 ± 0.1 s on average in WT mice; Table 4.1), 
suggesting adenosine is rapidly generated/released within lamina II, precisely where PAP 
and NT5E are found (Zylka et al., 2008, Sowa et al., 2010b). Remarkably, transients were 
detected in all WT slices but only ~50% of all Pap-/-, Nt5e-/- and dKO slices. And, within the 
subset of Pap-/-, Nt5e-/- and dKO slices where transients were observed, the frequency of 
adenosine transients was reduced by more than half. These data strongly suggest that PAP 
and NT5E generate adenosine transients in lamina II by rapidly hydrolyzing endogenously 
released nucleotides. Rapid generation of adenosine is consistent with ectonucleotidases 
being in close proximity to nucleotide release sites (Joseph et al., 2003).  
Nucleotides like ATP are released from several cell types by point-source burst 
release, which occurs spontaneously at a low frequency (0.38 ± 0.18 bursts/min in rat 
astrocytes) (Arcuino et al., 2002). Intriguingly, adenosine transients occur at a similar 
frequency (0.35 ± 0.04 events/min; Table 1), possibly reflecting the pulsatile availability of 
nucleotide substrate. Several distinct mechanisms of ATP release have been reported in 
neurons, glia and other cell types, including from vesicles (exocytosis), connexin 43 
hemichannels, P2X7 ion channels and volume activated anion channels (VAACs) (Sabirov 
et al., 2001, Coco et al., 2003, Pascual et al., 2005, Suadicani et al., 2006, Pangrsic et al., 
2007, Kang et al., 2008, Sawada et al., 2008, Fields and Ni, 2010). Many of these 
mechanisms are kinetically fast and Ca2+ dependent. Future studies will be needed to 
determine which cells release ATP and which molecular mechanisms underlie nucleotide 
release in nociceptive circuits.  
Our data also suggests it might be possible to dynamically regulate adenosine 
transient frequency through physiological and genetic factors. Indeed, we found adenosine 
transients were reduced in frequency in WT slices under zero Ca2+ conditions and in dKO 
slices; however, transients did not disappear (Table 4.1). Similarly, capsaicin-evoked 
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adenosine release from synaptosomes (isolated from dorsal spinal cord) was reduced in 
Ca2+-free conditions and when nonselective ectonucleotidase inhibitors were used [19]. 
Since adenosine transients were not eliminated in dKO mice, there must be additional 
mechanisms underlying their generation. These mechanisms could include: 1) hydrolysis of 
extracellular nucleotides by ectonucleotidase(s) other than PAP and NT5E and/or 2) direct 
release of adenosine from cells, such as by exocytosis or reverse transport through 
equilibrative nucleoside transporters (Sweeney et al., 1989, Wall and Dale, 2008).  
Physiological Significance of Pulsatile Adenosine 
Our physiological and behavioral data suggest that ectonucleotidases, and the 
adenosine transients they generate, endow nociceptive circuits with a way to transform 
pulsatile or sustained nucleotide release into an inhibitory adenosinergic signal. Notably, we 
found that transients were generated in all WT slices but only in ~50% of all Pap-/-, Nt5e-/- 
and dKO slices, suggesting more ―failures‖ when ectonucleotidases are eliminated. 
Moreover, the frequency of these events was significantly reduced in slices from all three 
mutant genotypes. The failure to generate transients, combined with reduced transient 
frequency likely explains why excitatory neurotransmission was not inhibited after treating 
dKO slices with DIP. These data suggest that PAP and NT5E generate adenosine 
endogenously at a level that is sufficient to activate A1R and inhibit excitatory 
neurotransmission in lamina II. However, in the absence of these enzymes, less adenosine 
is tonically produced, causing unimpeded excitatory neurotransmission and enhanced 
nociceptive responses.  
In addition, adenosine transients and the enzymes that generate these transients 
appear to be biochemically ―tuned‖ to dynamically activate A1R. In particular, transients have 
a peak adenosine concentration of 530 ± 60 nM as measured by FSCV (Table 4.1), and 
could be slightly higher given that analyte concentration is distance dependent with respect 
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to its point of release/production (Wightman et al., 1995). Extracellular adenosine 
concentration in hippocampus was similarly ~300-1500 nM (Dunwiddie and Diao, 2000). 
This concentration range is remarkably similar to the concentration range that half-maximally 
stimulates A1R (760 nM-3.1 µM) (Gerwins et al., 1990, Ragazzi et al., 1991, Dunwiddie and 
Diao, 1994). Since the peak adenosine concentration of each transient falls within the most 
sensitive region of the A1R dose-response curve, small increases or decreases in transient 
frequency, especially when integrated over time, could have profound effects on A1R 
signaling. Lastly, ectonucleotidases can ―channel‖ adenosine directly to A1R (Cunha et al., 
1998), which could further maximize the signaling effects of enzymatically produced 
adenosine.  
Adenosine has a tonic inhibitory effect on excitatory neurotransmission in the spinal 
cord and brain (Keil and DeLander, 1996, Dunwiddie et al., 1997, Dunwiddie and Diao, 
2000, Tian et al., 2010), although the molecular origins of this inhibitory tone are unknown.  
Since PAP and NT5E rapidly generate adenosine from nucleotides and deletion of PAP and 
NT5E reduced the frequency of adenosine transients, we next hypothesized that PAP and 
NT5E might generate the inhibitory adenosine tone in nociceptive circuits.  Field excitatory 
post synaptic potentials (fEPSPs) were measured in lamina II of the spinal cord, and were 
inhibited when DIP was on board, indicating that a buildup of adenosine could be causing 
this inhibition.  Furthermore, the dampening of the fEPSPs with DIP on board was 
significantly smaller in dKO mice (Street et al., 2011).  Indeed, FSCV data shows that DIP 
significantly elevated extracellular adenosine levels for an extended time period when AMP 
was pressure ejected into lamina II (Figure 4.4), indicating DIP promotes the buildup of 
ectonucleotidase-generated adenosine outside cells. 
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Conclusion 
 Here, FSCV was used to directly determine the contributions of the enzymes PAP, 
NT5E, and alkaline phosphatase to the hydrolysis of AMP into adenosine in spinal 
nociceptive circuits.  Furthermore, the first ever adenosine transients, spontaneously 
occurring fluctuations in adenosine concentration, were reported, and their production was 
determined to also be dependent on PAP and NT5E.  These findings help to confirm that 
PAP, NT5E, and alkaline phosphatase are the main ectonucleotidases in lamina II of the 
spinal cord and directly hydrolyze AMP, and that alkaline phosphatases perform the 
remainder of the function, especially when PAP and NT5E are not present.  Finally, 
adenosine transients are the first direct measure of adenosine being produced in the 
extracellular space in tissue, and could have implications in determining the origin of an 
adenosine tone and its contribution to antinociception. 
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Chapter V 
High Performance Liquid Chromatography for Quantifying Total Tissue Neurotransmitter 
Content 
Introduction 
 Over the last century, chromatography has become an integral part of analytical 
chemistry and a useful method for separating complex mixtures (Hadden, 1971).  In this 
chapter, the use of reversed phase high performance liquid chromatography (RP-HPLC) to 
analyze total tissue content of brain samples for neurotransmitters and their metabolites will 
be discussed.   
Liquid chromatography separates mixtures based upon their polarity.  In RP-HPLC, 
the stationary phase is non-polar while the mobile phase can vary in polarity depending on 
the analytes being separated.  The stationary phase is typically bonded to a solid support, 
often small (~5 µm diameter) silica particles or gels for other applications.  For most 
separations, the stationary phase consists of long chain alkanes (typically C5-C30), although 
various different types of substitutions can be made for different types (ion separation and 
size exclusion, for example).  The time it takes for an analyte to elute from a column is called 
its retention time (tR), a compound specific property which is dependent upon the make-up 
of the mobile phase.  Polar compounds elute faster since they spend more time in the 
mobile phase, while non-polar compounds elute later because they interact more with the 
stationary phase.  For this reason, RP-HPLC is best utilized for separating non-polar 
compounds because the analytes will spend more time in the stationary phase. 
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The tR of analytes which elute later can be reduced by adding an organic modifier to 
the mobile phase.  Examples of organic modifiers include methanol, acetonitrile, and 
isopropyl alcohol.  The concentration of organic modifier is of great importance when 
considering a separation of similar compounds.  As the concentration of these organic 
modifiers increases in the mobile phase, more highly retained species will elute faster, 
spending more time with the non-polar portion of the mobile phase.  Biological separations 
depend on the ability of the use of aqueous mobile phases since the biogenic amines as 
well as the metabolites of interest are often water soluble.  Water based separations are 
also useful because they can be coupled to other separation methods such as capillary 
electrophoresis for 2-D separations, as well as sensitive detection methods such as 
electrospray ionization for tandem mass spectrometry (Zhang et al., 2008, Zhao and Suo, 
2008).  Typically, small amounts of an organic modifier are used in mobile phases for 
separations (5-20%).  Organic modifiers can be added to the mobile phase at a constant 
amount (isocratic elution), or starting at a small amount, and gradually increased over time 
(gradient elution).  Isocratic elution suffers from poor resolution for less retained species, 
and cause band broadening for more highly retained species.  Gradient elution is a useful 
tool for decreasing the tR of highly retained species, which decreases band broadening of 
highly retained species, and increasing the resolution of less retained analytes.   
Electrochemical detection (ECD) can be used to monitor the current which arises 
from species which are eluting from a column and are oxidized or reduced at the electrode 
surface.  ECD is a good choice for analyzing brain tissue punches because it is an 
extremely selective method, and thus insensitive to the brain matrix (Ramstrom et al., 2009).  
While there are many compounds in the brain which absorb light in the UV-Vis region, or 
produce complex mass spectra, there are only a select few which are oxidizable at 
potentials allowed by the solvent window for water making the chromatogram simpler, and 
easier to interpret.  One disadvantage of ECD is that gradient elutions cannot be used since 
 128 
the increase in organic modifier with time changes the charging of the electrode’s double-
layer, causing the baseline to shift.  The simplicity of the chromatograms associated with 
ECD makes it a desirable choice for analyzing biogenic amines in response to 
pharmacological, genetic, or environmental changes (Lahdesmaki et al., 2002, Vriend and 
Dreger, 2006, Filipov et al., 2007). 
In this chapter, RP-HPLC with ECD is used to study the total content of biogenic 
amines as well as their metabolites in tissue samples.  Various different strains of animals, 
as well as genetically altered animals are studied herein, and the comparisons made 
between the different groups allows for insight into the different biological mechanisms 
which can be related to data observed with fast-scan cyclic voltammetry (FSCV) as well as 
in behavioral experiments.  Specifically, norepinephrine (NE) and dopamine (DA) content 
were analyzed in the bed nucleus of the stria terminalis (BNST), nucleus accumbens (NAc) 
and dorsolateral striatum of an animal used as a model for post-traumatic stress disorder 
(PTSD), Lewis rats, were compared to the more commonly used Sprague Dawley laboratory 
rat.  Also, DA as well as the DA metabolite 3,4-Dihydroxyphenylacetic acid (DOPAC), were 
analyzed in the NAc and dorsolateral striatum of mice lacking the maternal copy of the 
Ube3a gene (Ube3am-/p+) and compared to WT animals as a model for Angelman Syndrome.  
Finally, 5-hydroxytryptamine (5-HT, serotonin) content was determined in the substantia 
nigra reticulata (SNr) in WT animals before and after acute treatment with citalopram, a 
serotonin transporter (SERT) blocker. 
Experimental 
HPLC Instrumentation, Materials, and Chemicals 
 An Agilent HP 1050 pump (Santa Clara, CA) was used for mixing all mobile phases 
and flowing the mobile phase through the system, and a Waters Atlantis C-18 column was 
used for all separations (5 µm, 4.6 x 250 mm, Milford, MA).  A modified version of the 
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methods first described by Mefford was used to analyze standard and tissue samples 
(Mefford, 1981).  The mobile phase consisted of a citric acid buffer containing (in mM) 100 
citric acid, 1.0 sodium hexyl sulfate, 0.1 EDTA, and was adjusted to pH=3 with NaOH.  
Buffers were filtered with a 0.2 µm vacuum filter and were prepared with HPLC grade water.  
HPLC grade methanol at a concentration of 5-10% served as the organic modifier.  10-20 µL 
injections of analytes were detected with a thin-layer radial electrochemical flow cell 
(Bioanalytical Systems, West Lafayette, IN) with the working electrode being held at + 700 
or + 800 mV relative to a Ag/AgCl reference electrode.  Hydroquinone (HQ) was utilized as 
the internal standard.  Analyte stock solutions were made to be 1-10 mM in 0.1 N HClO4, 
and standard mixture solutions were made 1-10 µM by diluting stock solutions in 0.1 N 
HClO4.  Response ratios of catecholamines and their metabolites were determined daily. 
Tissue Sample Collection for Sprague Dawley and Lewis Rats 
 Rats (Jackson Laboratories, Bar Harbor, ME, USA) were anesthetized with urethane 
(1.5 mg/kg), decapitated, and the brain was rapidly removed and placed into ice cold aCSF 
containing (in mM) 126 NaCl, 2.45 KCl, 25 NaHCO3, 1.2 MgCl2, 2.4 CaCl2, 1.2 NaH2PO4, 20 
HEPES, and 11 glucose saturated with 95% O2 / 5% CO2.  The brain was then mounted, 
sliced into 300-500 µm thick sections, patted dry, and frozen over dry ice before excising the 
region of interest.  The tissue was then massed and 200-300 µL of 0.1 N HClO4 containing 1 
µM HQ was added to the tissue.  The mixture was then homogenized with a wand sonicator 
(Fisher Scientific, Pittsburgh, PA), and centrifuged at 6000 rpm for 10 min.  The supernatant 
was removed, and filtered with a 0.2 µm syringe filter (Millex-LG, Millipore, Billerica, MA) 
before being injected onto the column. 
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Tissue Sample Collection for Ube3am-/p+ Mice 
Mice were deeply anesthetized with sodium pentobarbital and brains were snap 
frozen in methylbutane on dry ice.  Brains were serially sectioned on a cryostat, until 
reaching the rostral pole of the (NAc).  Tissue punches (pooled from both hemispheres) 
were taken from the NAc and dorsolateral striatum (17 and 15 gauge, respectively) and 
massed.  Punches were stored at -80°C until use.  The tissue was then mixed with 200 µL of 
0.1 N HClO4 containing 1 µM HQ.  The mixture was then homogenized with a wand 
sonicator (Fisher Scientific, Pittsburgh, PA), and centrifuged at 6000 rpm for 10 min.  The 
supernatant was removed, and filtered with a 0.2 µm syringe filter (Millex-LG, Millipore, 
Billerica, MA) before being injected onto the column. 
Tissue Sample Collection for Mice Before and After Citalopram Administration 
Wild-type C57-BL/6J mice (Jackson Laboratories, Bar Harbor, ME, USA) were taken 
as naïve, or administered with citalopram (DOSAGE HERE).  Mice were then anesthetized 
with ether, decapitated, and the brain was rapidly removed and placed into ice cold aCSF 
containing (in mM) 126 NaCl, 2.45 KCl, 25 NaHCO3, 1.2 MgCl2, 2.4 CaCl2, 1.2 NaH2PO4, 20 
HEPES, and 11 glucose saturated with 95% O2 / 5% CO2.  The brain was then mounted, 
sliced into 300-500 µm thick sections, patted dry, and frozen over dry ice before excising the 
region of interest.  The tissue was then massed and 200-300 µL of 0.1 N HClO4 containing 1 
µM HQ was added to the tissue.  The mixture was then homogenized with a wand sonicator 
(Fisher Scientific, Pittsburgh, PA), and centrifuged at 6000 rpm for 10 min.  The supernatant 
was removed, and filtered with a 0.2 µm syringe filter (Millex-LG, Millipore, Billerica, MA) 
before being injected onto the column. 
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Chromatographic Data Analysis 
 The determination of peak areas for HPLC total tissue content analysis was 
performed using custom-written Igor programs.  These programs were designed in the 
Jorgenson Lab at UNC-CH.  The peak area of the analyte was taken as a ratio to that of an 
internal standard, hydroquinone (HQ) at a known concentration, adjusted for differential 
detector response.  The ratio was then used to calculate a mass or number of moles of 
analyte in the extraction solution which was normalized by the mass of tissue taken 
(represented as µg neurotransmitter/ g tissue or nmoles neurotransmitter/ g tissue).  Again, 
n indicates the number of animals used; however, replicate extractions and injections were 
performed to reduce random error in the chromatographic measurements. 
Statistical Analysis 
Statistical analysis was performed in GraphPad Prism (GraphPad Software, Inc., 
San Diego, CA, USA).  Student’s t-tests were used to test for significant differences between 
data sets.  Data were considered significant at the 95 % confidence level and are reported 
as the mean ± SEM.  The number of slices is indicated by n, unless noted otherwise.    
Results 
 Separation of the analytes of interest were performed on a reversed phase C-18 
column using a citric acid buffer, an ion pairing agent, sodium hexylsulfate, and methanol as 
the organic modifier (5%).  Figure 5.1 shows a representative chromatogram for the 
separation of 10 µM standard solution containing norepinephrine, hydroquinone (the internal 
standard), dopamine, DOPAC, and 5-HT using electrochemical detection.  Note the long 
time that it takes for DOPAC and 5-HT to elute from the column.  In studies where 
norepinephrine, an analyte which elutes from the column very quickly, are not present the 
amount of organic modifier can be increased in order to allow DOPAC and 5-HT to elute  
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Figure 5.1.  Chromatogram of a standard mixture of analytes.  A mixture of the analytes of 
interest (5 µM each) was separated on an Atlantis C18 column (Waters) with a citric acid 
(100 mM) buffer, pH = 3 as the mobile phase.  Sodium hexylsulfate (1 mM) was used as an 
ion pairing agent, and EDTA (0.1 mM) was added to the mobile phase.  Methanol (5%) was 
used as the organic modifier.  ECD was performed at a carbon electrode held at 700 mV vs. 
Ag/AgCl.  Peak identification: 1 – solvent front, 2 – NE, 3 – HQ, 4 – DA, 5 – DOPAC, 6 – 5-
HT. 
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more quickly, decreasing longitudinal diffusion and sharpening the observed peak.  A 
chromatogram such as this can be used to determine the elution order of the analytes of 
interest, the retention time of each analyte for identification during analysis of brain samples, 
and for determining the response ratio of the electrochemical detector between the analytes 
and the internal standard.  Response ratios were determined during each experiment before 
analysis of brain tissue samples. 
Tissue samples were collected from rodents in various regions of interest.  Figure 5.2 
shows coronal brain slices from The Allen Institute for Brain Science Mouse Brain Atlas 
indicating the areas from which samples were taken.  The nucleus accumbens (Figure 
5.2A), dorsolateral straitum (Figure 5.2B), BNST (Figure 5.2C), and SNr (Figure 5.2D) were 
the regions of interest during different studies.  While Figure 5.2 shows the anatomy for the 
mouse brain, the rat has similar anatomical landmarks and tissue punches were taken from 
similar areas in the Sprague Dawley and Lewis rats.  Locations were chosen based on the 
optimal coordinates that were used during fast-scan cyclic voltammetry experiments for the 
study of the release of the neurotransmitters of interest. 
 Upon homogenization of the tissue, and extraction of neurotransmitters and 
metabolites into the perchloric acid solution, the samples were analyzed using the same 
method as for the standard solutions.  Due to the high selectivity of electrochemical 
detection, very few peaks are observed on the chromatograms, and are often confined to 
just the internal standard and the analytes of interest.  This makes identification of the 
analytes based on retention time alone possible.  Figure 5.3 shows representative 
chromatograms from the dorsolateral striatum from a Ube3am+/p+ mouse showing the peaks 
for dopamine and DOPAC (Figure 5.3A), from the BNST of a Sprague Dawley rat showing 
the peaks for NE and dopamine (Figure 5.3B), and from the SNr of a WT mouse before 
citalopram administration showing the peaks for dopamine and 5-HT (Figure 5.3C).  Note  
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Figure 5.2.  Location of punches taken in various brain regions in the mouse brain.  Black 
circles denote the regions from which punches were taken from the (A) nucleus accumbens 
(AP +1.1 mm from bregma), (B) dorsolateral striatum (AP +0.5 mm from bregma), (C) bed 
nucleus of the stria terminalis (AP +0.25 from bregma), and (D) substantia nigra reticulate 
(AP -3.0 mm from bregma).  Images are modified from The Allen Institute for Brain Science 
Mouse Brain Atlas (Science, 2009). 
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Figure 5.3.  Representative chromatograms from tissue samples.  Extractions from tissue 
samples were separated on an Atlantis C18 column (Waters) with a citric acid (100 mM) 
buffer, pH = 3 as the mobile phase.  Sodium hexylsulfate (1 mM) was used as an ion pairing 
agent, and EDTA (0.1 mM) was added to the mobile phase.  (A) BNST sample (1.1 mg) 
from a Lewis rat with methanol (5%) as the organic modifier.  (B) Dorsolateral striatum 
sample (7.4 mg) from a WT mouse with methanol (10 %) as the organic modifier.  (C) SNr 
sample (1.6 mg) from a WT mouse with methanol (12%) as the organic modifier.  ECD was 
performed at a carbon electrode held at 700 mV vs. Ag/AgCl.  Peak identification: 1 – 
solvent front, 2 – AA, 3 – NE, 4 – HQ, 5 – DA, 6 – DOPAC, 7 – 5-HT. 
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that the relative sizes of peaks between the chromatograms will differ greatly depending on 
the mass of the tissue being used, as well as the tissue preparation procedure used before 
slicing and excising of the tissue of interest. 
Tissue Content of Catecholamines in Sprague Dawley and Lewis Rats 
 Using the above stated methods, total tissue content of dopamine in the dorsolateral 
striatum and NAc, and total tissue content of dopamine and NE in the BNST was performed 
on two strains of rats, Sprague Dawley, and Lewis rats.  Table 5.1 summarizes the findings.  
The total content of dopamine was determined to be significantly higher in the dorsolateral 
striatum of Lewis rats compared to Sprague Dawley rats (3.87 ± 0.30 and 5.20 ± 0.18 µg/g 
respectively, n = 5 for each strain, p < 0.01, student’s t-test).  In the NAc, however, the 
difference between the dopamine content of the two strains fell short of significance (5.25 ± 
0.96 µg/g for Sprague Dawley rats and 6.06 ± 0.32 µg/g for Lewis rats, n = 5 for each strain, 
p = 0.45, student’s t-test).  This is because of the high variability in the dopamine content in 
the Sprague Dawley animals.  In the BNST, both the norepinephrine and the dopamine total 
content were significantly higher when comparing the two strains.  The norepinephrine 
content was determined to be 4.55 ± 0.84 µg/g in Sprague Dawley rats and 10.86 ± 1.52 
µg/g in Lewis rats (n = 5 for each strain, p < 0.01, student’s t-test).  The dopamine content 
was determined to be 1.06 ± 0.32 µg/g in Sprague Dawley rats and 3.15 ± 0.46 µg/g in 
Lewis rats (n = 5 for each strain, p < 0.01, student’s t-test).  These data show the significant 
difference that changing the kind of animal being used has on neurotransmitter content in 
areas with high amounts of catecholaminergic innervation. 
Tissue Content of Catecholamines in Ube3am-/p+ Mice 
 Total dopamine and DOPAC content were determined for wild-type (WT) and 
Ube3am-/p+ mice.  These regions were selected due to differences which were observed in  
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Table 5.1.  Total neurotransmitter tissue content of Sprague Dawley and Lewis rats.  T-tests 
were performed to compare the neurotransmitter content between different strains of rats in 
each brain region.  Data are presented as mean ± SEM (µg/g).  n = 5 for all values,  **p < 
0.01. 
 
 
 
 
Region (Neurotransmitter) Sprague Dawley Lewis 
dl striatum (DA) 3.87 ± 0.30 5.20 ± 0.18** 
NAc (DA) 5.25 ± 0.96 6.06 ± 0.32 
BNST (NE) 4.55 ± 0.84 10.86 ± 1.52** 
BNST (DA) 1.06 ± 0.32 3.15 ± 0.46** 
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behavioral experiments performed in the lab of Ben Philpot in the Department of Cell and 
Molecular Physiology at the University of North Carolina at Chapel Hill which showed 
decreased cocaine motor activity (indicating a decrease in dopamine release in the 
dorsolateral striatum) as well as a decreased reward threshold upon electrical stimulation 
(indicating a decrease in dopamine release in the NAc).  Furthermore, FSCV data collected 
by Elyse Dankoski in these regions showed a decrease in dopamine release upon high 
frequency electrical stimulation in both of these regions (data not shown).  DOPAC content 
as well as the ratio of DOPAC: DA was determined to see if the ubiquitin produced by the 
Ube3a gene played a role in the breakdown of the dopamine metabolite.  Table 5.2 
summarizes the data collected for the animals in both brain regions.  The data are 
represented as nmol/g in these studies so that the DOPAC: DA ratio could be determined.   
T-tests of the data showed that the dopamine content was the same between the WT 
and Ube3am-/p+ mice in the dorsolateral striatum (46.93 ± 5.60 and 40.96 ± 4.63 nmol/g, 
respectively).  The same was true for the DOPAC content (3.37 ± 0.93 and 3.15 ± 0.64 
nmol/g, respectively), and the DOPAC:DA ratio (0.07 ± 0.02 and 0.07 ± 0.01, respectively).  
Similar data were observed in the NAc of the WT and Ube3am-/p+ mice for dopamine (23.72 ± 
2.49 and 25.13 ± 2.52 nmol/g, respectively), DOPAC (1.98 ± 0.51 and 2.46 ± 0.55, 
respectively), and the DOPAC: DA ratio (0.09 ± 0.03 and 0.10 ± 0.02, respectively).  These 
data indicate that although differences in the behavioral and FSCV data exist, there is no 
differences in the total amount of dopamine synthesized or stored in the cells, and that the 
breakdown of the DOPAC metabolite is not affected by the deletion of the maternal copy of 
the Ube3a gene (p > 0.05 for all brain regions and analytes, n = 5 or 6, student’s t-test).   
Tissue Content of 5-HT in WT Mice during Citalopram Administration 
 WT mice were used to determine the total tissue content of 5-HT in the SNr in naïve 
animals as well as animals which were treated with an acute administration (30 minutes  
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Table 5.2.  Total dopamine and DOPAC content of WT and Ube3am-/p+ mice.  T-tests were 
performed to compare genotypes for each analyte in each brain region.  Data are 
represented as mean ± SEM (nmol/g). 
 
 
Region (Neurotransmitter) WT Ube3am-/p+ 
dl stiatum (DA) 46.93 ± 5.60 (n = 5) 40.96 ± 4.63 (n = 6) 
dl striatum (DOPAC) 3.37 ± 0.93 (n = 5) 3.15 ± 0.64 (n = 6) 
dl striatum (DOPAC:DA) 0.07 ± 0.02 (n = 5) 0.07 ± 0.01) (n = 6) 
NAc (DA) 23.72 ± 2.49 (n = 5) 25.13 ± 2.52 (n = 5) 
NAc (DOPAC) 1.98 ± 0.51 (n = 5) 2.46 ± 0.55 (n = 5) 
NAc (DOPAC:DA) 0.09 ± 0.03 (n = 5) 0.10 ± 0.02 (n = 5) 
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before sacrifice) of citalopram (5 mg/kg), a SERT blocker.  Furthermore, animals which were 
chronically injected with either vehicle or citalopram (5 mg/kg) for 14 days were also 
analyzed for total 5-HT content in the SNr.  Upon normalization of the data for the tissue 
mass, the 5-HT content for the naïve animals was determined to be 2.04 ± 0.29 µg/g, while 
the 5-HT content was found to be 2.21 ± 0.40 µg/g for animals acutely treated with 
citalopram.  Animals which were chronically administered with vehicle has 5-HT content of 
2.04 ± 0.28 µg/g while chronic administration of citalopram led to tissue content of 2.55 ± 
0.21 µg/g 5-HT.  Performing a one-way ANOVA of the data to compare the groups using a 
Newman-Keuls post-hoc test to compare individual group, no significant difference was 
observed between the groups (Table 5.3, p > 0.05 for all, n = 5 or 6 for each, one-way 
ANOVA).  These data indicate that acute administration of citalopram has no significant 
effect on the synthesis or storage of 5-HT in the SNR. 
Discussion 
 HPLC-ECD is a simple, inexpensive, and useful tool for the determination of total 
tissue content of various neurotransmitters in many different brain regions.  Interpretation of 
the data is simple when electrochemical detection is used, because the chromatograms only 
contain peaks for analytes which can be oxidized at or below the potential applied to the 
working electrode in the amperometric detector while interfering species such as proteins go 
undetected.  Coupling this detection scheme with an internal standard and normalization 
with the mass of the tissue used allows for comparisons between genetically different 
animals, as well as animals before and after administration of a drug which changes the 
release or uptake properties of neurotransmitters of interest.  The data contained in this 
chapter show how a method which has been in use since the 1980s can still be used today 
to answer interesting questions about the synthesis and storage of neurotransmitters in the 
brain today (Mefford, 1981). 
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Table 5.3.  5-HT content in the SNr before and after treatment with SERT inhibitor 
citalopram.  One-way ANOVA with Newman-Keuls post-hoc test was performed to compare 
groups (p > 0.05 for all comparisons).  Data are represented as mean ± SEM (µg/g). 
 
 
Treatment 5-HT Content in SNr (µg/g) 
Naïve  2.04 ±  0.29 (n = 5) 
Acute Citalopram 2.21 ±  0.18 (n = 5) 
Chronic Vehicle 2.04 ±  0.28 (n = 6) 
Chronic Citalopram 2.55 ±  0.21 (n = 6) 
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Tissue Content of Catecholamines in Sprague Dawley and Lewis Rats 
 Drug abuse remains a complex public health issue for which there is no real cure 
and many different physiological mechanisms which play a key role.  Furthermore, relapse is 
a common problem among addicts, and stress disorders are often found to be a recurring 
problem with patients who show high rates of relapse.  Research into the comorbidity of 
these disorders has highlighted the role of adrenergic systems and the endogenous opioid 
system as targets for the link joining the two (Van Bockstaele et al., 2001, Smith and Aston-
Jones, 2008).  The BNST receives the largest projection of norepinephrine in the central 
nervous system, and serves as a relay between the cognitive-emotive brain centers and 
reward and stress nuclei, modulating critical aspects of addiction (McElligott and Winder, 
2009).  Given these important inputs, the BNST plays a key role in the reinstatement of 
seeking, conditioned place aversion to opiate withdrawal, anxiety-like behavior, and the 
affective component of pain (Poulin et al., 2009).  Furthermore, plasticity within the BNST 
can be modulated by chronic stress (McElligott et al., 2010).   
Lewis rats, in particular, have been used to study anxiety disorders and drug abuse 
due numerous observed properties such as high levels of self-administration of opiates 
(Sanchez-Cardoso et al., 2007), high baseline anxiety (Cohen et al., 2006), BNST-
dependent generalized expression of fear (Duvarci et al., 2009), and elevated levels of 
norepinephrine released in the BNST to a stressor as compared to Sprague Dawley rats as 
measured by microdialysis (Pardon et al., 2002).  Both the mesolimbic dopamine pathway 
and the BNST of naïve Lewis rats have been said to resemble Sprague Dawley rats which 
are opioid dependent (Beitner-Johnson et al., 1991, Guitart et al., 1992, Guitart and Nestler, 
1993). Interestingly, recent studies have indicated that if the BNST of Lewis rats are 
lesioned, the animals no longer exhibit fear generalization and have lower anxiety (Duvarci 
et al., 2009).  These observations also make them a good animal model for Post-Traumatic 
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Stress Disorder (PTSD).  These previous observations lead to the need for a fundamental 
study of the total neurotransmitter content in both the BNST as well as the dopaminergic 
terminals in the striatum.  These data indicate that the total amount of catecholamines 
synthesized and stored in both the dorsolateral striatum and BNST are significantly higher in 
these brain regions leading to the above mentioned phenotypes.  Reasons for these 
differences could include increase in the amount of tyrosine hydroxylase or phosphorylated 
tyrosine hydroxylase, the enzyme used during the rate dependent step of catecholamine 
synthesis, or differences in the amount of enzymes which break down catecholamines after 
release or uptake, such as monoamine oxidase. 
Tissue Content of Catecholamines in Ube3am-/p+ Mice 
 Angelman syndrome is a neurodevelopmental disorder characterized by intellectual 
disability, profound language impairment, seizures, and a propensity for a happy disposition 
(Steffenburg et al., 1996, Peters et al., 2004, Williams et al., 2006).  Angelman Syndrome 
results from loss of function of the maternally-inherited UBE3A allele at the 15q11-q13 locus 
(Kishino et al., 1997).  The Ube3a gene encodes a HECT domain E3 ubiquitin ligase 
(UBE3A, also known as E6AP) involved in protein degradation through the ubiquitin-
proteasome pathway (Kishino et al., 1997, Sutcliffe et al., 1997).  Behavioral experiments 
performed in the lab of Dr. Ben Philpot in the Department of Cell and Molecular Physiology 
on mice lacking the maternal copy of the Ube3a gene showed a decrease in cocaine 
induced motor sensitivity, as well as a decrease in the reward threshold of the animals 
during intracranial self-stimulation experiments (data not shown).  Furthermore, FSCV 
studies showed an increase in the dopamine release in the NAc of the Ube3am-/p+ animals 
compared to WT, but no difference in dopamine release in the dorsolateral striatum of the 
mice upon stimulation of the ventral tegmental area (VTA) or substantia nigra (SN) (data not 
shown). 
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 These observations lead to the total tissue content analysis of Ube3am-/p+ as 
compared to WT animals to help determine the role UBE3A plays in these dopaminergic 
systems.  Content analysis showed no difference between the two genotypes in terms of the 
dopamine or DOPAC content as well as no differences in the ratio of the DOPAC: DA.  
These findings support the assertion that UBE3A plays an integral, pathway-specific role in 
the release of dopamine in the mouse model of Angelman Syndrome.  This role, however, is 
not directly associated with the synthesis or storage of dopamine in these presynaptic 
terminals.  This is supported by the observation that there is no difference in the amount of 
tyrosine hydroxylase (TH) as determined by Western Blot (data not shown), or the total 
amount of TH positive cells in the VTA and SN (data not shown).  This example shows how 
HPLC total tissue content determination can be used to discount possible hypotheses for 
observations in differences in catecholamine release in the striatum of genetically different 
animals, specifically, an Angelman Syndrome mouse model. 
 Tissue Content of 5-HT in Mice during Citalopram Administration 
 Serotonin is an important neurotransmitter that is involved in a myriad of functions 
including sleep, motivated social behaviors and most famously, depression (Petty et al., 
1996).  Selective serotonin reuptake inhibitors (SSRIs), such as citalopram are a common 
pharmacological treatment for depression, although the exact mechanism of their 
therapeutic action remains ambiguous (De Montigny, 1981, Sharp and Cowen, 2011).  
Furthermore, it has been hypothesized that changes in phasic and tonic levels of 5-HT, 
typically modulated by the 5-HT1a receptor, could be effected by SSRIs such as citalopram 
(Best et al., 2011).  Recently, FSCV of 5-HT release in the SNr was completed by 
stimulation of the dorsal raphe nucleus (DRN) and the medial forebrain bundle (MFB) 
allowing for real-time measurement with a method with high spatial and temporal resolution 
(Hashemi et al., 2009, Hashemi et al., 2011).  In these studies, acute administration of 
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citalopram showed an increase in the maximal measured concentration of 5-HT in the 
extrasynaptic space as well as a slowing of the uptake of 5-HT.   
 Work has since moved into studying the mechanisms of 5-HT release in the SNr in 
mice as opposed to rats.  In order to study if acute treatment of animals with citalopram 
changes the synthesis or packaging of 5-HT in the SNr, HPLC determination of total tissue 
content was performed pre and post administration of citalopram.  The data showed no 
difference in 5-HT content in the SNr 30 minutes post-injection.  These data are supported 
by previously reported values which showed that while pharmacological administration of 
drugs changed binding of 5-HT to SERT, no change was seen in total tissue content of 5-HT 
(Callaghan et al., 2006).  While there is an upward trend in the content of animals 
administered with citalopram chronically, these findings fall short of statistical significance 
and could be due to the location of the punches and the small size of the region.  Given 
these observations, we can conclude that the changes in phasic 5-HT release are not due to 
differences in synthesis or packaging of 5-HT given acute administration of an SSRI, but 
rather the blockage of SERT itself.  Furthermore, chronic inhibition of SERT does not lead to 
long-term changes in intracellular mechanisms governing the total content of 5-HT in the 
SNr. 
Conclusion 
In this chapter, a simple analytical tool, HPLC-ECD, is used in order to answer 
fundamental questions about the synthesis, storage, and total tissue content of 
neurotransmitters in various brain regions under different conditions.  Differences in 
dopamine and norepinephrine content were observed when comparing different strains of 
rats showing the fundamental difference between the two, and these results were put into 
context in terms of how they are used as a model system for Post-Traumatic Stress Disorder 
and drug addiction.  In a stark contrast, no differences were observed in mice lacking the 
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maternal copy of the Ube3a gene, a model mouse for Angelman Syndrome, although 
differences had been observed between the animals in both behavioral and FSCV 
experimentation.  Lastly, 5-HT content in the SNr was determined to be no different between 
animals before or after treatment with citalopram,  showing that this method can also be 
used not only to compare genetically different animals, but also for animals pre- and post- 
drug administration.  Experiments such as these should always be conducted when studying 
genetically different animals and making comparisons so that data can be properly 
interpreted. 
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Chapter VI 
Surface Analysis of Nafion Coated Ag/AgCl Reference Electrodes 
Introduction 
Fast-scan cyclic voltammetry (FSCV) is a powerful tool for studying in vivo, sub-
second neurotransmitter dynamics (Ewing and Wightman, 1984, Kuhr et al., 1984, Hashemi 
et al., 2009, Park et al., 2009).  Miniaturization of the electronics associated with FSCV has 
allowed correlation of transient dopamine concentration fluctuations with behavior in freely 
moving rats (Cheer et al., 2007, Owesson-White et al., 2008).  These behavioral 
experiments necessitate a ‘survival’ surgery in which an electrical stimulating electrode, a 
guide cannula and a Ag/AgCl reference electrode are permanently implanted into the brain 
of a rat.  After a recovery period (typically 4 days), the rat is placed in an operant chamber 
and a fresh carbon-fiber electrode is lowered into the brain for voltammetric recordings of 
dopamine during behavior.  These recordings often yield cyclic voltammograms where the 
oxidation and reduction potentials associated with dopamine redox processes are ‘shifted’ 
with respect to in vitro recordings.  This electrochemical shift, typically of + 0.2 to 0.3 V, can 
have dramatic effects on the voltammetric measurements.   First, the identification of the 
species electrolyzed, which is based upon the position of the voltammetric peaks is 
confounded.   Second, the sensitivity of the responses is altered because the voltammetric 
response to adsorbed species depends upon the potential limit of the voltage scan 
(Takmakov et al., 2010).  These electrochemical shifts arise from a drift in response of the 
chronically implanted reference electrode because they are not seen with acute implantation 
(Garris and Wightman, 1994, Robinson et al., 2003).  
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Deterioration of probes permanently implanted in the brain is commonly seen in a 
variety of experiments (Rousche and Normann, 1998, Williams et al., 1999, Nicolelis et al., 
2003), and the brain’s response towards implanted devices has been well-documented 
(Stensaas and Stensaas, 1976, Smith et al., 1986, Szarowski et al., 2003, Polikov et al., 
2005).  When a foreign body is inserted into the tissue, a dense network of glial cells 
encapsulates the device, isolating it from the tissue in a process called gliosis or glial 
scarring (Kreutzberg, 1996, Turner et al., 1999, Biran et al., 2005).  For FSCV 
measurements, the electrochemical shift affects the quantification of dopamine levels and 
reproducibility of substrate identity.  In the past, we have offset the potential shift.  While this 
approach is effective, it is desirable to prevent the shift from occurring so that the potentials 
employed in the brain are accurate.    
Past research has focused on strategically shaping, texturing, coating or optimizing 
materials for devices to reduce tissue responses (Edell et al., 1992, Yuen and Agnew, 1995, 
Rousche et al., 2001, Nicolelis et al., 2003, George et al., 2005).  In 1994, Moussy et al. 
found that the rapid subcutaneous degradation of Ag/AgCl could be prevented with Nafion 
modifications to the reference electrode surface (Moussy and Harrison, 1994).  Here, their 
method was optimized and applied it to in vivo neurochemical FSCV by coating sintered 
Ag/AgCl electrodes with Nafion, and surface analysis of the electrodes was performed in 
order to analyze the surface after various implantation times in the brain.  Scanning electron 
microscopy and energy dispersive x-ray spectroscopy (SEM-EDS) were performed to image 
the electrodes, and analyze the changes on the surface.  SEM imaging showed buildup of 
tissue on uncoated electrodes while Nafion coated electrodes remained clean.  
Furthermore, EDS showed a gradual decrease in the Nafion coating over implantation time 
along with a more dramatic decrease in relative chlorine on the surface of bare electrodes, 
indicating a possible mechanism for the fouling of electrodes in vivo.   
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Experimental 
Animals and Surgery 
Surgery for voltammetric measurements of dopamine were performed as previously 
described (Phillips et al., 2003). Briefly, male Sprague-Dawley rats aged 90-120 days (275-
350 g) (Charles River Labs., Raleigh, NC, USA) were anesthetized with urethane (1.5 g kg -1 
rat weight) and affixed into a stereotaxic frame (Kofp instruments).  Flat-skull surgical 
techniques were employed using coordinates from a stereotaxic atlas (Paxinos and Watson, 
2007).  A guide cannula (Bioanalytical Systems, West Lafayette, IL) was implanted above 
the nucleus accumbens (NAc) (stereotaxic coordinates relative to bregma: 2.2 mm anterior, 
1.7 mm lateral) and a bipolar stimulating electrode (Plastics One, Roanoke, VA) was 
lowered into the medial forebrain bundle (MFB) (stereotaxic coordinates relative to bregma: 
1.8 mm posterior, 1.7 mm lateral, 8.5 mm ventral).  Reference electrodes (prepared as 
described below) were implanted in the contralateral hemisphere.  Electrodes were 
stabilized with skull screws and cranioplastic cement.  After voltammetry and impedance 
experiments, acetone was applied to the cement around the reference electrode in order to 
soften it. A small crater was drilled around the reference electrode pin so that it could be 
removed carefully from the tissue minimizing tissue damage.  All surgical procedures were 
approved by the University of North Carolina Institutional Animal Care and Use Committee 
and in concordance with the NIH Guide for the Care and Use of Animals. 
Fast-Scan Cyclic Voltammetry 
Carbon-fiber microelectrodes were used for voltammetric recordings of dopamine.  
T-650 carbon fibers (Thornel, Amoco Corp., Greenville, SC) were aspirated into glass 
capillaries (AM Systems, Sequim, WA), pulled on a vertical pipette puller (model PE-22, 
Narishige Group, Tokyo, Japan), and cut to a length of 50-100 µm.  An electrochemical 
waveform was applied to the electrode that scanned from -0.4 V to 1.3 V at a rate of 400 V 
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s-1 at 10 Hz.  The holding potential of -0.4 V between voltammetric scans allows for 
adsorption of dopamine to the electrode.  Waveform application, current monitoring, and 
stimulus application were performed using a customized version of the TH-1 software (ESA, 
Chelmsford, MA) written in LabVIEW (National Instruments, Austin, TX) with a custom built 
potentiostat (UEI, University of North Carolina Chemistry Department Electronics Facility) for 
waveform application.  A DAC/ADC card (NI 6251 M, National Instruments) and a triggering 
card (NI 6711, National Instruments) were used to interface between the software and the 
instrument and the timing of the electrical stimulation with the waveform application. 
Flow Injection Analysis 
Flow injection analysis was used for in vitro calibration experiments (Kristensen et 
al., 1986).  The carbon-fiber microelectrode was placed in the output of a six-port HPLC loop 
injector mounted on a two-position actuator (Rheodyne model 7010 valve and 5701 
actuator), operated by a 12 V DC solenoid valve kit (Rheodyne, Rohnert Park, CA, USA). 
The apparatus enabled the introduction of a rectangular pulse of analyte to the 
microelectrode surface using a syringe infusion pump (Harvard Apparatus model 940, 
Hollison, MA, USA) at a flow rate of 2 mL/min.  The flow injection buffer was constituted with 
the following: Trizma hydrochloride (15 mM), NaCl (140 mM), KCL (3.25 mM), 2H2O CaCl 
(1.2 mM), H20 NaH2PO4 (1.25 mM), Mg Cl2 (1.2 mM) and Na2 SO4 (2.0 mM) all purchased 
from Sigma-Aldrich (St. Louis, MO, USA). 
Nafion Coatings 
Reference electrodes were fabricated using a modified procedure originally 
described by Moussy et al. (Moussy and Harrison, 1994). Sintered Ag/AgCl reference 
electrodes (E255A, In Vivo Metric, Healdsburg, CA) were mounted and soldered into 
conductive pins.  The entirety of the electrode was dipped in 5% Nafion solution (Liquion-
1105-MeOH, Ion Power, DE) for 10 seconds using a slow agitating motion.  This coating 
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was allowed to dry for 30 minutes and the process was repeated for a total of 5 coatings. 
The electrodes were air dried overnight and then cured at 120 °C for 1 hour.  Because of the 
toxic nature of the methanol solvent, the curing process at 120 °C is essential to ensure full 
evaporation of the methanol from the thick Nafion membrane. 
SEM-EDS 
Scanning electron microscopy and energy dispersive x-ray spectroscopy (SEM-EDS) 
was performed on an S-4700 Cold Cathode Field Emission Scanning Electron Microscope 
(Hitachi, Pleasanton, CA).  SEM images were collected under high vacuum, using an 
excitation voltage of 20 kV.  EDS data were collected using a Si (Li) detector and quantified 
using the INCA PentaFET -x3 software (Oxford Instruments, Concord, MA), and calibrated 
using 99% Cu.  EDS spectra were collected at three distinct 300 x 300 µm locations on each 
electrode and the values for atomic % fluorine were averaged. 
Results and Discussion 
Electrochemical Shift in Electrochemical Peaks for Dopamine 4 Days after Implantation  
FSCV experiments in behaving rats require a period of recovery after the surgery to 
implant the reference and stimulating electrodes.  Within this 4-day period, chemical or 
physical processes occur around the reference electrode surface such that when dopamine 
is measured with a fresh carbon-fiber microelectrode, the oxidation and reduction potentials 
are ‘shifted’ with respect to their in vitro positions.  Figure 6.1 illustrates this type of response 
in a freely moving rat that had undergone surgery 4 days previously.  The color plot in panel 
(i) displays cyclic voltammograms collected at 10 Hz for 15 seconds in the NAc during an 
electrical stimulation (at 5 seconds) of the MFB.  The time of the electrical stimulation is 
indicated with the black bar under the color plot.  This electrically evoked response has 
previously been characterized anatomically, physiologically, chemically and  
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Figure 6.1.  Chronically implanted references electrodes shift over time.  (i) Color plots with 
potential on the y-axis plotted against time on the x-axis and the current response 
represented in false color.  These plots represent (A) the signal obtained in the NAc of a 
freely-moving rat upon MFB stimulation (black bar under the color plot denotes the 
stimulation time and duration) 4 days after initial surgery.  (B) The same signal after a - 0.3 V 
‘offset’, (C) an in vitro injection of dopamine (1 µM) vs. a fresh Ag/AgCl reference electrode 
and (D) an in vitro injection of dopamine (1 µM) vs. the Ag/AgCl electrode explanted from 
the rat used in signal (A).  (ii) (A)-(D) Representative cyclic voltammograms taken from the 
vertical white dashed lines.  
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pharmacologically to arise from neuronal release of dopamine (Kuhr et al., 1984).  However, 
the peaks for this substance recorded in vivo do not occur at the same potential as those for 
authentic dopamine (1 µM) measured in vitro (Figure 6.1C) using a freshly fabricated 
Ag/AgCl electrode.  This is also apparent in the corresponding cyclic voltammograms shown 
in panel (ii) of Figure 1.  In vivo, the oxidation occurs at around 0.95 V instead of 0.65 V and 
the reduction occurs at 0.0 V instead of -0.2 V showing that a process at the implanted 
reference electrode has offset the potential of the applied waveform.  Moreover, this change 
in waveform seems to enhance sensitivity to the pH changes that occur after the stimulation, 
making it more difficult to distinguish smaller dopamine signals.  We have previously 
compensated for this by applying a counter potential offset as illustrated in Figure 6.1B 
where the horizontal white dashed lines show the position of the maximum oxidation with 
respect to the in vitro signal.  In this example, the waveform was offset by -300 mV, which 
shifts the oxidation response to 0.65 V and the reduction to -0.2 V.  This response then 
matches the in vitro response (Figure 6.1C).   
Interestingly, the potential of this ‘shifted’ reference electrode is not permanently 
altered.  To establish this, we removed the reference electrode from the rat’s brain and used 
it as a reference electrode in vitro for dopamine measurements.  Figure 6.1D shows that 
despite the shifted electrochemical response in vivo, the reference electrode yields an  
electrochemically characteristic dopamine cyclic voltammogram that is not offset in vitro.  
Thus, the mechanisms leading to the electrochemical shifts are specific to the local 
environment around the reference electrode in vivo. 
Prevention of Electrochemical Shift with Nafion-Coated Ag/AgCl Reference Electrodes 
In our previous work, and in the example showed in Figure 6.1, we constructed 
Ag/AgCl reference electrodes by electroplating AgCl onto a silver wire (Phillips et al., 2003).  
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Because this resulted in a thin chloride layer, it may be particularly susceptible to an 
alteration in chemical composition when implanted in the brain.  Thus, we used 
commercially available, sintered Ag/AgCl electrodes (E255A, In Vivo Metric, Healdsburg, 
CA).  The Ag/AgCl is sintered in a mesh matrix, and a Ag wire is forced into the matrix to 
create the electrode that has a much thicker AgCl coating than the homemade reference 
electrodes.  However, despite the thicker chloride layer, these electrodes also showed a 
potential shift of similar magnitude in vivo 4 days after implantation.  
Moussy et al. previously described Nafion coatings on Ag/AgCl reference electrodes 
that prevented the degradation of their electrochemical performance (Moussy and Harrison, 
1994).  We have previously utilized Nafion extensively in our electrochemical recordings 
(Kristensen et al., 1987, Wiedemann et al., 1990, Hashemi et al., 2009) therefore we 
optimized their coating technique in an attempt to stabilize the potential of our reference 
electrodes.  The sintered electrodes were used because their rough surface is ideal for 
adherence of polymer coatings.  The electrodes were dipped 5 times in 5% Nafion solution 
for 10 seconds with a slow agitating motion and each coating was allowed to dry for 30 
minutes.  These electrodes were dried in air overnight and then cured at 120 °C for 1 hour. 
To test their stability we performed experiments where we implanted both Nafion and 
uncoated reference electrodes into the brains of rats who were then allowed to recover for 7, 
14, and 28 days.  After these periods, the rats were anesthetized, an acute reference 
electrode and carbon fiber electrode were implanted into their brain and dopamine release 
was compared with recordings using each of the 3 reference electrodes (acute, Nafion-
coated, permanently implanted and bare, permanently implanted).   
Figure 6.2A (i) shows a color plot of the dopamine response in the NAc of an 
anesthetized animal upon MFB stimulation when the potential was applied versus the 
acutely implanted Ag/AgCl reference electrode.  Figures 6.2B (i) and 2C (i) show  
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Figure 6.2.  Nafion coatings prevent electrochemical shifts upon chronic implantation.  (i) 
Color plots with potential on the y-axis plotted against time on the x-axis and the current 
response represented in false color. These plots represent (A) a dopamine signal in the NAc 
of an anesthetized rat upon MFB stimulation (stimulation time and duration noted by black 
bar under the plot) vs. an acutely implanted Ag/AgCl reference electrode, (B) a dopamine 
signal in the same rat vs. a bare electrode implanted for 7 days, (C) a dopamine signal in 
the same vs. a Nafion-coated electrode implanted for 7 days. (ii) (A) –(C) Representative 
cyclic voltammograms taken from the vertical white dashed lines. (iii) Averaged volts shifted 
from an acutely implanted Ag/AgCl reference electrode for bare (blue) and Nafion-coated 
(black) electrodes for 7, 14 and 28 days (n=6 per group (18 in total ± SEM). Results were 
analyzed using a two-way ANOVA  showing a significant difference in potential shift 
between Bare and Nafion electrodes (p<0.001) and post-tests to compare groups at the 
different time points, *p<0.05, **p<0.01. 
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comparisons of this same response, at the same carbon-fiber microelectrode in the same 
rat, however, vs. bare (B) and a Nafion-coated (C) chronically implanted reference 
electrodes that had been implanted for 7 days.  Panel (ii) shows the corresponding cyclic 
voltammograms.  As before, the bare electrode displays shifted oxidation and reduction 
peaks (0.93 V and 0.08 V respectively); however, the Nafion-coated reference electrode 
prevents this effect.  The positions of the oxidation and reduction peaks are maintained and 
correlate not only with the acutely implanted reference electrode, as indicated by the 
horizontal white dashed line, but also to an in vitro experiment (0.65 V and -0.2 V 
respectively).  This effect is maintained over multiple days.  Figure 6.2 (iii) shows a 
histogram that compares dopamine potential shifts between acutely implanted reference 
electrodes and bare (blue) and Nafion-coated (black) electrodes that have been implanted 
into the brain for 7, 14 and 28 days (n=6 for each group (18 in total) ± SEM).  The bare 
electrodes display shifts in all cases, most robustly after 28 days as evidence by the small 
error margin.  The Nafion coated electrode reduces this shift however.  We analyzed the 
shifts in peak potential using a two-way ANOVA, with appropriate post-tests, and found that 
Nafion coatings had a significantly different behavior than the bare electrodes on potential 
over time (P<0.001).  Using the post-tests, it was determined that there was no significant 
difference between the groups after 1 week implantation (p>0.05), but a significant 
difference after two and four weeks of implantation (p<0.01 and p<0.05, respectively).  We  
can therefore increase the stability of the reference electrodes robustly and significantly for 
up to 28 days using this technique. 
Surface Analysis of Chronically Implanted Reference Electrodes 
To test the idea of whether or not cells adsorb to the bare electrode surface to a 
larger extent that to the Nafion surface, scanning electron microscopy (SEM) and energy 
dispersive x-ray spectroscopy (EDS) was performed on reference electrodes after they were 
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removed from tissue.  Figure 6.3 shows SEM images of bare (i) and Nafion coated (ii) 
electrodes before implantation (A), after 7 days (B), 14 days (C), or 28 days (D) in the rat 
brain.  Before implantation, there is a clear visual difference between the bare electrode and 
the Nafion coated electrodes.  The bare electrodes have a coarse appearance due to the 
sintered Ag/AgCl surface, while the Nafion coated electrodes are smooth.  The non-polar 
coating gives the surface a shiny appearance and is easily distinguishable from the 
Ag/AgCl.  As implantation time is increased, a build-up of large plaques is apparent on the 
bare electrode surface; this is particularly striking after 28 days (B) and is highlighted with 
the focused image in (C).  In contrast, the Nafion-coated surfaces (ii) remain free of plaques.  
This is consistent with the histological data that shows that the cells remain intact in the 
tissue and indeed with the voltammetric data that shows no electrochemical shifts.  
However, as implantation time is increased up to 28 days (B), the Nafion-coated electrode 
resembles a bare electrode, showing that the Nafion coating has degraded.  The 28-day 
marker is again consistent with the voltammetric data that shows a small percentage of 
electrodes that shift after 28 days and with the histological data that shows a rough surface 
lesion around the Nafion-coated electrode’s implant site in tissue.  
We next chemically analyzed three distinct sites on the electrode’s surface with EDS. 
EDS displays high spatial resolution with an ability to measure the atoms present microns 
below the outermost surface.  Hence, we can observe the Ag present under the Nafion 
coatings.  Figure 6.4 shows representative EDS spectra for (A) a bare electrode before 
implantation, (B) a Nafion coated electrode before implantation, (C) a bare electrode after 14 
days implantation, and (D) a Nafion coated electrode after 14 days implantation.  Peaks 
were quantified as the atomic percent of each atom observed.  The Nafion coated 
electrodes display the same peaks positions as the bare electrodes (Ag doublet at 3 keV, Cl 
peaks at 0.1 and 2.8 keV), and in addition have peaks for carbon (peak at 0.3 keV), sulfur  
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Figure 6.3.  SEM images of chronically implanted electrodes. Representative scanning 
electron microscopy images of bare (i) and Nafion-coated (ii) electrodes before implantation 
in the brain (A) and after 28 days implantation (B) in the brain and (C) zoomed section as 
outlined by the white box.  Scale bar A-B 500 µM, scale bar (C) 100 µm. 
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Figure 6.4.  EDS spectra of chronically implanted electrodes.  Representative EDS spectra 
for Ag/AgCl reference electrodes uncoated before brain implantation (A), Nafion-coated 
before brain implantation (B), uncoated after 2 weeks brain implantation (C), and Nafion-
coated after 2 weeks brain implantation (D).  Peaks are labeled indicating the atom they 
represent.  (E) Atomic percent fluorine on the surface of Nafion-coated electrodes after 0, 7, 
14, and 28 days brain implantation (*p<0.05, ***p<0.001, one-way ANOVA with appropriate 
post-hoc test compared to 0 days).  (F) Normalized, atomic percent chlorine on the surface 
of Nafion-coated (white) and bare (black) electrodes after 0, 7, 14, and 28 days brain 
implantation (student’s t-test were performed on unpaired data, *p<0.05 was taken as 
significant). 
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(peak at 2.3 keV) and fluorine (peak at 0.7 keV), key components of the non-polar per-
fluorinated coating.  After 14 days, additional peaks can be observed on the bare electrodes 
including carbon and oxygen (peak at 0.6 keV).  This confirms that the compositions of the 
hard plaques apparent in Figure 6.3 are organic, providing yet more evidence that cells are 
adsorbing to the bare electrode surface.  We can quantify the Nafion levels on the electrode 
surface by measuring the atomic percent of fluorine as implant time was increased. Figure 
6.2E shows that the content of fluorine on the surface of the electrode is around 60% before 
implantation.  After 7 days, the content is around 50% (p<0.05 compared to pre-
implantation).  At 14 days, the fluorine content is around 30% (p<0.001 compared to pre-
implantation) and dramatically lower after 28 days at around 7% (p<0.001 compared to pre-
implantation).  These data quantifiably support the visual observation from Figure 6.3 that 
the Nafion coating becomes unviable after 28 days. 
Conclusion 
These studies support the notion that the Nafion coatings on reference electrodes are stable 
up to 28 days in the rat brain.  Voltammetric signals both in vitro and in vivo show that 
electrochemical shift of the signal can be eliminated by coating the reference electrodes with 
a thick layer of Nafion to protect it.  Cell adsorption onto the reference electrodes is 
consistent with the loss of chlorine on the surface and subsequently with the electrochemical 
shift.  Viable Nafion coatings prevent cell adsorption, maintaining the chlorine layer, hence 
preventing electrochemical shifts. 
Dr. Parastoo Hashemi is gratefully acknowledged for her contribution to the work of 
studying the voltammetric signal before and after Nafion coating the electrodes. 
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